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ABSTRACT 
The current sequential explanatory mixed-methods study investigated the relation of 
trait anxiety and health outcome variables (pain intensity, depression, quality of life, 
hospitalisation frequency) in Sickle Cell Disease (SCD). SCD is a hereditary blood 
disease that causes frequent pain in people with the disease. Pain management is a 
goal of disease management in SCD. Trait anxiety was used as a hyper-vigilance 
construct to investigate the relationship between hyper-vigilance and health 
outcomes in SCD and across an illness comparison group (Blood Cancer, BC) and 
an illness exposure control group (Carers). Participants (N = 51) completed online 
self-report measures of anxiety, depression, pain intensity and quality of life.  
Hierarchical regression results showed that the variance in trait anxiety was 
significantly predicted by: depression scores (48.1%, p = .001) and quality of life 
scores (27.1%, p = .001) in the complete sample (SCD, BC, Carers); and by 
depression scores (67.2%, p = .001) and quality of life scores (17.7%, p = .021) in 
the complete SCD sample (n = 28). Multivariate results with equal group sizes (n = 
24) revealed the SCD group experienced significantly greater sensory pain (p = 
0.018) and lower general health (p = 0.019) relative to Carers. The SCD group also 
experienced significantly lower depression (p = 0.044) relative to the BC group 
despite having similar levels of trait anxiety as the BC group. Thematic analysis of 
qualitative semi-structured interview data revealed six themes: pain appraisal, 
purpose and change in identity, coping strategies, anger and frustration, social 
construction of illness and personal control. Data integration showed hyper-vigilance 
behaviour was more prominent in SCD, relative to BC and more likely to be used as 
an adaptive coping strategy in pain monitoring and prevention, or in pain adjustment. 
Counselling psychologists and healthcare practitioners may need to consider that 
reducing hyper-vigilant behaviour in SCD may increase pain experience and affect 
pain management negatively.  
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Chapter 1: Introduction 
 Sickle Cell Disease (SCD) is one of the most common single gene disorders 
in the world (Rees, William & Gladwin, 2010). There are 250 000 people in the 
United Kingdom (UK) who are carriers of the sickle cell gene and 13 500 people who 
have SCD (National Health Service; NHS, 2006). In addition, Brousseau, Panepinto, 
Nimmer & Hoffman (2010) estimated that 89 000 people have the disease in the 
United States (US). Consequently, it is the most common inherited blood disorder in 
the UK (NHS, 2006; Rees et al., 2010) and in the US (Brousseau et al., 2010; 
Hassell, 2010). These figures indicate the presence of SCD in countries outside the 
geographical areas where there is a selective advantage for people who are carriers 
of the gene, but do not have the disease itself; resistance to malarial parasites in the 
red blood cells is increased in people who are carriers of the SCD gene and also, to 
a lesser extent, in people who have the disease (Rees et al., 2010).  
 Rationale for the Current Study 
 SCD has traditionally been conceptualised and managed using the medical 
model (Anie, 2005; Anie & Green, 2002; Rees et al., 2003), which focuses on the 
biological and physical symptoms of the disease and on medication adherence. 
Psychological interventions are used to assist disease management in SCD (Anie, 
2005; Midence & Elander, 1994; Rees et al., 2010); managing pain symptoms in 
particular. Reporting the development or efficacy of psychological interventions for 
ongoing management of SCD is in its infancy in academic research (Anie & Green, 
2002; 2012). Only 11 research papers (randomised or quasi-randomised 
methodologies) reporting the efficacy of psychological interventions for the ongoing 
treatment of SCD emerged in an international review in 2012, six of which were 
suitable for the review: Borroffice (1991), Broome, Maikler, Kelber, Bailey & Lea 
(2001), Gil et al. (1996), Gil et al. (1997), Kaslow et al. (2000) & Thomas, Dixon & 
Milligan, 1999 (Anie & Green, 2012). Anie & Green (2012) reported that cognitive-
behavioural therapy (CBT), psycho-education and psychodynamic psychotherapy 
were the main psychological interventions used in SCD to support ongoing disease 
management.  Anie & Green (2012) only reviewed randomised or quasi-randomised 
studies in their report; however, other non-randomised studies have suggested the 
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usefulness of including psychological interventions in the ongoing management of 
SCD (Cummins & Anie, 2003; O’Connell-Edwards et al., 2009; Thomas, Wilson-
Barrett & Goodhart, 1998). These papers were not included in Anie & Green’s (2012) 
review because they were not thought to be methodologically rigorous; however, the 
results from these studies do indicate that there are different methodological ways of 
demonstrating psychological relevance in SCD management, including mixed 
methods studies and cross-sectional studies. It is apparent that whilst psychological 
research in SCD exists, there is room to add to this literature through mixed-methods 
research. It is important to hear the participants’ voices and their perspectives of 
their problems, in order to make subjective sense of measurable objects i.e. pain 
experience (Bhaskar, 1998).  
An important psychological variable to consider in pain management is trait 
anxiety. Trait anxiety (as opposed to state anxiety) is considered to be an enduring 
personality trait or an enduring characteristic (Block, 2002; Spielberger, O’Neil & 
Hansen, 1972; Spielberger & Smith, 1966; Spielberger & Vagg, 1984). Individuals 
with high trait anxiety show a constant awareness of potentially impending primary 
anxiety, rather than anxiety in response to the presentation of an actual anxiety-
causing trigger (Block, 2002; Spielberger et al., 1972). According to Spielberger’s 
state-trait model (Spielberger et al., 1972; Spielberger & Vagg, 1984), external 
stimuli (environmental, social or situational stressors), as well as internal stimuli 
(thoughts, feelings and biological needs), are appraised in a way that either induces 
anxiety in a person or not. The appraisal of the stimuli is thought to be a function of a 
person’s level of trait anxiety (Spielberger et al., 1972; Spielberger & Vagg, 1984). If 
the stimuli are cognitively appraised as being threatening, defence mechanisms are 
engaged that adjust for avoiding or reducing the threat to the person, which in turn 
causes behavioural change. Trait anxiety, as measured on the State-Trait Anxiety 
Inventory (STAI-T; Spielberger, Gorsuch, Lushene, Vagg & Jacobs, 1983), is known 
to be stable over time and is, therefore, considered to be a measure of dispositional 
tendency towards anxiety. Research has shown that the trait anxiety personality type 
does bias the memory for items that cause worry and elicits the fear response in the 
presence of these items (Reidy, 2004) and creates a bias towards negative events 
associated with these items (Eysenck & Derakshan, 1998). In addition, Eysenck 
(1992) reported a hyper-vigilance theory that proposed that hyper-vigilance caused 
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by high levels of trait anxiety influences the cognitive vulnerability factor for clinical 
anxiety. Hyper-vigilance has been defined as the behaviour of constantly scanning 
the body for somatic sensations; pain in particular (Chapman, 1978). High trait 
anxious participants have been found to perceive and detect threats faster than low 
trait anxious participants in a study that aimed to examine the relationship between 
threat estimation and trait anxiety (Longin, Rautureau, Perez-Diaz, Jouvent & Dubal, 
2013). From these findings it was suggested that the hyper-vigilance to a threat may 
be adaptive in a person when it increases the ability and the speed of detecting risks 
and increases the speed with which these risks can be avoided. High levels of trait 
anxiety have been associated with chronic pain diseases, such as fibromyalgia 
(Crombez, Eccleston, Van den Broeck, Goubert & Houdenhove, 2004), rectal cancer 
(Ristvedt & Trinkaus, 2009) and SCD (Burlew, Telfair, Colangelo & Wright, 2000; 
Thomas et al., 1998; Thomas et al., 1999). Thus, the role of trait anxiety across 
these illnesses may differ due to the different presentations and aetiologies of these 
diseases. Despite this observation, very little research has focused on the 
relationship between trait anxiety and health outcomes, especially in relation to SCD. 
The current study aims to focus on how psychological variables interact with 
health outcomes in SCD by focussing specifically on trait anxiety and pain 
management. This study aims to gain an appreciation and an understanding of the 
role of trait anxiety in pain management in SCD. It is hoped that attempting to 
understand the underlying role of trait anxiety will improve the efficacy of 
psychological interventions in future studies and will demonstrate how a critical 
realist approach to SCD can help to reveal that there are different levels of anxiety in 
the disease. The next section will describe the presentation, aetiology and 
management options for the disease to demonstrate the practical and emotional 
difficulties of living with the disease. Demonstrating these difficulties will highlight the 
relevance of including psychological perspectives and interventions in pain 
management for SCD. 
Sickle Cell Disease 
 SCD is the term used to define a group of blood disorders that are caused by 
an inherited, mutated single recessive gene that causes the protein bonds that hold 
a blood cell’s shape to change from creating a healthy round shape to creating an 
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incorrect sickle shape (Elander, 2007). Sickle cells are elongated red blood cells that 
give the blood cell a crescent shape rather than the normal round disc shape when 
oxygen concentrations in the red blood cells are lowered (Elander, 2007; Idemudia, 
Helen, Kolawole & Morenike, 2001). This results in a lack of oxygen in cells and a 
lack in capacity to transport oxygen to other red blood cells. In addition, the irregular 
shape of these crescent-shaped cells causes blockages in blood vessels.  
Sickled-blood cells obstruct the blood vessels due to the incorrect shape of 
the red blood cell, which leads to pain in bones, organs and muscles (vaso-occlusive 
crises; Rees et al., 2010; Shapiro, 1997). Vaso-occlusive crises can also lead to 
subsequent organ damage, an increased likelihood of blood clots and strokes and an 
increased vulnerability to infections, especially if the spleen has had to be removed 
due to the disease (Sogutlu, Levenson, McClish, Rosef & Smith, 2011). 
Consequently, SCD is a multi-systemic disease (it affects all the blood vessels in the 
body, and therefore all the systems e.g. cardiovascular, immune, respiratory 
systems) with a range of acute and chronic symptoms and effects which also 
includes experiencing varying degrees of anaemia which affects physical mobility 
and functionality (Anie, Egunjobi & Akinyanju, 2010; Anie & Green, 2012). A vaso-
occlusive crisis can last from a few hours to a few weeks depending on the severity 
of the form of disease (NHS, 2006) and can be frequent and unpredictable. 
Consequently, frequent hospitalisations, increased risk of bacterial infection, chronic 
organ damage and reduced life expectancy all become part of life for the sufferer 
(Idemudia et al., 2010). The physical symptoms of the disease can have acute or 
chronic effects on the body. This and the unpredictable nature of the disease can 
affect psychological processes associated with disease management. 
The most common form of SCD is sickle cell anaemia HbS/S which accounts 
for approximately 70% of SCD presentations (Rees et al., 2010). Other forms of SCD 
include different strains of sickle cell anaemia and numerous thalassaemia strains 
(Rees et al., 2010). Thalassaemia is a form of sickle cell disease where the red 
blood cells do not contain sufficient haemoglobin to transport oxygen through the 
body (Anie & Massaglia, 2011). There can be an overload of iron compounds in the 
body’s systems (Anie & Massaglia, 2011), however, thalassaemia is not 
predominantly identified by pain experience (Rees et al., 2003), whereas acute, 
chronic and/or recurring pain (vaso-occlusive crises) is a significant symptom of 
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sickle cell anaemia (Rees et al., 2003; 2010). It is reasoned that the longevity and 
the life-threatening nature of SCD can affect the perception and management of the 
disease. 
 Aetiology 
 The disease manifests from as early as six months after birth and is caused 
by the inheritance of a single sickle haemoglobin recessive gene from both parents 
(Anie, 2005). The sickle cell gene is thought to have evolved as an evolutionary 
adaptation against malaria and is subsequently prevalent on the African and Asian 
continents where malaria is prevalent and in the African and Asian Diaspora that 
originated from these continents (Anie & Green, 2012; Idemudia et al., 2001; Rees et 
al., 2010). It is believed that the advantage of being a carrier of the gene (having one 
copy of the gene, compared to two copies of the gene as in those with SCD) is that 
the presence of sickle cells in a smaller proportion of the blood in gene carriers (and 
in SCD to a lesser extent) prevents malarial parasites from being able to populate 
these cells (Rees et al., 2010). Therefore, the malarial parasites are unable to 
spread and populate adjacent blood cells subsequently killing the host by causing 
strokes, by preventing the transport of oxygen through the body or by killing red 
blood cells (Idemudia et al., 2001). Nigeria is thought to have the largest population 
with SCD in the World (Anie et al., 2010; Taylor, Stotts, Humphreys, Treadwell & 
Miaskowski, 2010), but the disease is also prevalent in other African countries, in 
Saudi Arabia, the Mediterranean, the Caribbean, India and the U.S. (Idemudia et al., 
2001) and exists worldwide due to migration.  
Disease Management 
Disease management primarily involves medication and regular medical 
monitoring to reduce the likelihood of blood clot formation and anaemia (Rees et al., 
2003; 2010). Folic acid, antibiotics, analgesics, hydroxyurea (a form of 
chemotherapy), blood transfusions and anti-coagulant medication for blood clots are 
the usual methods of managing the disease (Cummins & Anie, 2003; Rees et al., 
2003; 2010). Pain medication and antibiotics are administered frequently for 
managing pain and reducing the risk of infection, respectively (Adam, Telen, 
Jonassaint, De Castro & Jonassaint, 2010). Bone marrow transplants in children are 
the only cure for SCD and the procedure is rarely used due to a lack of compatible 
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bone marrow donors and the high risk surgery complications associated with the 
procedure (Rees et al., 2010). Psychological therapy may also be provided to assist 
with managing the illness (Anie & Green, 2012; Cummins & Anie, 2003; Thomas et 
al., 1999). 
Treatment for SCD is a combination of medical and psychological 
interventions. Of the limited studies of the different types of psychological 
interventions for pain in SCD, the cognitive-behavioural strategies are the most 
thoroughly researched (Anie & Green, 2012). SCD patients have been found to have 
high levels of anxiety and depression (Levenson et al., 2008; Thomas et al., 1998) 
and low levels of self-efficacy and illness identity (Idemudia et al., 2001; Thomas et 
al., 1999). In SCD, active pain management is very important outside of hospitals as 
approximately 90% of emergency hospital admissions in SCD are for managing pain 
crises (Thomas, Hambledon & Serjeant, 2001). Therefore, developing pain 
management strategies may help to prevent hospitalisation for pain. In addition, 
management strategies that avoid negative thinking about pain and avoid passive 
coping have been shown to predict better pain outcomes in the disease (Anie et al., 
2012; Midence & Elander, 1994). Negative emotional responses to pain have been 
found to be associated with impaired quality of life, higher levels of distress and 
anxiety and more frequent hospitalisations (Anie, Steptoe & Bevan, 2002; Anie et al., 
2012). Highlighting the psychological indications of the disease helps to clarify how 
psychological factors can affect the physical factors of the disease. There may be 
psychological differences between children, adolescents and with adults with SCD 
as these different populations may be affected by differences in age and maturation-
related processes. Therefore, it is important to focus potential research on a specific 
age group: across age-groups, or over the lifespan cohorts, rather than as a 
combined group.  
Investigating Psychological Differences in Adults  
The decision to focus solely on adults in the current study was informed by 
the participant bias of past academic studies. There are comparatively fewer 
academic studies examining psychological variables or interventions in adults with 
SCD; the majority focus on children and adolescents (Anie, 2005; Burlew et al., 
2000). One of the reasons suggested for this literature imbalance was that 
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previously, patients with SCD were likely to die before the age of 30 (Platt, 
Thorington, Brambilla, Milner & Ross, 1991), therefore research was conducted with 
the age groups that would benefit from subsequent psychological interventions i.e. 
children and adolescents. Recent reviews of life expectancy in SCD (Claster & 
Vichinsky, 2003; Taylor et al., 2010) have reported that the average life expectancy 
for a person with SCD has increased to between approximately 42 to 50 years of 
age for both men and women. The life expectancy has increased partly because 
treatment and disease management strategies have improved (Rees et al., 2010) 
and are more readily available (Rees et al., 2003; 2010). The rationale for only 
selecting adult participants for this study emerged from the need to contribute to the 
psychological literature on adults with SCD. 
There are psychological consequences of having relatively low life 
expectancies in SCD. Taylor et al. (2010) reported that the average life expectancy 
for a person with SCD was 42 years for women and 48 years for men in the US. 
Claster & Vichinsky (2003) identified the life expectancy as being 50 years for both 
men and women. However, the average life expectancy in the UK is 77.7 and 81.9 
years of age for men and women respectively (Office of National Statistics, 2010); 
and 75.6 and 80.8 years of age for men and women in the U.S respectively (United 
Nations, 2006). These figures show the contrast in life expectancy for the person 
with SCD. This and other factors e.g. frequent hospitalisation for pain crises (Anie et 
al., 2012) and psychological distress caused by the disease (Citero et al., 2007; 
Levenson et al., 2008; Thomas, et al., 2001) can affect pain experience and 
management in adults (Elander & Midence, 1996; McClish et al., 2005; Smith et al., 
2005) and affect receptiveness to medical and psychological treatment (Caird, 
Camic & Thomas, 2011; Jenerette, Brewer & Ataga, 2014). The presence of these 
factors indicates a specific need to develop and improve the psychological 
understanding of disease management in SCD and this can be achieved by 
focussing on the psychological aspects of SCD, which was the intention of the 
current study. 
Current Study 
The current study employed a two-phased sequential explanatory mixed 
methods design (Creswell & Plano Clark, 2006) to explore the nature of the 
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relationship between psychological factors (e.g. trait anxiety) and how they affect 
pain management in SCD in adults. The study aim was to contribute to the 
psychological literature on adults with SCD in order to develop a greater 
understanding of psychological variables relevant to pain management in SCD. This 
was achieved by focussing on the role of trait anxiety in pain management. In 
addition, as the study examined the effect of trait anxiety in SCD, it was important to 
study a demographic that had more stable and identifiable traits i.e. in adults, rather 
than in children and adolescents who were still developing cognitively and 
emotionally.  
This thesis continues by discussing the contribution of this study to 
counselling psychology and discussing the epistemological framework of the study. 
The literature review discusses theories of pain management in SCD, pain 
management and trait anxiety studies relevant to this study and how these past 
studies have informed the development of the research questions in this study. The 
methodology chapter reports the mixed-methodology used to investigate and explore 
the effect of trait anxiety in SCD. The two subsequent chapters report both the 
quantitative and qualitative analyses separately. The findings reported in the 
quantitative and qualitative chapters are triangulated and critically discussed in the 
discussion chapter, where limitations of the study and implications for future 
research are also discussed. 
 Contribution to Counselling Psychology 
 The current study hypothesised that high levels of trait anxiety manifested 
differently in SCD compared to another ill group. Rather than trait anxiety being 
perceived as maladaptive, as previous research has suggested in SCD (Thomas et 
al., 1998; 1999) and in other general chronic pain conditions (Tang et al., 2009; Van 
Esch, Roukema, Van der Steeg & De Vries, 2011), I suggest that high levels of trait 
anxiety are adaptive and are possibly advantageous in SCD given that elevated trait 
anxiety may facilitate disease monitoring and pain management. It is also suggested 
that high trait anxiety in SCD may affect the efficacy of psychotherapeutic 
interventions, CBT in particular and such a suggestion warrants further research in 
future studies. Investigating and exploring the former suggestion could add to the 
knowledge about the role of trait anxiety in SCD and help to understand how to 
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incorporate this role in psychological interventions for pain management. It is 
tentatively suggested that using CBT to manage anxiety and depression in pain 
management for SCD may be counter-productive if the role of trait anxiety is not 
understood properly. To explain further, it may not be helpful to reduce hyper-vigilant 
behaviour (measured by trait anxiety), through CBT interventions for anxiety, in 
people who use hyper-vigilance to monitor and manage their pain. Using hyper-
vigilance to monitor and manage pain could be considered to be advantageous in a 
person experiencing chronic or recurring pain. Understanding how trait anxiety and 
its relationship with health outcomes (hospital admission frequency, depression, 
quality of life and pain intensity) impacts on pain management in SCD may help 
healthcare providers treat SCD more effectively and may inform the debate about 
the importance of pain monitoring and hyper-vigilance behaviours in SCD. This may 
be of particular interest to counselling psychologists and other practitioner 
psychologists who practice in pain management. It is important to clarify the 
perspective of this current study, as this will help the reader to understand its 
premise; this is discussed in the following section. 
Epistemology 
Counselling psychologists are trained as scientist-practitioners (Blair, 2010); 
the implications of which means that counselling psychologists, like other practitioner 
psychologists, are often negotiating conflicting ideologies, frameworks and 
paradigms due to the multi-disciplinary nature of their work and the union with the 
different counselling frameworks that emphasise subjective meaning and 
interpretation (Gil-Rodriguez & Hanley, 2011). Kasket (2012) argues that counselling 
psychologists are unique in the applied psychological sciences for having a 
pluralistic approach to research and its applications; that the counselling 
psychologist researcher has to be open to exploring all the paradoxes and research 
paradigms available in order to explore research questions in a manner that is akin 
to the profession’s philosophy. Gil-Rodriguez & Hanley (2011) reflected that contrary 
to Kasket’s (2012) aforementioned opinion, the majority of the contributions to the 
Counselling Psychology Review, a British Counselling Psychology journal, were 
qualitative paradigms. This suggests that there is a subconscious drive to encourage 
qualitative worldviews in counselling psychology. Despite this subconscious 
methodology drive, counselling psychologists are able to use quantitative, qualitative 
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and mixed-method methodologies to answer research questions. These research 
methodologies are determined by philosophical perspectives (Plowright, 2011) i.e. 
post-positivist, social constructionist, advocacy/participatory or pragmatic 
perspectives (Creswell, 2009). According to Blair (2010) and Kasket (2012), 
research methodology decisions should not be limited to personal philosophical 
perspectives, but rather should be determined by identifying the best approach to 
explore and/or examine the research question.   
The traditional bipolar paradigms of positivism and constructivism (Plowright, 
2011) lend themselves to quantitative and qualitative approaches respectively, and 
the remaining paradigms sit at varying points between the two. Positivism is the 
absolute realist perspective of the world (Plowright, 2011) which has evolved to post-
positivism, which assumes that outcomes can be influenced by changing variables 
and acknowledging that there is no absolute truth (Creswell, 2009). The post-
positivist view is, however, reductionist and includes empirical observation and 
measurement and theory verification (Robson, 2002).  In contrast, the social 
constructivist view claims that reality is dependent on the individual and is 
subsequently constructed through social experience (Plowright, 2011). Robson 
(2002) adds that social constructivists assume that individuals seek understanding of 
the world that they live in by developing subjective meanings of their experiences. 
This view is about understanding multiple participant meanings, social and historical 
construction and generating theory (Creswell, 2009). Kasket’s (2012) vision of the 
counselling psychologist researcher was that rather than focussing on research 
methods, the researcher should prioritise finding the best method of answering a 
research question by using both approaches in one study. Whilst this idea is noble, 
practicalities of agendas, time constraints and transferability can make combining the 
approaches difficult to achieve in reality (Howe, 1988; Plowright, 2011; Tashakorri & 
Teddlie, 1998). Merging the two paradigms can be achieved by critically evaluating a 
realist perspective (Bhaskar, 1998; Howe, 1988). 
Traditional perspectives of realism are grounded in positivism, but modern 
perspectives of realism are positioned between post-positivism and social 
constructionism. Realism shares features with both of these paradigms, of which 
there are two forms: empirical realism and critical realism (Bryman, 2008). Empirical 
realism proposes that if researchers use the appropriate methods to study the social 
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world, they can really understand what reality is. In contrast, critical realism argues 
that there are differences between objects and the terms used to describe and 
understand them (Bhaskar, 1975). Considering both these stances, it could be 
suggested that critical realism acknowledges that there are real objects in the world 
that are perceived and utilised individually, whereas empirical realism suggests that 
all objects, even those perceived subjectively can be measured and observed if the 
correct methodologies are used, thus lending itself to reductionism. It can thus be 
deduced that studies embracing the realist philosophy employ qualitative and/or 
quantitative methods. 
A critical realist philosophy guided the formulation of this study’s objective and 
methodology. Bhaskar (1975; 1998) suggested that critical realist research 
organically identifies a research question that can be observed and measured in 
reality, but requires an exploration of subjective phenomena to hypothesise 
mechanisms that can be used to explain certain outcomes. This current study follows 
a perspective that rejects the traditional dualisms; constructivism did not allow for 
variables to be observed, which was necessary to suggest a relationship between 
variables i.e. to measure trait anxiety as a specific type of anxiety and to show that a 
relationship existed between trait anxiety and health outcomes in SCD. However, 
empiricism did not allow for the interpretation of subjective meaning, which is an 
important social construct and part of human experience and of relating to the world 
(Stone & Elliott, 2011). Being able to explore human experience was particularly 
relevant to this study – it was important to hear the participants’ voices and how they 
experienced their illnesses; the experience of chronic pain and chronic illness is an 
extremely personal one and different phenomena can emerge from this type of 
research question. Insight into subjective phenomena is invaluable and cannot be 
explored without prior indication or insight. Robson (2011) confirmed this idea by 
positing that the world cannot be reduced to absolutes because it can also be 
constructed individually, for which there are an infinite number of experiences or 
responses. The critical realist position understands the philosophical integration of 
objective and subjective meanings in a method that lends itself well to the 
philosophical underpinnings of counselling psychology (BPS, 2005) and the 
generation of this current study was based on this ontology.  
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 In summary, this chapter reported the study’s objective, the epistemological 
framework of this study and the importance of investigating psychological variables 
that may influence or affect pain management in SCD. It was important to establish 
the framework of the study and show the perspective and intention with which the 
researcher followed to identify and attempt to answer the research questions. The 
next chapter will review theories and research on pain management in SCD. The 
research objectives, hypotheses and questions can be found at the end of the 
literature review. 
Chapter 2: Review of the Literature 
This chapter presents the relevant literature on SCD and pain management. 
The chapter reviews psychological aspects shown to be related to pain management 
in SCD and identifies trait anxiety and its relationship to certain health outcomes as a 
psychological construct that requires further investigation in SCD. There are no other 
identified studies specifically investigating or exploring the relationship of trait anxiety 
with health outcomes in the management of pain in SCD. Subsequently, this study 
proposed that investigating this set of relationships is important because high levels 
of trait anxiety may represent an adaptation to monitoring physical symptoms of the 
disease (through hyper-vigilance), thus enabling SCD patients to prevent or prepare 
for painful crises, subsequently managing their pain. This chapter is organised to 
show the relevance of investigating trait anxiety and its relationship with pain 
management in SCD and concludes with the objective of the study and the research 
questions that were investigated and explored in this study. 
This review is based on published psychological quantitative and qualitative 
literature. Electronic searches of medical and psychological databases (Academic 
Premier, Cinahl+, Embase, Psychinfo, Psychlit, PubMed and The Cochrane Library) 
were conducted mainly focussing on SCD-specific papers and these key search 
terms: trait anxiety, mood, pain, pain management and quality of life. The inclusion 
criteria included English language publications and publications from and including 
1992 to the present (2014). Papers were excluded if they were not reports or 
reviews. The focus of this study was adults with SCD; therefore, whilst this review 
does not specifically discuss studies concerning children and adolescents, a few 
studies concerning this age group have been referenced where they support or 
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disagree with a critique in the review. There are variations in the design, consistency 
and rigour of the findings presented in this review, therefore the findings are collated, 
criticised and presented tentatively. The content of this review includes sub-sections 
on pain theories, pain management research and psychological variables specific to 
SCD. This chapter concludes with a summary of the literature review addressing the 
knowledge gap highlighted by the literature review and with the research questions 
of this thesis. 
Theories of Pain used in SCD Management 
 The experience of acute and chronic pain in SCD is a complex subjective and 
multidimensional experience influenced by biological, psychological, environmental 
and sociological factors (Anie et al., 2002; Elander & Midence, 1996; Gil et al., 2004; 
Taylor et al., 2013). Acute pain is defined as pain that lasts six months or less 
(Ogden, 2012) and can be managed through hospital treatments or medical therapy 
(British Pain Society, 2010; Rees et al., 2010). Chronic pain, in contrast, lasts longer 
than six months and can vary in severity, or become increasingly worse due to 
worsening physical conditions (Jenerette & Lauderdale, 2008; Rees et al., 2010).  
The function of pain is to provide constant bio-feedback about the body’s 
condition (Ogden, 2012) enabling adjustments to be made to either correct or 
maintain the body’s condition. Pain has been defined as an unpleasant reaction in 
the body caused by illness and/or injury (Melzack & Wall, 1965). The definition of 
pain also incorporates emotional suffering or distress (British Pain Society, 2010). 
The experience of pain triggers help-seeking behaviour (Anie et al., 2012; Gil et al., 
2004; O’Connell – Edwards et al., 2009) for the biological causes of pain e.g. by 
attending hospital for medical treatment; the experience may also generate anxiety 
(Forand & DeRubeis, 2013; Thomas et al., 1999) and distress (Citero et al., 2007; 
Howard, Anie, Holdcroft, Korn & Davies, 2005; Thomas et al., 2001; Wellington et 
al., 2010). Pain can be caused by anxiety, or anxiety can cause pain (Linton & Shaw, 
2011). This complex relationship between anxiety and pain can influence the 
perception of pain and can increase pain sensitivity because of increased hyper-
vigilance of pain (Crombez et al., 2004) or because of a lower tolerance of pain 
(James & Hardardottir, 2002).  
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Relevant literature on chronic pain has incorporated psychological theory in 
pain models (De Vries, Van der Steeg & Roukema, 2009; Min et al., 2013; 
Salthouse, 2012; Tang et al., 2009). Melzack & Wall (1965) developed the gate 
control theory of pain (GCT) to demonstrate how using psychology improved the 
concept and understanding of pain experience. The model hypothesises that a gate 
exists at the level of the spinal cord which receives sensory input from peripheral 
nerve fibres, from descending central influences from the brain e.g. emotions, 
attention or self-efficacy; and from other large and small nerve fibres in the body 
(Brannon, Feist & Ipdegraaf, 2013). Melzack & Wall (1965) also suggested that the 
gate integrates the received information and sends information to the action system 
in the body, which results in pain perception (Ogden, 2012). The model suggests 
that whilst pain may be organic in origin, the management of pain requires a 
combination of physical and psychological assessment (Brannon et al., 2013); the 
model also suggests that the pain patient is active in their experience of pain as they 
are actively interpreting and appraising painful stimuli (Ogden, 2012) and this 
process may affect pain perception.  
The gate is thought to be opened by physical factors (e.g. injury), emotional 
factors (e.g. anxiety, depression) or behavioural factors (e.g. hyper-vigilance) 
(Melzack & Wall, 1965). Factors thought to close the gate and decrease pain are 
physical factors (e.g. medication), emotional factors (e.g. happiness, increased self-
efficacy) or behavioural factors (e.g. relaxation, distraction) (Melzack & Wall, 1965). 
This model has been criticised for assuming that pain is purely organic in origin 
(Ogden, 2012), however, this model may be more useful in certain communities 
where beliefs about origins of disease and pain conflict with the uptake of 
appropriate pain management for psychological factors (Anie, Dasgupta, Ezenduka, 
Anarado & Emodi, 2007; Asnani, Fraser, Lewis & Reid, 2010; Dennis-Antwi, Culley, 
Hiles & Dyson, 2011; Idemudia et al., 2001). In addition, the GCT model (Melzack & 
Wall, 1965) posits that hyper-vigilance behaviour (i.e. excessive monitoring and 
awareness of areas of pain) increases the perception of pain, but does not allow for 
a possible relationship between hyper-vigilance and self-efficacy in the management 
of pain. Alternatively, it could be suggested that being able to detect and 
subsequently change the course of pain precipitators in certain pain conditions could 
improve a sense of personal control over pain, thus leading to increased self-
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efficacy. Melzack & Wall (1965) posited that increasing self-efficacy would reduce 
pain perception. This paradox highlights an area in pain management that requires 
further investigation. 
Variants of this bio-psychosocial model of pain (Melzack & Wall, 1965) have 
evolved over the years (Linton & Shaw, 2011) and have been adapted for disease-
specific pain management models. There are four disease-specific models of pain in 
SCD which evolved from Melzack and Wall’s (1965) gate control theory of pain. 
These are the health beliefs in SCD model (Leavell & Ford, 1983), the biomedical 
model (Maxwell, Streetly & Bevan, 1999), the conceptual explanatory model of pain 
and utilisation over time in SCD (Smith et al., 2005), and the bio-psychosocial-
spiritual model of chronic pain in SCD (Taylor et al., 2013). All these models share 
the idea that psychological factors can influence pain perception. Where they differ is 
in the extent and depth at which the models include psychological factors.  
Smith et al.’s (2005) and Taylor et al.’s model (2013) both emphasise 
biological, psychological and sociological factors equally and in more depth 
compared to the other two models. Smith et al.’s model (2005) suggests that 
disease-related aspects, psychosocial factors and readiness variables combine to 
explain pain perception and experience over time in SCD. Smith et al.’s model 
(2005) focuses on how these variables influence healthcare utilisation, rather than 
the experience of pain, but the model does demonstrate clear directional 
relationships between the variables. Taylor et al.’s (2013) model specifically 
highlights spirituality in their model, however, they also identified that spirituality 
could be included in the social aspect of the model as a coping mechanism or factor, 
rather than as a separate variable. Quantitative and qualitative studies (Jenerette & 
Lauderdale, 2008; O’Connell-Edwards et al., 2009) both support the addition of 
spirituality to Taylor et al.’s (2013) model. Smith et al.’s (2005) model does not 
specifically focus on spirituality compared to Taylor et al.’s (2013) model, but it does 
clearly demonstrate and provide evidence for how the different elements of the 
model are linked to each other compared to the latter model. Several published 
academic papers have used and provided evidence for the conceptual explanatory 
model of pain and utilisation over time in SCD (Citero et al., 2007; Levenson et al., 
2007; 2008; McClish et al., 2005; 2006; 2009; Smith & Scherer, 2010; Sogultu et al., 
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2011). The next section will look at pain management research in SCD in relation to 
Smith et al.’s (2005) bio-psychosocial model of pain in SCD (see figure 1). 
Pain Management in SCD 
The experience of acute and/or chronic pain has been described as the 
hallmark feature of SCD (Benjamin, 2008; Rees, 2003; 2010). Disease-related 
variables (e.g. disease-type, co-morbidity, pain location) are known to be the primary 
causes of pain perception in SCD (McClish et al., 2009; Rees et al., 2003; 2010; 
Smith et al., 2005; van Tuijin, van Beers, Schnog & Biemond, 2010).  
Pain in SCD is known to be affected by: anxiety (Anie et al., 2012; Thomas et 
al., 1999), depression (Asnani et al., 2010; Grant, Gil, Floyd & Abrams, 2000; Hasan, 
Hashmi, Alhassen, Lawson & Castro, 2003; Laurence, George & Woods, 2006), 
distress (Citero et al., 2007; Howard et al., 2005; Wellington et al., 2010), quality of 
life (Adam et al., 2010; Anie, 2005; Asnani, Lipps & Reid, 2009; Gibson et al., 2013; 
Thomas et al., 2001), fatigue (Ameringer & Smith, 2011), coping (Caird, Camic & 
Thomas, 2011; Edwards et al., 2006; Jonassaint, Jonassaint, Stanton, De Castro & 
Royal, 2010), social life and relationships (Jenerette, Leak & Sandelowski, 2011; 
Thomas & Taylor, 2002; van Tuijin et al., 2010) and somatisation (Grant et al., 2000; 
McCrae & Lumley, 1998; Sogultu et al., 2011; Wellington et al., 2010). The following 
sections review the literature on these psychological variables and demonstrate 
specific gaps in the literature; some of which are included in the focus of this current 
study. 
Mood in SCD 
Pain Catastrophising 
One of the well studied aspects of mood in SCD is pain catastrophising. Pain 
catastrophising is a negative affective reaction in response to anticipated pain based 
on previously experienced pain (Citero et al., 2007). Increased pain catastrophising 
has been associated with increased anxiety and depression (Citero et al., 2007; 
McCrae & Lumley, 1998). Pain catastrophising has also been associated with 
greater perceived pain intensity and more frequent use of medical services in SCD 
due to increased somatic awareness (McCrae & Lumley, 1998). McCrae & Lumley 
(1998) examined the relationships between somatic awareness and illness worry  
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Figure 1: Draft Conceptual Explanatory Model of pain and utilisation over time in SCD 
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with pain severity and hospitalisation frequency in SCD and reported that 61.3% of 
the total variance in pain intensity in their sample was attributed to negative thinking 
and passive adherence in SCD. This finding indicated that catastrophising and 
passive coping (e.g. relying on others for support) exacerbated pain perception. In 
contrast, Citero et al. (2007) investigated the role of catastrophising in pain and 
found there were no significant differences between high-scoring catastrophisers and 
low-scoring catastrophisers in terms of pain intensity, medical service use or pain 
frequency. This finding implies that catastrophising does not affect the physical 
perception of pain in SCD. Citero et al. (2007) were not able to generalise the 
findings to other pain conditions; however the median catastrophising score in SCD 
was reported to be significantly higher than in other chronic pain conditions (Citero et 
al., 2007). Citero et al.’s (2007) finding differs from the relationship between 
catastrophising and pain intensity in other chronic pain illnesses e.g. in fibromyalgia 
(McDermid, Rollman & McCain, 1996) where higher catastrophing scores were 
related to increased perceived pain. Citero et al.’s (2007) finding suggests that 
catastrophising may have a different relationship with pain in SCD compared to other 
chronic pain illnesses. One explanation for this could be attributed to the nature of 
the longevity of SCD (from birth) and the life-threatening nature of the disease. This 
finding is an example of how a psychological construct can have different 
relationships with other psychological variables in SCD compared to with other 
chronic pain illnesses. Pain catastrophising is known to be related to negative 
thinking and depression (Barbarin & Christian, 1999) and considering how 
depression affects pain and distress in SCD may provide insight into pain 
management. 
 Depression 
There is co-morbidity of depression in SCD. Levenson et al. (2008) reported 
that 27.6% of their SCD sample (N = 308) suffered from depression and 6.5% had 
an anxiety disorder, as measured by the Patient Health Questionnaire, a screening 
and diagnostic tool for depression, anxiety and somatisation (PHQ; Spitzer, Kroenke 
& Williams, 1999). Using a widely used psychometric tool allowed for depression 
incidence comparisons to be made across SCD studies. The aim of Levenson et al.’s 
(2008) study was to investigate the impact of anxiety and depression on healthcare 
utilisation, quality of life and medication use in SCD. The study reported that the 
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depressed participants experienced pain on significantly more days (71.1%) 
compared to the non-depressed participants (49.6%), however, pain was measured 
through pain diaries rather than through a standardised pain measure e.g. the Short 
Form Health Questionnaire (SF – MPQ; Melzack, 1987). Using pain diaries instead 
of standardised pain measures decreased the reliability of the pain reports in 
Levenson et al.’s (2008) study as these pain diaries had not been validated and thus, 
it would be difficult to replicate their findings. 
Asnani et al. (2010) investigated the co-existence of depression with 
loneliness in SCD in age and sex-matched non-SCD controls. Depression was found 
in 21.6% of the SCD sample (n = 277) and in 9.4% of the controls (n = 65). These 
participants were screened using the Beck Depression Inventory II (BDI-II; Beck, 
Steer & Brown, 1996), however, the BDI-II is a depression screening tool and not a 
diagnostic tool, so conclusions about depression should have been suggested 
tentatively, rather than assertively. Asnani et al. (2010) also reported that depression 
in SCD was significantly associated with frequent hospital visits (based on the mean 
hospital visits of the SCD sample) and with frequent pain crises. Although, we would 
expect loneliness to be significantly associated with depression, Asnani et al.’s 
(2010) study reported that loneliness was significantly associated with 
unemployment and higher education attainment, rather than with depression in the 
SCD participants. It would have been interesting to subjectively explore the 
experience of loneliness in depressed SCD participants and in depressed non-SCD 
controls to allow similarities and differences in loneliness to emerge from the data to 
provide better insight into what causes depression in SCD.   
The BDI-II (Beck et al., 1996) was used to screen for depressive symptoms in 
SCD during routine visits to an SCD clinic in Hasan et al.’s (2003) study. Hasan et al. 
(2003) reported a depression incidence of 44% (N = 50) in their sample, which was 
relatively high compared to the incidence rates reported previously by Asnani et al. 
(2010) and Levenson et al. (2008). The difference between the three SCD samples 
was the sample size; Hasan et al.’s (2003) sample was comparatively smaller (N = 
50) compared to the other two studies – (N = 342) and (N = 308) respectively. Hasan 
et al.’s (2003) small sample size may not have been statistically powerful enough to 
reject their hypothesis had it been false. Hasan et al. (2003), however, also found 
significant associations between higher depression scores and poor pain control, 
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inadequate social support, low socioeconomic status and in being female. Whilst 
these depression studies report an association between hospital frequency, 
perceived pain and depression in SCD, only Levenson et al. (2008) measured how 
anxiety was related to depression and pain management in SCD. SCD studies that 
have measured anxiety and depression together have generally reported these 
variables together and termed them as the variable ‘distress’. 
Distress 
Distress is a psychological variable that combines extreme depression, 
anxiety and emotional pain (Thomas et al., 2001). Distress was not measured by a 
specific standardised measure in Howard et al.’s (2005) study which investigated the 
extent of cannabis use for pain relief and the relief of emotional distress in SCD. 
However, Howard et al. (2005) reported that 39% (N = 86) of their sample used 
cannabis specifically to relieve their distress (self reported anxiety and depression), 
compared to 52% (N = 86) who used cannabis for pain relief. These findings 
indicated that anxiety and depression were secondary factors to managing perceived 
pain in SCD. This is an important implication, because it suggests that anxiety and 
depression may not be problematic factors in SCD if pain is controlled i.e. anxiety 
and depression may be directly influenced by pain experience. However, Howard et 
al.’s (2005) study was cross-sectional; therefore the results of the study could not 
imply causation and could only indicate avenues for further research.  
Culture has also been found to be influential in the expression of distress in 
SCD. Thomas et al. (2001) investigated psychological distress and coping across a 
UK and a Jamaican SCD cohort using the STAI-T (Spielberger et al., 1983) to 
measure distress – the STAI-T traditionally measures trait anxiety and does not 
depression. Thomas et al. (2001) reported that the UK cohort had higher trait anxiety 
scores (M = 52.0, SD = 12.4) than the Jamaican cohort (M = 41.5, SD = 9.9). The 
Jamaican cohort reported less distress, lower perceived levels of pain and less 
frequent medical service use. Thomas et al. (2001) suggested that the Jamaican 
community had a more integrated sense of belonging that may have contributed to 
the Jamaican cohort experiencing less distress related to their perceived pain than 
the UK cohort and suggested that experiencing more control over pain would lead to 
lower trait anxiety in their sample. The focus on anxiety and distress in SCD is not as 
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prominent as the focus on depression and catastrophising in SCD. There appears to 
be a gap in the literature that examines the effect of anxiety in SCD and its role in 
perceived pain. 
Anxiety 
Whilst SCD literature does suggest an association between anxiety and 
perceived pain in SCD, the literature is limited in the diversity of variables assessed. 
As mentioned previously, Levenson et al. (2008) reported that 6.5% (N = 308) of 
their SCD sample met the threshold for an anxiety disorder (as measured by the 
PHQ, Spitzer et al., 1999), but the specific diagnoses of anxiety were not reported. 
Levenson et al. (2008) reported that the anxious SCD participants experienced more 
perceived pain, more distress and lower quality of life as measured by the Short 
Form Health Outcome Survey (SF – 36, Ware & Sherbourne, 1992) compared to the 
non-anxious SCD participants. Only 6.5% of the participants in Levenson et al.’s 
(2008) study registered as having anxiety problems compared to the 27.6% who met 
the threshold for depression. We would expect a similar percentage of incidences for 
both anxiety and depression given the large sample size and the similar occurrences 
of both anxiety and depression in general pain literature (Eccleston, Crombez, 
Aldrich & Stannard, 2001; Linton & Shaw, 2011), but Levenson et al.’s study (2008) 
did not reflect this. Both depression and anxiety were also measured using the PHQ, 
which may not have been sensitive enough towards anxiety (Spitzer et al., 1999), 
therefore not providing a true measure of the incidence of anxiety in their sample.  
Anxiety and depression in SCD have often been studied together. Anie et al. 
(2012) investigated the association between perceived pain, mood (anxiety and 
depression) and quality of life during hospitalisation for vaso-occlusive crises. Their 
study reported a cross-sectional directional relationship between high levels of 
perceived pain, reduced mood and low quality of life which improved during the 
hospital stay of SCD participants. One criticism of this study is that it examined 
participants in hospital for acute pain treatment. This alone biased the study, 
because the participants were experiencing high levels of perceived pain at the time 
of assessment, which may have influenced how they perceived their mood and the 
perception of their quality of life whilst in the hospital environment. Future studies 
could examine participants who are not hospitalised at the time of assessment and 
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who will be, therefore, better able to provide more accurate accounts of their general 
perceived pain. 
Separating the different types of anxiety into state and trait anxiety may also 
be beneficial to future studies. Leavell & Ford (1983) were one of the first SCD 
researchers to investigate the role of anxiety in SCD. Leavell & Ford (1983) 
investigated if anxiety mediated vaso-occlusive crises in SCD using the STAI 
(Spielberger et al., 1983). Their findings (N = 16) did not support their hypothesis that 
higher levels of anxiety mediated vaso-occlusive crises. This may have been due to 
their low sample size, which would have reduced the ability of the study to reject the 
null hypothesis (Coolican, 2001; Field, 2013). Leavell & Ford (1983) reported a trait 
anxiety score mean (M = 40.3) and a state anxiety score mean of (M = 38.4), which 
were scores that were below the clinical cut-off score of 44 (Spielberger et al., 1983) 
and indicated that their SCD participants did not have clinical levels of trait anxiety. 
Leavell & Ford (1983) did not report standard deviations and doing so would have 
shown the range of trait and state anxiety scores across their sample, which may 
have also shown that some participants may have experienced clinical levels of trait 
anxiety.  
A more recent study by Thomas et al. (2001) reported trait anxiety scores of 
(M = 52.0, SD = 12.4) in their London cohort and (M = 41.5, SD = 9.9) in their 
Jamaican cohort. The state anxiety scores they reported were (M = 50.3, SD = 11.8) 
in the London cohort and (M = 42.7, SD = 15.2) in the Jamaican cohort. These 
results indicated that the London cohort experienced higher levels of both trait and 
state anxiety than the Jamaican cohort. It is possible that the difference in anxiety 
between the two groups was related to the sense of control of pain management, 
where the Jamaican cohort felt more in control of their perceived pain. As shown, 
there are differences in types of anxiety and it is not always beneficial to a study to 
combine anxiety and depression as one variable as both depression and anxiety 
may have different associations with perceived pain in SCD. Future research in 
anxiety in SCD could focus on separating trait anxiety from state anxiety to reveal 
the associations between these forms of anxiety and pain management. 
Future research could also unpack the relationship between trait anxiety and 
depression as the relationship is unclear in both general mood and in SCD research. 
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Research indicates that high levels of trait anxiety co-exist with high levels of 
depression in breast cancer and in SCD (De Vries et al., 2009; Thomas et al. 1998), 
which is an expected finding. Interestingly, Min, Lee, Lee, Lee & Chan (2012) 
showed that depressed participants (non-pain, nor SCD) simultaneously experienced 
high levels of resilience with low levels of trait anxiety and that these participants 
responded better to anti-depressants than depressed participants with low resilience 
and high trait anxiety. This was an unexpected finding, as depressed participants 
would be expected to have low resilience and high trait anxiety as previous research 
between depression and resilience in SCD has shown (Burlew et al., 2000; Caird et 
al., 2011; Citero et al., 2007; Thomas et al., 1998). The methodological difference 
between the latter findings and Min et al.’s (2012) findings is that Min et al. (2012) 
sampled a non-clinical and non-SCD sample rather than an SCD sample, thus again 
demonstrating that psychological variables may have different relationships with 
other psychological variables in SCD. For example, Thibodeau, Welch, Katz & 
Asmundson (2013) showed, using a non-clinical sample, that trait anxiety and 
depression were not associated with pain perception, but that anxiety sensitivity was 
associated with increased pain tolerance in their sample. This finding implied that 
mood did not affect pain perception in non-clinical samples; however, previously 
cited research indicates that mood does affect pain perception in clinical samples. 
There is specific interest in how trait anxiety is associated to health outcome 
variables in other pain conditions. Ristvedt & Trinkaus (2009) found higher trait 
anxiety was associated with lower quality of life among rectal cancer participants in 
remission. Employing Watson & Pennebaker’s (1989) symptom perception 
hypothesis, Ristvedt & Trinkaus (2009) suggested that the significant relationship 
between trait anxiety and self-reported physical functioning was a consequence of 
an underlying disposition of psychosomatic distress among the participants. Thus, 
participants with high levels of trait anxiety were more likely to notice negative 
physical functioning changes in themselves than the participants with lower levels of 
trait anxiety. This conclusion would suggest that trait anxiety is part of a decision-
making process that involves consciously paying attention to and acting on physical 
changes within the body. 
Trait anxiety has been implicated in decision-making processes. Peng, Xiao, 
Yang, Wu & Miao (2014) evaluated low versus high trait anxiety groups on self-
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framing and decision-making in a sample of non-SCD university students (N = 328). 
Researchers found that the high trait anxiety group tended to make more 
conservative and less risky decisions relative to the low trait anxiety group (Peng et 
al., 2014). These authors concluded that higher levels of trait anxiety were related to 
risk avoidance and these levels caused an over-estimation of potential risks in 
participants by inducing an attention bias in the participants in the high trait anxiety 
group. This attention bias may have caused the participants in this group to prioritise 
the processing of information seen as a perceived risk to the participants (Peng et 
al., 2014). The researchers were able to suggest that these were causal 
relationships because of the experimental nature of their study; they had recalled 
previously STAI-T (Spielberger et al., 1983) assessed participants to engage in a 
controlled and manipulated decision-making task. Peng et al.’s (2014) findings were 
supported by Butler & Matthews’ (1987) theory that the purpose of trait anxiety in 
people was to induce risk avoidance of perceived risks by over-estimating potential 
risks. Consequently, people with high levels of trait anxiety may demonstrate an 
attentional bias to risk and may also present with an increased avoidance to risk, 
which may be pertinent to people who experience relatively higher levels of risk 
consistently. In chronic pain conditions, these attentional biases to risk may mean 
that trait anxiety may be related to perceived pain, if pain perception is perceived as 
a risk. 
Pain tolerance has been reported to be greater in general population 
participants with lower, rather than higher trait anxiety (James & Hardattordir, 2002). 
It was suggested that high trait anxiety fostered attentiveness to possible 
environmental threats that would increase the experience of pain (James & 
Hardattordir, 2002). This finding supports Melzack & Wall’s (1965) GCT model that 
suggests that increased attentiveness (hyper-vigilance) increases pain perception. 
Although James & Hardottordir (2002) employed the SF-MPQ (Melzack, 1987) to 
study pain, their study did not separate or report group differences in sensory or 
affective pain. It would have been useful to know if the difference in pain perception 
in this study was related to sensory or affective pain as this would have informed the 
debate on hyper-vigilance behaviour and its interaction with pain perception i.e. if 
hyper-vigilance behaviour was emotionally-driven or sensory-driven.  
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This section clarifies that there are different forms and interpretations of 
anxiety and whilst there are SCD studies that quantitatively measure anxiety, it can 
be seen that there is a need to explore subjective anxiety in order to identify and 
increase awareness of the different meanings of anxiety and the relationships that 
anxiety has with other health outcomes in SCD. 
 Somatisation  
 Somatisation is a concept that may be related to trait anxiety due to the use 
of attention for observing the body. Somatisation (pathological attention to a range of 
bodily symptoms and conditions regardless of their cause; Sogultu et al., 2011) has 
been found to predict negative psychological experiences in adults with SCD e.g. 
depression, anxiety, resistance to treatment, (Wellington et al., 2010). Findings from 
Wellington et al.’s (2010) study suggested that their SCD participants had a self-
monitoring bias that led them to be more sensitive to small changes in their health, 
especially regarding their pain intensity levels. It would have been useful if 
Wellington et al. (2010) had utilised a self-monitoring or a hyper-vigilance tool e.g. 
the STAI-T (Spielberger et al., 1983), to support their self-monitoring bias theory. 
Future research could investigate how a self-monitoring bias may affect disease 
management in SCD. In addition, Jenerette et al.’s (2014) mixed-method study 
identified a theme of ‘phases and cues’ from interviews with SCD participants (N = 
69) who indicated that they (84%) received signs and cues from their body before a 
vaso-occulsive crisis began. It could be argued that these participants may have 
used hyper-vigilance behaviour to monitor and assess these cues and signs in order 
to prepare them to either avoid or manage the impending crisis. This is not unlike 
high trait anxious individuals who also experience greater expectations of anxiety 
than low trait anxious individuals when experiencing physiological symptoms such as 
pain (Eysenck, 1992).   
Quality of Life 
Pain catastrophising, depression, distress, anxiety and somatisation are all 
variables that affect quality of life in SCD. Quality of life is the general wellbeing of a 
person and encompasses emotional, cognitive, physical and social wellbeing (Anie, 
2005; Ware & Sherbourne, 1992). Pain management plays an important role in the 
quality of life of a person with SCD and in other chronic illnesses (Anie, 2005; 
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Bennett & Nelson, 2006; Malouff, Thorsteinsson, Rooke, Bhullar & Schutte, 2008). 
Frequent opioid analgesic use is related to experiencing lower levels of quality of life 
in SCD (Adam et al., 2010), however, this finding may not be surprising if the 
relationship between opioid analgesic need and experience of pain are considered; 
general wellbeing is thought to improve when perceived pain is reduced (McClish et 
al., 2005). In addition, mood, general health and quality of life improve when levels of 
pain decrease (Anie et al., 2012). However, despite a decrease in pain levels, some 
patients (29%; N = 510) often still have residual daily pain (Anie et al.’s 2012) after 
hospital discharge. Chronic pain is often a way of life for people with SCD and 
experiencing higher levels of quality of life for these people is not synonymous with 
not experiencing any pain. Having a greater internal locus of control is related to 
higher quality of life scores and lower depression scores in SCD (Gibson et al., 
2013). An internal locus of control may be more influential to quality of life in people 
with SCD in terms of increasing the self-efficacy in managing pain, rather than trying 
to reduce perceived pain. 
Research has shown that affective coping (catastrophising, anger and fear 
self-statements, praying and hoping & isolation) is related to lower levels of quality of 
life in SCD (Anie et al., 2002). Anie (2005) surmised that quality of life in SCD was 
affected by activity and functioning and by anxiety and depression. Other research 
studies have supported this directional relationship (Levenson et al., 2008; Taylor et 
al., 2010). However, McLish et al. (2005) compared quality of life subscale scores 
from the SF – 36 (Ware & Sherbourne, 1992) to that of the general population and to 
those of other chronic disease cohorts (cystic fibrosis, haemodialysis and asthma 
participants) and found that quality of life did not affect emotional wellbeing in SCD; 
SCD emotional wellbeing scores were similar to those of the general population, but 
were better than the other chronic disease cohorts in that study. McLish et al. (2005) 
suggested that this finding could mean that the SCD participants had greater social 
support and used different coping mechanisms to reframe their illness compared to 
the other chronic disease cohorts. However, it could also be suggested that anxiety 
and depression may have different roles and/or relationships with quality of life in 
SCD and these different relationships may have mediated the more positive 
emotional wellbeing outcome.  
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The previous sections have shown that there are gaps in the literature that 
warrant further investigation, but also indicate that there appear to be different 
relationships between psychological variables in SCD compared to other chronic 
illnesses and to non-clinical samples. It is also important to consider how to improve 
the relationships between these variables so that pain management is improved and 
quality of life is more favourable for SCD sufferers. The next sections attempt to 
address this. 
Psychological Strategies for Improving Pain Management 
This section is of particular relevance to counselling psychologists because it 
relates to clinical practice and discusses some of the strategies that can be focussed 
on in clinical work with SCD.  
Social support has been found to be an influential predictor and moderator of 
pain intensity, pain frequency, anxiety and depression. A qualitative study reported 
that access to friends and family formed the context with which participants were 
able to manage their disease and their subsequent pain (Caird et al., 2011). Such 
social relationships enable the SCD sufferer to form their own identity and establish 
meaning and purpose in their life, thereby improving their quality of life (Caird et al., 
2011). However, social support received in SCD by significant others may not always 
be helpful. Edwards et al. (2006) reported that parental support offered in the context 
of substance abuse could lead to the adoption of less adaptive coping strategies e.g. 
catastrophising and to an increase in intense sensory pain experiences. Such 
support was modelled by the adult substance-abusers to their adult children whilst as 
children through social learning (Edwards et al., 2006) and was not found to be 
helpful in adjusting to the effects of the disease. Contrastingly, van Tuijn et al (2010) 
did not find that social support predicted pain experiences; they found that reduced 
quality of life was more likely to predict or be predicted by pain experiences than 
social support. This finding puts the experience of pain in SCD into perspective; the 
perception of pain is authentic, but other psychological variables can affect the pain 
experience by improving or worsening it.  
The unpredictability and variability of SCD has made it difficult for sufferers to 
relate to others and form meaningful relationships outside of their immediate families 
(Thomas & Taylor, 2002). In addition, Jenerette et al. (2014) surmised that young 
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adults with SCD found it difficult to manage their pain and care alone and required 
additional assistance from family and healthcare workers, but found it difficult to ask 
for additional help due to the stigma associated with help-seeking in SCD. Therefore, 
interventions that focus on improving and developing reliable social interactions and 
networks may be of benefit in SCD. Qualitative studies on the meaning of quality of 
life and adequate social support could help to unpack the subjective perceptions of 
these constructs and provide more meaning of the value of these constructs in 
quantitative research. 
Using adequate coping strategies can improve pain management. Midence & 
Elander (1996) suggested that the use of coping strategies was an important part of 
managing pain in SCD and that the use of passive coping strategies (e.g. isolating, 
surrendering to pain) was related to less favourable health outcomes (e.g. 
depression, loneliness). In addition, Anie and colleagues (2002) found that active 
coping (intentional efforts to minimise negative effects of pain, or trying to continue 
despite pain) was positively correlated to the number of pain episodes requiring 
hospitalisation (increased number of necessary hospital visits), whilst passive 
adherence coping was related to increased pain intensity. Resilience is thought to 
improve active coping strategies in SCD. The qualitative theme of resilience 
emerged as a factor that facilitated the use of more adaptive coping strategies in 
SCD (Caird et al., 2011). Resilience was defined as an active attempt to manage the 
disease by: creating meaning in pain and suffering by creating a positive purpose of 
having the disease; developing a personal identity independent of SCD; and by 
developing a sense of control over the disease by using positive coping strategies 
(Caird et al. 2011). This definition of resilience emerged by exploring the subjective 
experiences of resilience in SCD and substantiates the idea that it is important to 
listen to participant perspectives as well as measuring quantifiable data, because 
new themes specific to SCD can emerge that can inform the literature and clinical 
interventions. 
Being hyper-vigilant and maintaining healthy behaviours have also been 
attributed to adaptive coping.  Paying attention to bodily symptoms has been 
attributed to longevity (Jenerette et al., 2011) and to self-care (Benjamin, 2008; 
Jenerette & Lauderdale, 2008). Living beyond expectations was also found to be 
rewarding in SCD and increased positive quality of life perceptions (Jenerette & 
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Lauderdale, 2008), especially when health professionals showed surprise at the 
longevity of their SCD patients. Benjamin (2008) suggested that a palliative care 
model should be introduced in the early years of disease management in SCD and 
used as a model of care throughout life in SCD. It is a recognised, regular framework 
of intervention that has been developed to help sufferers gain more control of their 
lives and their pain, thus improving their overall quality of life over the lifespan 
(Benjamin, 2008). Marlow & Chichella (2002) reported that pain management can 
also be affected by adherence to medication and healthy-living, which supported the 
ideology of healthy-living and personal control affecting pain management.  
The consistency with which patients live their lives can also improve their 
sense of control of their condition and improve their self-efficacy and their ability to 
manage their pain. Such consistency can improve mood and quality of life, both of 
which are reported to be predictors of pain frequency and pain intensity. Abedian, 
Howard, Rawle & Thomas (2010) explored what would influence adherence when 
taking preventative medication in SCD. Four main themes thought to influence non-
compliance emerged from their study: the duration, schedule and dosage of the 
medication; the lack of immediate consequences of not taking the medication; 
difficulties in patient lifestyle and social support and physical side effects from taking 
medication over a long period of time. Abedian et al.’s (2010) study was interesting 
because it showed that despite participants knowing the benefits of taking long-term 
medication to prevent infections that they were more susceptible to, many preferred 
to take the risk of contracting an infection than to continually take antibiotics over a 
long period of time. Perceived risk and/or benefits of taking medication would fall into 
the ‘readiness variables’ part of Smith et al.’s (2005) conceptual model. According to 
the literature, perceived risk is influenced by medical complications and by types of 
treatment, but Smith et al.’s model (2005) does not reflect this direct link between 
disease-related variables and readiness variables. 
Psychological support and interventions have been used to improve pain 
management strategies. Thomas et al.’s (1999) study examined the effect of a CBT 
intervention on pain management in SCD. The general results supported a CBT 
intervention for pain management; although the effects of this CBT intervention were 
short-term (baseline levels of anxiety and depression returned six months post-
intervention). One suggestion for this post-intervention finding could be that CBT 
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reduces hyper-vigilant behaviours in SCD, which would increase pain perception in 
the long-term, thus causing a return to hyper-vigilant behaviours over time and a 
return to baseline levels of anxiety and depression. Contrastingly, Cummins & Anie 
(2003) used a cross-sectional exploratory study to investigate how quality of life, 
anxiety and depression and pain differed in SCD participants (N = 36) who attended 
a CBT group (n = 21) compared to those in a hydroxyurea pharmacological 
intervention group (n = 15). Whilst the participants in the CBT intervention group 
reported a higher pain frequency than the pharmacological intervention group 
participants, quality of life scores, hospital admission duration and psychological 
coping improved favourably in the CBT group compared to the pharmacological 
group (Cummins & Anie, 2003). Mood, however, was not improved in either 
intervention, which might indicate, in this study, that mood had a different causal 
relationship in pain management, or that the instrument used to measure mood 
(Hospital Anxiety and Depression Scale, HADS; Zigmond & Snaith, 1983) was not 
sensitive enough to pick up changes in anxiety and depression in the study.  
Alternative and more sensitive mood-specific measures e.g. STAI-T (Spielberger et 
al., 1983) or BDI-II (Beck et al., 1996) could be used instead of a unitary measure. 
The study may also have been more sensitive to mood changes if the numbers of 
participants had been more equal. 
It is important to briefly discuss the stigma of having the disease as perceived 
and actual stigma about the disease impacts on pain perception, pain management 
and the utilisation of healthcare services (Anie et al., 2010; Elander, Lusher, Bevan, 
Telfer & Burton, 2004; Jenerette & Brewer, 2010; Maxwell et al., 1999; Thomas & 
Cohn, 2006). The stigma around having the disease partly concerns being labelled 
or thought of as a ‘drug addict’ by hospital staff, which can lead to mistrust in hospital 
staff and neglect in hospital care (Maxwell et al., 1999). Mistrust and neglect can 
lead to low mood and anxiety about hospitalisations (Jenerette, Funk & Murdaugh, 
2005; Jenerette et al., 2014) and can be a barrier to seeking help for pain (Elander, 
Marczewska, Amos, Thomas & Tangayi, 2006;  Elander, Beach & Haywood, 2011; 
Thomas & Cohn, 2006). Young adults with SCD avoided attending Accident and 
Emergency departments in hospitals when they were in pain because of the non-
effective treatment they received in the past, either through hospital staffs’ lack of 
knowledge about how to manage their illness, or through the perception that SCD 
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patients were ‘drug addicts’ (Jenerette et al., 2014). Avoiding medical attention in 
hospitals can be detrimental in SCD as these patients do not access the pain relief 
that they need during vaso-occlusive crises and may exacerbate their condition by 
not receiving adequate medical attention. 
Other Pain-Related Variables in SCD 
So far, this literature review has focussed on mood, quality of life, 
somatisation, psychological strategies and stigma in SCD. Other pain-related 
variables in SCD concern differences and personal experiences in: gender (Leavell 
& Ford, 1983; McClish et al. 2006; Solomon, 2010), religion (Bediako et al., 2011; 
Jenerette et al., 2011; Sanders, Labott, Molokie, Shelby & Desimone, 2010), culture 
and identity (Rouse, 2011; Royal, Jonassaint, Jonassaint & Castro, 2011), medical 
attention, use and adherence (Abedian et al., 2010; Jegede & Rawle, 2008; Marlowe 
& Chichella, 2002), addiction (Elander, Lucher, Bevan, Telfer & Burton, 2003; 
Elander et al., 2006; Howard et al., 2005; Shapiro, Benjamin, Payne & Heidrich, 
1997), physical functionality (Jenerette & Maurdaugh, 2008; Pells et al., 2005; 
Swanson, Grosse, Kulkarni, 2011), professional support (Elander et al., 2011; 
Maxwell et al., 1999; Thomas & Cohn, 2006), barriers to help-seeking (Marlow & 
Chichella, 2002; O’Connell-Edwards et al., 2009), stigma (Jenerette & Brewer, 2010; 
Marsh, Kamuya & Molyneux, 2011) work and employment (Barbarin, Whitten, Bond 
& Conner-Warren, 1999; Gil et al., 2004., Laurence et al., 2006) and lastly, education 
(Barbarin & Christian, 1999). 
As pain management is a vital part of disease management in SCD, it is 
important to examine it from a psychological perspective as psychological factors 
have been shown to influence pain management in other chronic illnesses e.g. in 
chronic back pain, fibromyalgia, breast and rectal cancer (Bennett & Nelson, 2006; 
De Vries et al., 2009; Eccleston, 2011; Linton & Shaw, 2011; Malouff et al., 2008; 
Ristvedt & Trinkaus, 2009). The difference between pain management and 
experience in SCD compared to these other chronic illnesses is that SCD is a 
chronic pain disease that is present from birth and the pain can be recurring and 
unpredictable. This chronic and frequent pain experience, added to the life-
threatening nature of the disease, creates a difference in pain management 
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strategies required to manage the disease compared to other chronic pain illnesses 
that may not be as pervasive, or as life-threatening. 
Summary and Conclusions of the Review 
The conceptual explanatory model of pain and utilisation (Smith et al., 2005) 
is a model that best describes how health outcomes affect pain and disease 
management in SCD. There are high incidences of depression and anxiety in SCD 
and pain is experienced more in depressed SCD participants compared to non-
depressed SCD participants. The experience of pain, depression and anxiety is not 
homogenous within SCD; experiences can be grouped according to culture and 
disease-severity within SCD, but experiences can also differ within cultures and 
between different disease-types. Trait anxiety is thought to be an indicator of hyper-
vigilance of risk and high levels of trait anxiety are related to risk avoidance in the 
general population. High trait anxiety is also related to low quality of life and higher 
depression levels in the general population, in other chronic pain illnesses and in 
SCD. Social support, religion, active coping, psychological support and interventions 
and paying attention to body symptoms have all been reported to improve pain 
management in SCD. This leads us to the current study. 
Current Study 
On the basis of the review, it could be reasoned that there is evidence for 
examining psychological differences in SCD, such as trait anxiety, pain intensity, 
quality of life and depression. It could be argued that elevated levels of trait anxiety 
may have more of an adaptive function in SCD than in other chronic pain conditions 
due to the adaptive role of hyper-vigilance for this pain sub-group. Monitoring and 
being hyper-vigilant to physical body changes and to the environment can be thought 
of as advantageous in SCD e.g. SCD patients are negatively affected by cold and 
wet weather, or by air pressure changes, therefore, noticing adverse environmental 
and/or physical body changes as soon as they occur can help SCD patients to 
counteract these changes or take preventative measures to prevent experiencing 
vaso-occlusive crises. Being able to prevent a vaso-occlusive crisis can empower 
the SCD patient and increase their sense of control over their illness, which could 
lead to increasingly positive health outcomes (lower depression, higher quality of life 
levels, lower pain intensity). Yet to date, no extant research has evaluated the 
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possibility of elevated trait anxiety as serving an adaptive function in SCD 
management. 
Consequently, the objective of this thesis was to investigate if trait anxiety, as 
a measure of hyper-vigilance, was present in SCD and if it was, the aim was to 
investigate how trait anxiety was related to relevant health outcomes, as identified in 
the literature review. A clinical comparison group and a control group were used in 
the quantitative phase to investigate if any relationships between trait anxiety and the 
health outcomes were specific to SCD. Blood cancer (BC) was chosen as a 
comparison clinical pain group as patients with BC undergo similar rigorous 
treatments for pain and also experience acute and chronic pain until they are in 
remission. Carers were chosen as the non-clinical control group as they are a group 
known for having varying trait anxiety levels (Kuscu et al., 2009; Vignola et al., 2008; 
Yarkin, Tamer, Gamze, Micozkadioglu & Huseyin, 2009), for which to compare trait 
anxiety. It was also an intention to explore subjective perceptions of pain, anxiety 
and low mood in order to observe if hyper-vigilance emerged as a factor in SCD and 
if the role of hyper-vigilance in SCD was unique to SCD. The research questions and 
hypotheses follow. 
Research Aims and Hypotheses 
 Research Aim I 
To determine if there is a significant relationship between health outcome 
variables (depression scores, pain intensity scores, quality of life scores) and trait 
anxiety scores across the complete sample (SCD, BC, Carers) to determine what 
health outcome variables will be used to examine between-group differences [SCD, 
non-SCD comparison group (BC) and control group (Carers)] in the subsequent 
analyses (see Research Aim II). 
H1: Depression scores and pain intensity scores will be positively related to 
higher trait anxiety scores and quality of life scores will be negatively related to 
higher trait anxiety scores in the complete sample. 
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Research Aim II 
To evaluate between-group differences (SCD, BC, Carers) in self-reported 
health outcome variable scores (trait anxiety, depression, pain intensity, quality of 
life) across illness group (SCD, BC, Carers) to determine whether SCD group health 
outcomes are significantly different from an illness control group (BC) and a non-ill 
control group (Carers).   
H2: There will be a significant multivariate main effect for illness group (SCD, 
BC, Carers) on trait anxiety and depression scores. Such that the SCD group will 
report lower trait anxiety and depression scores than the BC group, but higher trait 
anxiety and depression scores than the Carers. 
H3: There will be a significant multivariate main effect for illness group (SCD, 
BC, Carers) on sensory and affective pain scores (pain intensity). Such that the SCD 
group will report higher sensory pain and lower affective pain scores than the BC 
group, but higher sensory pain and higher affective pain scores than the Carers. 
H4: There will be a significant multivariate main effect for illness group (SCD, 
BC, Carers) on quality of life subscale scores. Such that the SCD group will report 
higher quality of life subscale scores than the BC group, but lower quality of life 
subscale scores than the Carers. 
Research Aim III 
To explore how a BC participant and an SCD participant with clinical trait 
anxiety experience pain, anxiety and low mood in order to expand on the quantitative 
findings from the first two research aims by contributing to the understanding of the 
suggested role of trait anxiety in SCD. 
Chapter 3: Methodology 
The current study investigated the significance of the relationships between 
health outcome variables (trait anxiety, hospitalisation frequency, depression, pain 
intensity and quality of life scores) in SCD. The following sections will report the 
research design of the study and the role of the researcher. This chapter will also 
present information regarding study participants, materials and procedures used and 
will consider the ethical considerations that were necessary for this study to occur. 
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Research Design 
Mixed-methods research has become increasingly visible in counselling 
psychology research as an approach that can be used to examine and explore data 
holistically within the same study (Kasket, 2012). The literature speaks of the 
approach of combining quantitative and qualitative data in a specific research design 
as relatively new. However, the concept and the practice of collecting quantitative 
and qualitative data within the same study are not new (Creswell & Plano Clark, 
2006; Symonds & Gorard, 2009). Mixed-methods research has been implemented in 
counselling and psychosocial studies. A systematic review of mixed-methodology 
studies in health-related papers established that of a total of 59 papers, 24% of the 
papers were in the field of nursing, 19% were in psychosocial and behavioural 
research studies, 14% were in public health and health policy, 8% were 
epidemiology studies and a further 8% concerned ageing research (Pluye, Gagnon, 
Griffiths & Johnson-LaFleur, 2009). Hanson, Creswell, Plano Clark, Petska & 
Creswell (2005) showed that mixed-methodology research does have a place in 
counselling psychology, demonstrating that mixed-methodology has been used for: 
clinical assessments, determining constraints of group and individual counselling, 
and has been used in the counselling process and in diversity. This current study 
implemented this agenda to investigate and explore the relationships of certain 
health outcomes with the management of pain in SCD. 
Sequential Mixed-Methods Framework 
The intent of this cross-sectional two-phased sequential explanatory mixed 
methods study was to investigate the relationship between health outcomes in SCD. 
In the first phase, quantitative approaches were used to examine if trait anxiety could 
be predicted by health outcome variables. The first phase also investigated between-
group differences between the health outcome variables across three illness groups 
(SCD, BC, Carers). The qualitative phase of the study was designed as a multiple 
case study that explored subjective perceptions of the health outcomes in an SCD 
and a BC case; both with clinical trait anxiety.  
The rationale for using a mixed methods approach for this study was defined 
by the outcome of the literature review. The literature indicated that trait anxiety 
affected health outcomes, but it was not apparent if trait anxiety could be predicted 
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by health outcomes in the sample utilised in this study, which was a reason for its 
examination. It was also apparent from the literature that different relationships may 
exist between the health outcomes and the different illness groups. However, 
reasons for these differences were not thought to be fully addressed by using 
quantitative methods alone and consequently qualitative methods were used to 
explore subjective perceptions specific to a SCD participant and a BC participant. 
The current study aimed to investigate and explore any relationships that existed 
between trait anxiety and health outcomes in SCD and used a clinical health 
comparison group (BC) and a non-clinical control group (Carers) to help to 
understand the implication of the findings regarding SCD. 
Three issues were considered when designing this study: method priority, 
implementation and integration of methodology (Creswell & Plano Clark, 2006). The 
quantitative phase was given priority in this study because the study was focussed 
on examining the relationships between trait anxiety and the health outcomes and 
the relationship between the health outcomes across the illness groups. The 
quantitative phase had more focus and proportionally more time dedicated to it than 
the qualitative phase did, hence the priority of the study was quantitative (Brannen, 
2005). However, the two case studies used in the qualitative phase allowed the 
study to explore subjective differences within the study, which enriched the data from 
the statistical analysis. The study was implemented using a two-phased sequential 
explanatory design (Creswell, 2009; Tashakkori & Teddlie, 1998). The first phase 
consisted of using an online self-report questionnaire to collect data and needed to 
be collected prior to qualitative data collection in order to inform and direct the 
qualitative phase and allow for the self-selection of clinically trait anxious participants 
for the second phase of the study. The explanatory strategy of the design was used 
to tentatively suggest alternative reasons and interpretations for the differences in 
health outcomes (Tashakorri & Teddlie, 1998) between an SCD participant and a BC 
participant with clinical levels of trait anxiety. Integration of the quantitative and 
qualitative phases occurred twice in this study. The first stage of integration occurred 
during the process of selecting participants for the case study phase. The second 
stage of integration occurred during the process of interpreting the findings for the 
whole study. A visual representation of the sequential explanatory nature of this 
design is presented (see Figure 2). 
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Figure 2. Visual model of the sequential explanatory framework of the present study. 
Quant data collection phase = administration of questionnaires, including obtaining 
participant demographics; quant data analysis phase = preliminary analyses and 
statistical analyses leading to case selection for the qual data collection phase and to 
interpretation of the entire analysis; qual data collection phase = individual in-depth 
interviews with two participants; qual data analysis = coding and thematic analysis of 
transcripts; interpretation of the entire analysis = integration and triangulation of both 
phases of the study. 
The Role of the Researcher 
 The principle researcher’s role during the process of this study involved: 
applying for ethical approval to conduct the study; establishing relationships with the 
organisations and support groups from whom data was collected; collating research 
materials and collecting data; analysing the data; and discussing and disseminating 
the data. The researcher, with guidance from the Director of Studies, ensured that 
the study was conducted within ethical parameters and that the relevant skills were 
learned and applied in the process of data recruitment and collection and in data 
analysis. The researcher had the role of explaining the rationale and logistics of the 
study to different audiences (potential participants, support groups, conferences and 
workshops, and to peers and an ethics committee). Throughout the researcher’s 
role, it was important for the researcher to remain reflexive by facilitating a critical 
attitude in evaluating the impact of the researcher and researcher subjectivity on the 
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project design, in data collection and analysis, on the research participants and in 
the dissemination of the findings (Finlay & Gough, 2003). Whilst researcher 
reflexivity is variable and indefinable to some extent, critically analysing reflexivity 
can be insightful in critical research and can enrich the research process (Flick, 
2009). 
Ethical Considerations 
Ethical issues were considered during every stage of this study (BPS, 2010; 
BPS, 2013). Ethical approval for this study was granted by the University Of East 
London School Of Psychology Research Ethics Committee (see Appendix A). 
Subsequent approval of ethical approval amendments has also been included in 
Appendix A. Two separate informed consent forms were developed for the first and 
second phases of the study (see Appendix B). Consent was provided on the online 
survey by ticking ‘yes’ to continue, or ‘no’ to go to the debriefing page and exit the 
survey. An informed consent form was emailed back to the researcher by the 
participants interviewed over the telephone.  
There were limitations to confidentiality. Internet Protocol (IP) addresses of 
the participants who participated in the quantitative phase were retained in the event 
that participants would decide to withdraw their data from the study and their data 
would need to be identified in order to do so (BPS, 2013). The IP addresses were 
not kept in the same dataset with other identifying information, or with the remaining 
data. Only the primary researcher had access to identifying information. In addition, 
identifying information provided by participants from the quantitative phase of the 
study who wished to participate in the qualitative phase was separated from the data 
files used for statistical analysis. The transcripts from Phase II were anonymised and 
Phase II consent forms were kept separately from the transcripts and the audio data 
(BPS, 2010). 
During Phase II, it was necessary to include telephone interviews (after 
approval had been gained from the ethics committee) as an interview medium. 
Special consideration was given by being aware of emotional or physical distress in 
the participant during the interview and the researcher ‘checked in’ verbally (BPS, 
2010) with the participant more frequently than would be required for a face-to-face 
participant. 
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The Phase II participants were also reminded that general and non-
personified data would be kept for an additional four years, in accordance with the 
BPS guidelines for ethical practice (BPS, 2010). 
Data Collection 
Design of Phase I: Quantitative  
The participants in the cross-sectional phase were asked to complete a 15-
minute secure online survey (www.surveymonkey.com). The survey began by 
informing the participants about the nature and procedure of the study (see 
participant invitation letter, Appendix B). Participants were asked to provide informed 
consent to participate (see participant consent form, Appendix B). The following 
survey pages included the following standardised questionnaires (see Appendix C): 
the State-Trait Anxiety Inventory (STAI-T; Spielberger et al., 1983), the Beck 
Depression Inventory II (BDI-II; Beck et al., 1996), the Short Form McGill Pain 
Questionnaire (SF-MPQ; Melzack, 1987) and the Short Form Health Survey (SF-36; 
Ware & Sherbourne, 1992). Participants were asked to provide demographic data 
(e.g. age, ethnicity) and the survey concluded with a debriefing page that included 
helpline information for participants who required emotional and/or practical 
assistance (see Appendix C). 
Design of Phase II: Qualitative 
The participants in this quasi cross-sectional study self-referred for this phase 
at the end of the survey in the quantitative phase by leaving their contact details if 
they were interested in participating in the follow-up phase. The selection of the 
cases for this phase of the study was the first point of connection between the 
quantitative and qualitative phases in this sequential explanatory design. 
Participants 
Data was collected between January 2013 and January 2014. Participants 
were identified and sourced through purposive and snowballing sampling (Robson, 
2011) from SCD, BC and Carer support groups in the UK and through the online 
forums and social media sites for these groups (e.g. EHF Sickle Cell and 
Thalassaemia Support Group, Leukaemia Care, The Sickle Cell Society and Carers 
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UK). Snowballing sampling is the non-probability sampling conducted by current 
participants who recruit future participants from amongst their acquaintances 
(Robson, 2002). This type of sampling assisted participant recruitment. The types of 
blood cancer in the BC group were (leukaemia, hairy cell leukaemia, chronic 
lymphocytic leukaemia, myeloma and lymphoma). The Carers were recruited 
through a Carer’s online support website and through snowballing sampling and 
included Carers for SCD, BC, dementia and quadriplegia. Permission to post on 
forums and social media sites was provided by the administrators of the websites, 
who were provided with participant information sheets and consent forms prior to 
posting. Inclusion criteria included: adults aged 18 – 70 years; and being able to be 
allocated to one of the illness groups (SCD, BC, Carers). Exclusion criteria included: 
not being able to speak or read English at age 12 proficiency, not being able to 
provide informed consent, not falling within the specified included age range and not 
having SCD, BC or being a Carer.  
Quantitative data collection 
Sixty-three participants answered at least one quantitative survey question. Of 
those participants, twelve participants (19.7%) did not complete all the survey items 
and were excluded from analyses. The remaining participants (N = 51) answered all 
study questions and were included in the analyses. Sample characteristics 
(participant age, ethnicity and employment status are presented, see Table 1). The 
minimum age of the sample was 23 and the maximum age was 67. Twenty men 
(39.2%) and 31 women (60.8%) participated in the study. Most of the participants did 
not have carers (n = 39, 76.5%), however, six participants (11.8%) had part-time 
carers and five participants (9.8%) had full time carers. In addition, most of the 
sample was not in a romantic relationship (60.8%). 
Qualitative data collection 
Qualitative data was collected by purposively sampling self-selected SCD and 
BC participants who completed the quantitative survey and reported elevated levels 
of trait anxiety. Elevated trait anxiety was determined by an empirically derived cut-
off score on the STAI-T. Scores above 44 were used to identify participants with 
elevated ‘clinical’ trait anxiety (Spielberger et al., 1983). Participants scoring below 
the STAI-T cut off were not selected for the qualitative interviews.  The intention of  
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Table 1 
Participant Characteristics  
Variable M SD n % 
Age (years) 37.13 11.16 51 100 
Age SCD 31.88 8.39 8 15.69 
Age BC 50.79 10.68 8 15.69 
Age Carers 34.42 7.52 8 15.69 
Ethnicity     
Black African   21 41.2 
Black 
Caribbean 
  9 17.6 
Other Black   2 3.9 
White & Black 
African 
  1 2.0 
Other Mixed   1 2.0 
White British   1 2.0 
White Irish   8 15.7 
White 
European 
  1 2.0 
Other White   1 2.0 
Asian Indian   2 3.9 
Asian 
Pakistani 
  1 2.0 
Chinese   1 2.0 
Other Asian   2 3.9 
Employment     
Part time   11 21.6 
Full time   10 19.6 
None, unable 
to work 
  12 23.5 
None, retired   2 3.9 
None, student   10 19.6 
None, unable 
to find work 
  3 5.9 
Note. (N = 51). SCD = Sickle Cell Disease, BC = Blood Cancer
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the qualitative phase was to explore the perceptions of participants who had 
elevated levels of trait anxiety in order to explore differences in pain management 
whilst experiencing elevated trait anxiety. Subsequently, the participants who did not 
meet this requirement were not suitable for the interviews. Only two participants 
agreed to be interviewed (1 male SCD, 1 female BC).Their characteristics have been 
reported in detail in Chapter 5. Cross-study contamination was not an issue for this 
study as it was necessary to identify the participants for the qualitative phase by 
them completing the quantitative phase first.  
Participants provided informed consent before participating in the 50 – minute 
semi-structured interviews (see Appendix D for the interview outline) that were 
audio-recorded. The participants were purposively selected (Robson, 2011). 
Interviews were scheduled to suit participant availability and took place individually 
over the telephone under conditions that maintained participant confidentiality. 
Topics included the self-appraisal of low mood, anxiety, pain and their perceptions of 
illness. The research objective was to explore these experiences in depth to 
elaborate on the analytical findings from phase I. No adjustments to the interview 
protocol were required during the interviews.  
Measures 
The State-Trait Anxiety Inventory (STAI-T; Spielberger et al., 1983) was used 
to differentiate between participants with personality trait anxiety. The STAI-T was 
developed to measure trait anxiety among adults with a reading age of 12 
(Spielberger et al., 1983). The 20-item STAI-T self-report scale is scored on a 4-point 
continuum that ranges from 1 (almost never) to 4 (almost always). Sample items 
include, ‘I am a steady person’ and ‘I lack self-confidence’. Scores range from 20 - 
80, where higher scores indicate greater trait anxiety (Spielberger et al., 1983). An 
empirically derived cut-off score of 44 and higher was used to identify participants 
with clinical trait anxiety (Spielberger et al., 1983). The STAI-T has been found to 
have high concurrent validity as a self-report measure (α = .85; Tilton, 2008) and 
test-retest reliability (α = .86; Spielberger et al., 1983). The STAI-T demonstrated 
good internal consistency in the current sample (α = .93) (Mayers, 2013).  
The Beck Depression Inventory II (BDI-II; Beck et al., 1996) was used to 
assess the affective, behavioural, cognitive, motivational and vegetative aspects of 
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depression. It is a 21-item self-report questionnaire with questions ranging from 0 
(e.g. ‘I do not feel particularly guilty’), to 3 (e.g. I feel guilty all of the time’) scored on 
a Likert – type scale. Individual response scores are summed to create a total score 
(range: 0 – 63). Empirically derived cut-off scores are 0 – 13 (minimal depression), 
14 – 19 (mild depression), 20 – 28 (moderate depression) and 29 – 63 (severe 
depression) (Beck et al., 1996). In the current sample, the internal consistency of the 
BDI-II was excellent (α = .94) (Mayers, 2013). 
The Short Form McGill Pain Questionnaire (SF-MPQ; Melzack, 1987), was 
used to assess the severity of pain experienced (pain intensity) and has been used 
to assess pain intensity in studies comparing different groups’ pain (Tang et al., 
2009). This self-report questionnaire assessed several dimensions of pain 
experience using 15 (sensory and affective) verbal pain descriptors, a current pain 
index, and a visual analogue scale to assess pain intensity in the previous week 
ranging from 1 (e.g. ‘no pain’),  to 10 (e.g. ‘extreme pain’). Questions 1 – 11 are 
sensory pain descriptors (e.g. ‘throbbing pain’), rated on a Likert – type scale from 0 
(none), to 3 (severe). Questions 12 – 15 are affective pain descriptors (e.g. 
‘punishing – cruel pain’) rated on a Likert – type scale from 0 (none), to 3 (severe) 
(Melzack, 1987). From the sum of the rank value of the pain descriptors, a sensory 
(0 – 3) (α = .95; Adelmanesh et al., 2011), an affective (0 – 12) (α = .83; Adelmanesh 
et al., 2011) and a total pain score (0 – 45) (α = .84; Adelmanesh et al., 2011) have 
shown good internal consistency (Mayers, 2013). In the current sample, the internal 
consistencies of the sensory pain subscale (α = .92), the affective pain subscale (α = 
.83) and the combined total of the subscales (α = .93) were good (Mayers, 2013). 
The Short Form Health Survey 36 (SF-36; Ware & Sherbourne, 1992) is a 
non-disease-specific generic self-report measure of health that is related to 
functional status and wellbeing. This self-report measure has been previously been 
used to evaluate quality of life in SCD populations (Asnani et al., 2009; Citero et al., 
2007; McClish et al., 2005).It was used to assess quality of life across eight 
subscales (physical functioning, physical health limitations, emotional health 
limitations, fatigue, emotional wellbeing, social functioning, pain and general health). 
Subscales are measured on a scale from 0 – 100, where higher scores on the 
subscales of the SF – 36 indicated better levels of health (e.g. ‘in general, would you 
say your health is: 100 = excellent, 75 = very good, 50 = good, 25 = fair and 0 = 
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poor’). It was reported that the SF – 36 achieves high levels of criterion validity and 
high levels of reliability (Ware & Sherbourne, 1992). Asnani et al. (2009) reported 
that their subscales achieved good internal consistency ranging from (α = .70) to (α = 
.93). The subscales of the SF – 36 demonstrated good levels of internal consistency 
(Mayers, 2013) in this study: physical functioning (α = .94), physical health limitations 
(α =.93), emotional health limitations (α = .94), fatigue (α = .85), emotional wellbeing 
(α = .80), social functioning (α = .82), pain (α = .92) and general health (α = .87). 
 
Data Analytic Plan (Phase I) 
All quantitative analyses were conducted using the statistical package, SPSS 
(Version 20; IBM, 2011). Preliminary analyses were conducted to establish suitability 
of the data for parametric analysis and to assess applicability of potential covariates 
i.e. age, gender.  
Suitability of Data for Parametric Analysis 
The data was checked to ensure that the assumptions for multiple regression 
and multivariate analyses were met. There were more cases than independent 
variables for the regression analyses (Field, 2013); only participants who had 
completed the survey were included in the analyses; and univariate normality was 
checked by checking the normality of residuals for each dependent variable to 
ensure multivariate normality. However, using the latter method does not guarantee 
multivariate normality according to Field (2013). Distributions of study variables were 
not problematically skewed (Field, 2013), trait anxiety scores were normally 
distributed with skew of – 0.25 (SE = 0.33) and kurtosis – 0.69 (SE = 0.66). The 
regression of the standardised residual of the variables followed a normal distribution 
and the normal plot of the regression standardised residuals against the 
standardised predicted value did not show a specific pattern and thus indicated that 
it could be assumed that the data was linear (Coolican, 2001; Tabachnick & Fidell, 
2013). This data demonstrated that assumptions of homogeneity of variance had not 
been violated with the data. There were no within-cell outliers using a criterion z = +/- 
3.3 at p < .01 (Mayers, 2013). Results of evaluation of assumptions of normality, 
homogeneity of variance-covariance matrices, linearity and multi-collinearity were 
satisfactory.  
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Assessment of Covariates and Preliminary Correlations 
The associations between variables were assessed with bivariate correlations 
amongst the following variables: trait anxiety score (STAI-T), depression score (BDI-
II), age, number of annual hospitalisations, sensory and affective pain scores (SF-
MPQ) and the eight subscale scores from the SF-36 (physical and emotional health 
limitation scores, emotional wellbeing scores, fatigue scores, social functioning 
scores, general health scores and pain scores). The following five variables were 
eliminated from the analyses due to their lack of relationship with the variable trait 
anxiety in preliminary correlations, where r < +/- 0.3 (Tabachnick & Fidell, 2007) and 
where the significance of the relationships was greater than p = .05 (Mayers, 2013): 
hospital admission frequency over 12 months, r = .174, p = .221; physical functioning 
subscale from the SF-36, r = - .252, p = 0.075; pain subscale from the SF-36,            
r = - .165, p = .249; gender, r = - .004, p = .978; and age, r = .181, p = .205, where N 
= 51. 
Hierarchical regression (Research Aim I) 
A hierarchical regression was conducted with the full SCD sample (n = 28) to 
document the relationship of trait anxiety with the health outcome variables with the 
main participant group, SCD. Following this, a hierarchical regression was conducted 
using the full sample (N = 51) to determine whether trait anxiety scores (STAI-T) 
(dependent variable, DV) were significantly predicted by relevant health outcome 
variables [independent predictor variables were mean scores of depression (BDI-II), 
pain intensity (SF-MPQ) and quality of life (SF-36)]. The independent variables (IVs) 
were added to the regression model in three steps. The selection and the order in 
which the variables were added to the regression model were determined by the 
strength of their individual correlations with trait anxiety in the preliminary analyses. 
Depression scores were added in the first step as this was the strongest correlation, 
sensory and affective pain scores were added in the second step and quality of life 
subscale scores (physical and emotional limitations, fatigue, emotional wellbeing, 
social functioning and general health) were added in the third step.  
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MANOVA analyses (Research Aim II) 
Between-group differences (illness groups: SCD, BC and Carers) on mean 
scores of trait anxiety (STAI-T), depression (BDI-II), pain intensity (SF-MPQ) and 
quality of life (SF-36) were tested using three separate Multivariate Analysis of 
Variance Analyses (MANOVAs). Analysis of the DVs was separated across three 
MANOVAs because of measure scoring so that subscales of the same measure 
were analysed together. In addition, the separation of the DVs ensured that there 
were more cases than DVs in every cell of the analysis. If a cell had more DVs than 
cases, then every cell in the analysis would become singular and the assumption of 
homogeneity of variance-covariance matrices would have become un-testable 
(Tabachnick & Fidell, 2013). The current study had eight participants per cell and 
employed 10 DVs across three cells, therefore the analysis needed to have less than 
eight DVs per cell, per analysis. It was decided to separate the variables into three 
groups of a reduced number of variables: mood (measured by trait anxiety and 
depression scores), pain (measured by the SF-MPQ sensory and affective pain 
subscales scores) and quality of life (measured by the six selected subscales scores 
of the SF-36; physical and emotional limitations, fatigue, emotional wellbeing, social 
functioning, general health). 
Significant MANOVAs were followed up by univariate Analysis of Variance 
Analyses (ANOVAs) to establish whether significant group differences existed at 
each individual variable level. Significant univariate analyses were conducted using 
pair-wise post hoc comparison tests to identify which groups were statistically 
different within variables and the direction of the differences (Tabachnick & Fidell, 
2007). MANOVAs were chosen to investigate group differences in the three sets of 
variables instead of conducting separate ANOVAs and t-tests with 10 separate 
variables to avoid making Type I errors (Coolican, 2001) and to investigate the 
overall effects of the variable sets (mood, pain and quality of life), rather than simply 
investigating individual effects (Mayers, 2013).  
Qualitative Data Analysis (Phase II, Research Aim III) 
A thematic coding analysis (Braun & Clarke, 2006; Robson, 2011) was used 
to identify themes and thematic networks after the transcription (verbatim) of the 
interviews. Accuracy of the transcriptions was validated by comparing the audio data 
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with the transcribed data and the researcher reflected on the interview process 
immediately after each interview. Data collection and analysis were conducted 
simultaneously (Creswell, 2009; Flick, 2009). Five steps were followed for each 
analysis (adopted from Braun & Clark, 2006). Familiarisation with the data was the 
first step, by reading through each case’s transcript and generating initial codes 
(Flick, 2009). The next step was to organise the initial codes into bigger groups and 
bring meaning to those groups (Robson, 2011). The third step was to identify themes 
by grouping similar codes together and supporting each theme with quotes that 
supported each theme (Braun & Clark, 2006). The fourth step involved constructing 
thematic networks by linking related themes together from the same case (Robson, 
2011). The last step of the analysis was to construct a narrative that combined 
thematic descriptions for each case.  
After these steps were completed, it was necessary to examine the themes 
across the two cases to identify themes that occurred for both cases and themes that 
separated both cases. After this process the qualitative data was interpreted in 
relation to the quantitative data through integration (Braun & Clarke, 2006; Ostlund, 
Kidd, Wengstrom & Rowa-Dewar, 2011). Robson (2011) identified that the quality 
and validity of the data and the interpretations of the data needs to be evaluated to 
ensure data integrity. In this study, data quality was assessed by evaluating if the 
data was representative of the data collection process and using convergent and 
divergent triangulation (Ostlund et al., 2011) to compare and integrate the data. 
Researcher effects were tested using the process of researcher reflection and 
reflection using research supervision (Finlay & Gough, 2003). It was important to 
weigh up the evidence and evaluate the strength of the conclusions that could be 
made (Robson, 2002). As the data was so specific and the sample size was 
relatively small, it was not possible to generalise the implications of the study to the 
specific groups (Flick, 2009). The findings were generalised to the sample and 
suggested implications were indicative of future avenues of research, rather than as 
conclusive evidence. This study also focussed on looking for negative evidence as a 
method of validating conclusions made and testing the integrity of the process and 
the findings. 
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Chapter 4: Quantitative Results 
This chapter reports the findings from phase I. 
Sample Characteristics 
 Means and standard deviations of continuous variables of the total sample   
(N = 51) are presented (see Table 2). Eight BC participants (15.7%) completed the 
survey, compared to 28 SCD participants (54.9%) and 15 Carers (29.4%). Due to the 
potential of introducing experimental error due to sample size differences across 
groups and the likelihood of violating the MANOVA requirement of equal sample 
sizes in individual groups (Field, 2013; Tabachnick & Fidell, 2007), the total sample 
was reduced from 51 to 24 (n = 8 per group) for the reported MANOVA analyses. 
Using unequal sample sizes in the MANOVA, as would have been the case using 
the full sample (N = 51) would have reduced the robustness of the analyses and 
distorted the probability values (Tabachnick & Fidell, 2013). The SCD and Carer 
group participant numbers were reduced through random selection to match the 
number of participants in the BC group, (n = 8), thereby leaving three groups with 
eight participants in each group (total n = 24). Means and standard deviations of the 
selected continuous variables across the three equal sized illness groups are 
presented (see Table 2, n = 24). The MANOVA analyses were also run with the 
unequal group sizes (SCD, n = 28; BC, n = 8; Carers, n = 15) to show that there was 
no significant negative impact of reducing the group sizes to n = 8 in each group in 
order to maintain equal group sizes (see Appendix E). 
Hierarchical Regression (Research Aim I) 
Table 3 displays bivariate correlations and significance levels of relevant 
variables across the complete sample (N = 51). Significant positive correlations 
existed for trait anxiety scores and scores of depression, sensory and affective pain, 
physical and emotional health limitations, fatigue, emotional wellbeing, social 
functioning and general health. 
Results from the hierarchical regression demonstrated that trait anxiety was 
predicted by depression scores (48.1%) and by the quality of life subscale scores 
(physical and emotional limitations, fatigue, emotional wellbeing, social functioning 
and general health) (27.1%) in the complete sample. Addition of pain intensity 
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(sensory and affective pain) to the model did not create a significant F change. See 
Table 4 for regression results. 
Table 3 displays bivariate correlations and significance levels of relevant 
variables across the complete SCD sample only (n = 28). Significant positive 
correlations existed for trait anxiety scores and scores of depression, sensory and 
affective pain, physical and emotional health limitations, fatigue, emotional wellbeing, 
social functioning and general health. These significant relationships generally 
mirrored the significant relationships indicated in the regression analyses with the 
complete sample (N = 51). 
Results from the hierarchical regression demonstrated that trait anxiety was 
predicted by depression scores (67.2%) and by the quality of life subscale scores 
(physical and emotional limitations, fatigue, emotional wellbeing, social functioning 
and general health) (17.7%). As with the complete sample, the addition of pain 
intensity (sensory and affective pain) to the model did not create a significant F 
change. See Table 4 for regression results.  
MANOVA Analyses (Research Aim II) 
Three separate between – groups multivariate analyses of variance 
(MANOVA) were conducted to evaluate group differences across nine dependent 
variables: MANOVA 1 - trait anxiety scores (STAI-T) and depression scores (BDI-II), 
MANOVA 2 - sensory and affective pain intensity scores (SF-MPQ) and MANOVA 3 
- physical limitations, emotional limitations, fatigue, emotional wellbeing, social 
functioning and general health scores (SF-36). The IV was illness group (SCD, BC, 
Carers). As discussed earlier, a smaller and equal group subsample was used in 
these analyses to match the number of complete responses in the smallest illness 
group, where (n = 8) in each illness group to prevent the violation of MANOVA. A 
bootstrap (a statistical technique that re-samples the data to improve accuracy and 
reduce bias; Field, 2013) was conducted to control for the small sample size; 
however MANOVA did not bootstrap the main tests. The potential covariates of 
gender and age were not added to the MANOVAs as there was no significant 
relationship between gender or any of the dependent variables (Tabachnick and 
Fidell, 2007). Age was not included as a covariate because when the independence 
of the illness group was tested against age, it was significant indicating that including  
Trait Anxiety in SCD       
 
50 
 
Table 2 
Means and Standard Deviations of the variables in total sample (n = 51), in illness 
group sub-sample (n = 24) and in complete SCD sub-sample (n = 28) 
 Total sample  
(n = 51) 
Illness Groups (n = 24) SCD sub-
sample 
Variable Mean (SD) SCD 
(n=8) 
BC 
(n=8) 
C 
(n=8) 
SCD 
 (n=28) 
  M (SD) M (SD) M (SD) M (SD) 
Age (years) 37.33 (11.77) 31.88 (8.39) 52.04 (13.15) 34.42 (7.52) 33.32 (8.83) 
No of annual 
hospitalisations 
1.35 (2.95) 2.37 (4.27) 1.75 (3.15) 0 (0) 1.96 (3.48) 
Trait anxiety 49.49 (12.33) 49.75 (5.15) 56.63 (11.58) 43.13 (9.22) 50.07 (11.58) 
Depression 18.92 (13.95) 17.63 (6.74) 33.63 (17.44) 11.25 (9.21) 18.54 (11.63) 
Sensory pain 12.31 (9.18) 15.88 (5.39) 11.63 (11.07) 3.75 (6.18) 16.29 (6.98) 
Affective pain 4.04 (3.78) 4.38 (3.07) 3.75 (4.98) 1.50 (2.51) 5.18 (3.27) 
Physical health 
limits 
 
156.86 
(178.05) 
 
62.50 (118.77) 
 
125.00 
(175.26) 
 
262.50 
(192.26) 
 
103.57 
(147.78) 
Emotional 
health limits 
 
135.29 
(142.58) 
 
175.00 
(148.81) 
 
75.00 (138.87) 
 
200.00 
(141.42) 
 
125.00 
(137.77) 
Fatigue 134.12 (99.54) 162.50 (70.46) 65.00 (70.71) 197.50 (89.08) 124.29 (93.07) 
Emotional 
wellbeing 
270.59 
(108.32) 
272.50 (48.92) 
222.56 
(116.83) 
327.50 (95.58) 
264.29 
(103.76) 
Social 
functioning 
94.61 (60.89) 103.13 (52.50) 62.50 (42.56) 137.50 (62.68) 
 
80.36 (55.43) 
 
General health 
177.94 
(137.99) 
162.50 (60.18) 103.13 (86.02) 
318.75 
(133.46) 
131.25 
(106.85) 
Note. SF – MPQ = Short Form McGill Pain Questionnaire, SF – 36 = Short Form 
Health Survey 36, SCD = Sickle Cell Disease, BC = Blood Cancer, C = Carer
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Table 3 
Bivariate Correlations of Trait Anxiety and the health outcomes in total sample (N = 51) above the diagonal line and complete SCD-
only sample (n = 28) below the diagonal line 
 1 2 3 4 5 6 7 8 9 10 
1.Trait anxiety (STAI-T) _ .70** .37** .47** -.33** -.59** -.70** -.86** -.60** -.59** 
2.Depression (BDI-II) .82** _ .37** .42** -.30* -.45** -.57** -.74** -.56** -.58** 
3.Sensory pain (SF- 
MPQ) 
.37** .48** _ .83** -.61** -.34** -.48** -.35** -.54** -.60** 
4.Affective pain (SF- 
MPQ) 
.56** .65** .73** _ -.52** -.45** -.48** -.38** -.45** -.53** 
SF-36 subscales           
5.Physical health limits -.34* -.41* -.26* -.22 _ .52** .50** .28* .56** .63** 
6.Emotional health 
limits 
-.51** -.41* -.07 -.39* .31 _ .70** .49** .58** .52** 
7.Fatigue -.63** -.51** -.28 -.42* .21 .49** _ .63** .83 .72** 
8.Emotional wellbeing -.89** -.81** -.45** -.60** .38* .41** .60** _ .60** .53** 
9.Social functioning -.50** -.41* -.32* -.25 .41* .36* .78** .53** _ .69** 
10.General health -.53** -.57** -.35* -.40* .44* .27 .55** .53** .43** _ 
Note. * p < .05   ** p < .01; STAI-T = State-Trait Anxiety Inventory (Spielberger et al., 1983), BDI-II = Beck Depression Inventory-II (Beck et al., 
1996), SF –MPQ = Short Form McGill Pain Questionnaire (Melzack, 1987), SF –36 = Short Form Health Survey 36 (Ware & Sherbourne, 1992)
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Table 4 
Summary of Sequential Regression Results and Individual Predictors of Trait Anxiety 
in the total sample (N = 51) and in the complete SCD sub-sample (n = 28) 
Variable (N =51) R² t β f² p 
Dependent variable: trait anxiety 
scores 
     
Step 1:       
Depression scores .49 6.89 .70 .96 0.00 
Step 2: (Fchange = 141.691 ) .53   .04  
Sensory pain scores  -.58 -.11  0.56 
Affective pain scores  1.58 .29  0.12 
Step 3: (Fchange =  8.431) .77   .39  
Physical health limitations scores  .36 .04  0.72 
Emotional health limitations scores  -.92 -.10  0.37 
Fatigue scores  -1.17 -.18  0.25 
Emotional wellbeing scores  -5.84 -.64  0.00 
Social functioning scores  .45 .06  0.66 
General health scores  -.81 -.10  0.42 
Note. β = standardised beta weight from multiple regression
Variable (n = 28) R² t β f² p 
Dependent variable: trait anxiety 
scores 
     
Step 1:       
Depression scores .67 7.30 .82 2.03 0.00 
Step 2: (Fchange = 53.228 ) .68   .01  
Sensory pain scores  -.65 -.11  0.52 
Affective pain scores  .68 .13  0.50 
Step 3: (Fchange =  3.362) .85   .22  
Physical health limitations scores  .22 .03  0.83 
Emotional health limitations scores  -1.01 -.12  0.33 
Fatigue scores  -.86 -.18  0.40 
Emotional wellbeing scores  -3.54 -.7  0.00 
Social functioning scores  .50 .62  0.62 
General health scores  -.022 -.00  0.98 
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it would increase the error variance of the MANOVA (Mayers, 2013). In addition, 
running the MANOVA with these variables reduced the overall power of the 
analyses.  
MANOVA 1: Group differences in mood (trait anxiety and depression) 
MANOVA 1 was conducted to evaluate between-group (SCD, BC, Carers) 
differences in trait anxiety and depression scores. The result of the overall MANOVA 
was significant, Wilks’ Λ = .532, F (4, 40) = 3.71, p = .012, Cohen’s d = .371 (see 
Table 5). Follow-up univariate analyses revealed significant group differences in trait 
anxiety scores, F (2, 21) = 4.46, p = .024, Cohen’s d = .631, and in depression 
scores, F (2, 21) = 7.34, p = .004, Cohen’s d = .835.  
 
Table 5 
Multivariate Analysis of Variance results for Illness Group and DVs (mood, pain 
intensity, quality of life) 
 Wilks 
Lambda 
 
df 1 
 
 
df2 
 
 
Multivariate 
F 
d p 
Mood 
(STAI-T) & 
(BDI-II) 
.532 4 40 3.71 .371 .012* 
       
Pain 
Intensity 
(SF-MPQ) 
.599 4 40 2.92 .292 .033* 
       
 Pillai’s 
Trace 
Statistic 
     
Quality of 
Life (SF-36) 
.804 12 34 1.91 .672 .07* 
Note. * p < .05; STAI = State-Trait Anxiety Inventory (Spielberger et al., 1983); BDI-II 
= Beck Depression Inventory II (Beck et al., 1996); SF- MPQ = Short Form McGill 
Pain Questionnaire (Melzack, 1987); SF – 36 = Short Form Health Survey 36 (Ware 
& Sherbourne, 1992).  
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Bonferroni post hoc pairwise comparisons showed that the BC group reported 
significantly higher trait anxiety scores (M = 56.63, SD = 11.58) relative to the Carers 
(M = 43.13, SD = 9.22; p = .021). There was no significant difference in the trait 
anxiety scores between the SCD group (M = 49.75, SD = 5.15) and the BC group  
(M = 56.63, SD = 11.58; p = .430) or between the SCD group (M = 49.75, SD = 5.15) 
and the Carers (M = 43.13, SD = 9.22; p = .473). With regard to depression scores, 
the BC group also reported higher depression scores (M = 33.63, SD = 17.44) than 
both the SCD group (M = 17.63, SD = 6.74; p = .044) and the Carers group            
(M = 11.25, SD = 9.21; p = .004). There was no significant difference in depression 
scores between the SCD group (M = 17.63, SD = 6.74) and the Carers group         
(M = 11.25, SD = 9.21; p = .904). In summary, there was no difference in trait anxiety 
scores between SCD and BC, but the BC group did report significantly higher 
depression scores compared to the SCD group.  
MANOVA 2: Group differences in pain intensity (sensory and affective) 
MANOVA 2 was conducted to evaluate between-group (SCD, BC, Carers) 
differences in sensory and affective pain scores. The result of the overall MANOVA 
was significant, Wilks’ Λ = .599, F (4, 40) = 2.92, p = .033, Cohen’s d = .292 (see 
Table 5). Follow-up univariate analyses revealed significant group differences in 
sensory pain scores only, F (2, 21) = 4.79, p = .019, Cohen’s d = .675.  
Bonferroni post hoc pairwise comparisons showed that the SCD group 
reported significantly higher sensory pain scores (M = 15.88, SD = 5.39) relative to 
the Carers (M = 3.75, SD = 6.18; p = .018). There were no significant differences in 
sensory pain between the SCD group (M = 15.88, SD = 5.39) and the BC group     
(M = 11.63, SD = 11.07; p = .892), or between the BC group (M = 11.63, SD = 11.07) 
and the Carers (M = 3.75, SD = 6.18; p = .183). In summary, only sensory pain was 
different across the illness groups; the SCD group experienced more sensory pain 
than the Carers, but similar sensory pain to the BC group. 
MANOVA 3: Group differences in quality of life (physical and emotional 
health limitations, emotional wellbeing, fatigue, social functioning & general 
health) 
MANOVA 3 was conducted to evaluate between-group (SCD, BC, Carers) 
differences in quality of life subscale scores (physical health limitations, emotional 
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health limitations, fatigue, emotional wellbeing, social functioning and general 
health). Pillai’s trace statistic was used to observe significance in this MANOVA 
because Box’s test of equality of covariance matrices was significant at, p = .001, 
despite there being equal group numbers (n = 8 x 3 groups) (Tabachnick & Fidell, 
2007). Pillai’s trace results indicated that there was a marginally significant difference 
in quality of life subscale scores across the illness groups, Pillai’s trace V = .804,      
F (12, 34) = 1.91, p = .07, Cohen’s d = .672 (see Table 5). Follow-up univariate 
analyses revealed significant group differences in fatigue scores, F (2, 21) = 6.32,    
p = .007, Cohen’s d = .776; in social functioning scores, F (2, 21) = 3.99, p = .034, 
Cohen’s d = .617; and in general health scores, F (2, 21) = 9.41, p = .001, d = .947. 
Bonferroni post hoc pairwise comparisons showed that the BC group was 
marginally more fatigued (M = 65.00, SD = 70.71) than the SCD group (M = 162.50, 
SD = 70.46; p = .059), and was significantly more fatigued than the Carers             
(M = 197.50, SD = 89.08; p = .008). The BC group had lower social functioning 
scores (M = 62.50, SD = 42.56) than the Carers (M = 137.50, SD = 62.68; p = .031), 
but there was no significant difference in social functioning between the SCD group 
(M = 103.13, SD = 52.50) and the BC group (M = 62.50, SD = 42.56; p = .424), or 
between the SCD group (M = 103.13, SD = 52.50) and the Carers (M = 137.50,     
SD = 62.68; p = .629). The SCD group had lower general health scores (M = 162.50, 
SD = 60.18) than the Carers (M = 318.75, SD = 133.46; p = .019) and the BC group 
had lower general health scores (M = 103.13, SD = 86.02) than the Carers             
(M = 318.75, SD = 133.46; p = .001). However, there was no significant difference in 
general health scores between the SCD group (M = 162.50, SD = 60.18) and the BC 
group (M = 103.13, SD = 86.02; p = .781). In summary, there were group differences 
in the fatigue, social functioning and general health subscales of the SF-36 (Ware & 
Sherbourne, 1992). The SCD group were marginally less fatigued than the BC group 
and had lower general health scores than the Carers. 
Summary  
Hierarchical regression showed that trait anxiety, in both the complete sample 
(N = 51) and in the complete SCD sample (n = 28), was predicted by depression 
scores and quality of life subscale scores (physical and emotional health limitations, 
fatigue, emotional wellbeing, social functioning and general health). Three separate 
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MANOVAs were used to show that there was a difference in trait anxiety, depression 
and sensory pain scores across illness groups and there was a difference in fatigue, 
social functioning and general health across illness groups. 
Both the SCD group (M = 49.75, SD = 5.15) and the BC group (M =56.63,    
SD = 11.58) had similar trait anxiety scores as measured by the STAI -T (M ≥ 44 = 
clinical trait anxiety; Spielberger et al., 1983). However, the BC group had a mean 
severe depression score (M = 33.63, SD = 17.44) as measured by the BDI-II (Beck 
et al., 1996) that was significantly higher than that of the SCD group (M = 17.63,    
SD = 6.74). The SCD group (M = 15.88, SD = 5.39) had similar levels of mean 
sensory pain scores to the BC group (M = 11.63, SD = 11.07), but only the SCD 
group had significantly higher levels of sensory pain compared to the control group 
of Carers (M = 3.75, SD = 6.18). Despite the similar levels of sensory pain in both 
the SCD and the BC groups, and similar levels of trait anxiety, the BC group mean 
depression score was significantly higher than the SCD group mean depression 
score. Subsequently, Chapter 5 explores and discusses how the SCD and BC 
participants with clinical trait anxiety experienced their pain, anxiety and low mood to 
explore what could account for the difference in depression scores.  
Chapter 5: Qualitative Results 
The quantitative results demonstrated that trait anxiety was predicted by 
depression scores, physical and emotional health limitations, fatigue, emotional 
wellbeing, social functioning and general health. The quantitative results also 
showed that a difference in trait anxiety, depression scores, sensory pain scores and 
quality of life scores across the illness groups existed. However, despite the similar 
levels of sensory pain in the SCD and the BC groups and the relatively similar levels 
of trait anxiety, there was a significant difference in depression scores between the 
two groups; the BC group had higher depression scores than the SCD group. The 
qualitative phase was used to explore this difference (see appendix D for the 
interview outline) in one participant from both the SCD and the BC group. 
 Data collection and a thematic content analysis (Braun & Clarke, 2006; 
Robson, 2011) were carried out simultaneously on two cases: an SCD and a BC 
participant who were selected for Phase II because of their clinical trait anxiety levels 
Trait Anxiety in SCD       
 
57 
 
which were above the clinical cut off score of 44 (Spielberger et al., 1983) and 
because of the participants’ above average depression scores (Beck et al., 1996).  
Description of Cases 
 Case 1: Dee  
...I know my body will respond to my emotions and um, the connection 
between one’s mood and one’s physical self, um, if I am depressed I 
will feel more sick. If I am laughing....when I am laughing I cannot feel 
ill (from the interview with Dee). 
Dee was a 56 year old Asian Indian South African woman who partly lived in 
the UK and in South Africa. She was married and she and her husband had two 
adult children. She was recruited through a UK-based online support group for Hairy 
Cell Leukaemia, a form of Blood Cancer. She had lived with this form of leukaemia 
for three years and was in partial remission. She used to work as a political activist, 
as a writer and as a humanitarian and foster home manager, but was no longer able 
to work due to her illness.  
She had been admitted to hospital nine times in the previous 12 months and 
despite the physical difficulties with her illness, she did not have a carer. Her STAI - 
T score was 54, which indicated that she had clinical trait anxiety (above the clinical 
cut-off score of 44; Spielberger et al., 1983) and her BDI - II score was 31, which 
indicated that she had severe depression (Beck et al., 1996). Her sensory pain score 
was 29 out of a possible 33 (SF – MPQ; Melzack, 1987), which indicated high levels 
of sensory pain and her general health score (SF – 36; Ware & Sherbourne, 1992) 
was 25 out of a possible 500, indicating extremely low levels of general health and, 
subsequently a lower quality  of life level.  
 Dee was psychologically-minded and engaged well with the research 
questions. She was able to elaborate on her thoughts and feelings easily. She was 
interviewed via telephone because she was in South Africa at the time of the 
interview. Due to the emotional content, the mode of the interview and the scores 
indicating high levels of anxiety and high levels of low mood, extra care was taken to 
debrief Dee post-interview and ensure that she knew who she could contact if she 
felt she needed to address some of the issues raised by the interview. 
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Case 2: Samson 
  I have to be aware of my body all of the time; when I’m working, when 
I’m thinking, I must think ‘at what level can I do this’? At what level can 
my body tolerate this? And I must be aware of where is the pain now? 
(from the interview with Samson). 
Samson was a 37 year old Black African man who lived in Nigeria. He was 
unmarried and lived with his parents and siblings. He was recruited through an SCD 
conference held by the Sickle Cell Society in London. Although he had lived with 
SCD his whole life, he was only diagnosed with disease around the age of seven. He 
worked part-time as an IT manager and had a part-time carer to enable him to work 
part-time and manage his illness and medical treatment. 
Samson had twice been admitted to hospital in the previous 12 months. His 
STAI – T score was 59, which indicated that he had clinical trait anxiety (above the 
clinical cut-off score of 44; Spielberger et al., 1983) and his BDI-II score was 18, 
which indicated that he had mild depression (Beck et al., 1996). His sensory pain 
score was 21 out of a possible 33 (SF – MPQ; Melzack, 1987), indicated average 
levels of sensory pain and his general health score (SF – 36; Ware & Sherbourne, 
1992) was 150 out of a possible 500, indicating low levels of general health and, 
subsequently lower quality  of life levels.  
Samson engaged well with the research questions. He was proficient in 
English, which was his second language. He was able to express his feelings clearly, 
but because he was interviewed via telephone (he was in Nigeria at the time of the 
interview), it was sometimes difficult to hear him clearly. Care was taken to debrief 
the participant post-interview and ensure Samson knew who he could contact if he 
felt he needed to address some of the issues raised by the interview. 
Findings 
The qualitative findings addressed three main issues: 1) general pain 
experience, 2) general anxiety and 3) general low mood. The findings also 
addressed some general questions regarding attention to pain, changes in pain and 
mood, and participant identity. Six themes emerged from the data: pain appraisal, 
purpose and change in identity, coping strategies, anger and frustration, social 
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construction of illness and, personal control. Common and contrasting codes 
emerged from the interviews. A table of themes and sub-themes is presented (see 
Table 6). 
Pain Appraisal 
Both Dee and Samson reported that they experienced pain all the time.  
 Dee: ‘I’ve always got pain....if I had one day a month pain free...’ 
 Samson: ‘The pain is always with me...’ 
Dee described her pain as ‘completely indescribable’ and reported that she 
found no meaning in pain, whilst Samson indicated that whilst he was always in pain, 
there were times where the pain was worse and these times occurred when he faced 
additional stressors, ‘I don’t really have extra pain unless I stress myself’.  Both 
cases identified that stress made their pain worse, however, Samson regarded 
stressful situations as within his locus of control, ‘....unless I stress myself’, whereas 
Dee did not report her stress with this same internal locus of control, ‘my pain is 
always made worse if I’m stressed about something’.  
 Both cases reported different types of pain,  
Dee: ‘We’ve got neuropathy, we cannot walk, the pain in your feet and 
legs is too terrible...’ 
Samson: ‘My joints, my stomach, my legs...and my back’, 
which was a constant battle for them. Dee described the battle as,  
‘A steady slide down, like snakes and ladders. You think that you are 
getting better and you go up the ladder and then you slide back even 
further than before’.  
She positioned this battle in relation to the fact that she had not always been 
ill and that being ill had affected her life and her identity. Her statement also 
suggested that she subconsciously had hope that she would fully recover, but that 
having this hope meant that when the pain intensity increased her pain would feel  
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Table 6 
Main Themes and Sub-themes used in the thematic analysis for exploring pain 
experience and general anxiety and low mood 
Themes Sub-themes 
Pain Appraisal 
Causation 
Constancy 
Description 
Purpose and Change in Identity 
Former purpose and identity 
Current purpose and identity 
Change in purpose and identity 
Conflict between former and current purpose and identity 
Coping Strategies 
Avoidance 
Distraction 
Emotion Release 
Humour 
Internet 
Medicine 
Practical 
Rationalising 
Social Support 
Anger and Frustration 
Conflict in accepting current identity 
Link to other expressed emotions 
Other people’s perceptions of illness 
Reduced personal control 
Social Construction of Illness 
Available social support 
Isolation 
Lack of professionals’ understanding 
Others’ lack of understanding 
Personal Control 
Acceptance/resignation 
Hyper-vigilance 
Locus of control 
Mind/Body connection 
Powerlessness 
Suicidal Ideation 
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worse than it did before. In contrast, as Samson had suffered from SCD from birth, it 
appeared that he was more able to position his pain on a time continuum,  
‘I can say that it’s gone better...’  
and he had developed strategies to avoid pain,  
‘I usually do a lot to be able to try and stay away from pain...I’m 
watching everything around me. I watch everything to see what will 
affect my body’. 
Purpose and Change in Identity 
Both cases spoke about how their diseases had affected their identities and 
gave them different purposes in life than what they might have otherwise had. Dee 
spoke about having time to,  
‘Reflect on your life and try to understand the meaning of life...I felt I 
was living a worthwhile life and now it feels like I’m not living a 
worthwhile life’. 
Her purpose in life had changed,  
 ‘I’ve always said life will always be worthwhile if you can make one 
person per day smile and forget their troubles...so far I’ve managed to 
make people laugh, then I feel it was not a wasted day’, 
however, the change was not easy for her, 
 ‘It’s hard to find a life that has meaning and is worthwhile. You’ve got to 
work at it’. 
Where Dee spoke more of finding her purpose in helping others, Samson’s 
sense of purpose was grounded in fighting to survive and using others’ negativity 
towards him as a source of inner strength and resilience, 
  ‘You only try to live and try to survive...I want to survive. I want to 
survive. If I don’t continue living then I won’t survive. That’s the main 
thing. That’s what keeps me going, I think. I just want to survive. I want 
to try and make it and it will even show people, at least, that they think 
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that ‘they will die’, ‘they are useless’, you know to prove them wrong. 
To prove them wrong. That’s what keeps me going’. 
When Samson and Dee did experience conflict in accepting their identities, 
the difference in experiences was that Dee reported that she did have a different 
identity before she developed cancer, 
 ‘I’m a human rights activist. I was in and out of court trying to help other 
people with human rights abuses...I founded a children’s home for 
abandoned, abused and neglected children, children with HIV and 
children left and been dying on the pavement...I also got on the wrong 
side of the government and ...had to pull me out and take me to the 
UK...I’ve led a very, very, very busy and dangerous life...now my life is 
restricted to my bedroom and the hospital and my bedroom and the 
hospital. And my internet...I felt I was living a worthwhile life and now it 
feels like I’m not living a worthwhile life’. 
Dee spoke about how difficult it was for her to experience and accept her new 
identity because of who she had been before and that this shift from an old identity 
and schema from before she was ill to her new identity with leukaemia often left her 
with internal conflict, 
  ‘I find it extremely difficult that my life has changed so drastically that I 
can’t do what I used to be able to do. There’s always fighting going on 
in my head. I want my old life back. I want it back and I can’t get it back 
and I never will get it back...life has become much smaller...I have to 
come to terms with the fact that I’m not going to get my old life 
back...that’s the fight and frustration that I have with myself all the 
time...I have a new identity. First of all I didn’t want to accept it – I was 
in denial and chasing...I’ve had to accept this is the way it is right now’. 
Dee also struggled with wanting to take morphine to manage her pain, but not 
liking the personality changes she experienced as a side effect, 
‘On morphine the pain is controlled, but I don’t like who I am. I’ve 
become extremely aggressive and nasty. And impatient’. 
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Where Dee yearned for her ‘old’ life, it would appear that Samson yearned for 
a different life to the one that he had always had and did not experience the same 
internal conflicts that Dee experienced, 
  ‘I feel like I’m in inertia. I don’t like it at all...sometimes I compare 
myself to my friends and what they are doing with their lives. Some of 
them are driving their own cars, live in their own houses, having 
families of their own, but I can’t do that. Because really, I can’t. I can 
see that it (SCD) has really changed everything. So, it’s not something 
that we like, it’s just something that we try to manage and live on. I 
don’t like being sick. I don’t like having Sickle Cell. I don’t like it’. 
Coping Strategies 
A variety of coping strategies were used by both Dee and Samson; some 
strategies were common to both cases and some were different. Both Dee and 
Samson used practical coping strategies to cope with their pain, 
Dee: ‘I put a pillow over my face and scream...it gives me an outlet...I 
give myself medicine...’ 
Samson: ‘I will take a pillow underneath my back...I will use hot water 
because of the joints...when I use hot water the pain will go down much 
more than when I don’t do anything...I usually use Panadol...’ 
Both Dee and Samson also used distraction techniques, social interactions 
and the internet as effective coping strategies to help them manage their pain, 
  Samson: ‘I know I’m in pain, but when I see them (my friends) around 
talking the anger goes down...I usually go online, chat with my friends 
or watch movies...’ 
 Dee: ‘I’ve also joined a group that’ve got the same kind of disease I 
have...I can also help other people to feel better...I can only help others 
now by the internet...you cannot help somebody else without helping 
yourself...I write my emotions down...’ 
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In addition, Samson used avoidance strategies to help him manage his pain 
and his difficult emotions, 
  ‘I avoid using drugs that I don’t know...I can’t take just any drugs, or 
use any balm, or use any water, or use any type of soap...Me with 
Sickle Cell, I don’t do that. I don’t do things that way. I don’t take things 
(my health) for granted. I avoid things that cause me to struggle 
because I know that it will cause me anxiety’. 
In comparison, Dee predominantly used humour and rationalising to help her 
to manage her pain and her difficult emotions, 
 ‘I start thinking about all those that are much worse than me...I just 
have to get through for the next minute. I just have to do the next 
minute. For tomorrow, I will be able to stretch it to an hour...tomorrow 
will be better and today is better than yesterday...If I am laughing, I 
cannot feel ill. It’s not possible to laugh and feel ill at the same time...for 
those few seconds, those few minutes, you get a way past your 
problems...I try to find the funny side in everything...’ 
Avoidance strategies, using humour and rationalising difficult thoughts and 
events are common coping strategies used to manage chronic pain (Caird et al., 
2011; Edwards et al., 2006; Jonassaint et al., 2010). 
 Anger and Frustration 
Anger and frustration were emotions that featured prominently in both of the 
interviews. When asked about their anxiety, both cases described having frustration 
and anger, 
 Dee: ‘I don’t get anxiety. I have frustration.’   
  Samson: ‘I can’t really describe it. I get angry, especially when I am 
having pain...so, I’m usually angry, so that’s it. That’s when I can tell 
that I’m anxious’. 
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 Dee reported that the origin of her anger was the conflict she experienced 
with wanting her old life back and knowing what she once was and learning to accept 
this, 
‘I have to come to terms with the fact that I’m not going to get my old 
life back. And that’s the fight and frustration that I have with myself all 
the time’. 
The origin of Samson’s anger was often linked to other peoples’ perceptions 
or treatment of him, 
  ‘People treat us like some type of taboo, or we are going to die...once I 
hear it my blood will start boiling. Those are the things that make me 
angry...people do some silly things and look down on us, but it makes 
me angry and instead of getting better, the pain gets worse. The things 
that make me angry are like ‘they are going to die’, ‘they are useless’, 
‘they can’t do this, they can’t do that’’. 
Samson also reported getting angry when his relatives got upset when they 
saw him in pain and also when he would have to relinquish his personal control 
when in pain, 
  ‘They’ll start getting upset...so...I don’t like it, I even get angry. First, I 
can’t do anything on my own. Second, I will have to rely at least 70% 
on my family...babysitting is the thing they usually do...when I am in 
pain I can get so angry. I get angry easily’. 
Dee linked her frustration to her low mood, 
  ‘Sometimes the frustration gets to a certain level and then it’s like you 
let go of the frustration and then uh, you become depressed – you can’t 
get yourself out of this hole...’ 
Dee described the relationship between her anger and low mood as a dark 
hole which was linked to her lack of personal control, 
  ‘The feeling of helplessness and hopelessness and a certain amount of 
anger...it makes me very frustrated when, um, something needs to be 
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done and the people around me can’t see the need that it must be 
done. And then, I’m struggling to find that because I’ve always been 
helping others, I find it difficult to ask for help for myself’. 
 Samson also linked his anger and frustration to his personal control, but 
rather than feeling a lack of personal control, it seemed that his anger and frustration 
were something that he had to monitor so that he could control them, 
  ‘I can’t say that it (his anger) has changed and I can’t say that it has not 
changed, I just try to avoid getting angry, that’s what I do. I monitor my 
mood and it always starts off with me getting annoyed, then I will stop 
what I’m doing...’ 
Social Construction of Illness 
Three main sub-themes emerged within this overall theme: medical 
professionals’ lack of understanding, others’ lack of understanding and isolation. 
Both participants felt that medical professionals  did not understand how they 
experienced their respective diseases and did not have adequate knowledge,  
Dee: ‘The knowledge they do have is – mostly comes from post 
mortems...You can’t shave your legs if you’re a female because the 
hair follicles start bleeding. You can’t shave your face if you’re a 
man...it’s all these things that the medical profession don’t even know 
about...doctors will only see what they recognise or what they see and 
what they’ve been taught and will only recognise what they see, so if 
anything falls outside of that they will not actually see it’. 
Samson: ‘Sometimes, the doctor will give me some hard drugs and 
expect me to be coping, but it doesn’t always work’.  
In addition, Dee spoke of how doctors looked at patients with rare illnesses 
like hers, and detached themselves emotionally from them because they could not 
fully help them,  
  ‘The doctors eventually look at you and because they can’t help you 
anymore, I’ve been told, ‘just hang in there’, uh, you know ‘it’s a 
medical science, it’s getting breakthroughs every day’...and doctors 
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also start losing their compassion and empathy for you, because there 
is nothing they can do for you...you just become a number. You actually 
can feel that the doctor is pulling emotional attachment away from you 
because they’ve gotta cope with all their patients. If they were 
emotionally connected to all their patients they would constantly be 
grieving’. 
 Others’ lack of understanding was associated with anger in both participants. 
  Dee: ‘They (my friends) don’t really know what’s going on. They look at 
me and they say ‘but you look so well, you wouldn’t say you were ill!’ I’d 
like to smash her teeth in...there’s no empathy, there’s no compassion’. 
Samson: ‘People treat us like some type of taboo, or we are going to 
die...once I hear it, my blood will start boiling...they (his work 
colleagues) don’t know really what I go through and they don’t care...I 
don’t like it at all...I told her (a woman he had been courting) I had 
Sickle Cell, she said that she can’t be with a man that’s going to die – ‘I 
like him, but I can’t like him’. 
However, both also had people in their lives that were able to provide social 
support in coping with their illnesses, 
Dee: ‘I said to my husband, I just have to get through for the next 
minute. I just have to do the next minute...If I go out, I must go with the 
wheelchair. My husband must push me...Only my children speak to me 
and my mother’s always believed, has always stood by me’. 
Samson: ‘They (my parents) are used to it...so they are coping 
well...they are very supportive. When I don’t usually feel like walking, 
usually they help me. They are coping well...If I have any friends I can 
chat with I will ask them to come over. So that time at least I will feel 
much happier – the mood will change. So, that’s much better than just 
sitting there alone’. 
And there was also a theme of isolation regarding managing the illness, 
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  Dee: ‘You fall outside the protocol of the norm...I’m the only one in 
Africa...There’s a few of us where nobody knows what it’s like, how 
horrible it is...I don’t see many people because I don’t have an immune 
system...it’s completely destroyed my relationship with my family, uh 
only my children speak to me and my mother’s always believed...it gets 
to this point where the doctors are now actually pulling away from me. 
Emotionally.’ 
  Samson: ‘I wouldn’t want to leave my room because maybe my niece 
will come and they’ll start getting upset...I’m the only Sickle Cell in my 
family, so it’s not good...’ 
Personal Control 
The theme of personal control appeared to be a vital theme running through 
both interviews. Several sub-themes emerged from this theme that helped to cluster 
different aspects of personal control that were highlighted in both cases. The ability 
to accept or be resigned to the illness demonstrated the participants’ sense of their 
locus of control regarding their illnesses. There were times when they both felt they 
had no control, or were powerless and for both participants, that was a time when 
they would actively think of ways of regaining control of their illnesses, either through 
suicidal ideation or through hyper-vigilance of their symptoms. This sense of control 
was closely linked to their ideas of how their mind influenced their pain and vice 
versa. This sense of control was also linked to their ability and their identity, or to 
their beliefs about having a choice about what was happening to them and how they 
could manage what was happening to them.  
Feeling powerless was closely linked to suicidal ideation in both participants. 
Having no control was linked to frustration, anger and depression and was also 
linked to having to rely on others to carry out tasks for them, 
 Dee: ‘Sometimes the frustration gets to a certain level and then it’s 
like you let go of the frustration and then, uh, you become depressed 
– you can’t get yourself out of this hole. You, you know it’s a struggle 
to get out of that dark hole...I’m so tired that I can go down the stairs, 
but I know that I will not be able to come up the stairs without help. 
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That makes me very frustrated....I get scared that I’m not going to die. 
I don’t want to live my life like it is now. I want to be well and I choose 
to live. And it’s just a constant struggle to be. To be’. 
 Samson: ‘(When I’m in pain) I will have to hold someone or hold the 
wall if I’m trying to walk...I can’t do anything, because if I’m out I will 
be totally stranded. I can’t do anything, especially on my own when I 
have a crisis; totally, it spoils everything until that pain goes 
away...First, I can’t do anything on my own. Second, I will have to rely 
at least 70% on my family, they do everything for me. Babysitting is 
the thing they usually do. I won’t be able to go and relieve myself on 
my own. It’s a struggle...Low mood will bring me down every time. I 
will lose focus and everything will go down... As the pain goes down, 
for example, the back pain, I feel so relieved because I don’t want to 
rely on people...I have no choice. I’m trying to cope, but I am not 
coping well. Just trying’. 
Suicidal ideation occurred when both participants felt powerless, or 
overwhelmed by their symptoms and was tempered by their beliefs about their ability 
to choose to live, 
 Dee: ‘I am not afraid to die...I have a new treatment that just keeps me 
alive. My doctor says that not taking it is like suicide. Don’t get me 
wrong, I want to live, but there have been times when I feel that it’s not 
worth it. All of us (her support group), we have a stash of pills which we 
keep for when the time comes and the pain is so unbearable...There’s 
no need to feel anxious, because when you’ve had enough of it, you 
can always take the pills and die. That’s the last bit of control one has 
in one’s life and knowing there’s that option makes you feel that you still 
have control. You are choosing to live today’. 
Samson: ‘Everything just comes down. Bad images start coming up. 
Like, what will it be like if I go?’ 
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The ‘mind-body’ connection sub-theme suggested that both Dee and Samson 
were aware that their emotions and thoughts affected their pain management and 
that their pain, in turn, affected their emotions and thoughts. 
  Dee: ‘I know that my body will respond to my emotions and um, the 
connection between one’s mood and one’s physical self, um, if I am 
depressed I will feel more sick...when you are busy you are not 
conscious of your body at all. And when you are pain, it brings your 
consciousness to your own body; to your physical self...I used to be 
able to use my willpower to get past this tiredness’. 
Samson: ‘I don’t really have extra pain unless I stress myself...it’s like 
something happens in my brain. Everything just comes down. Bad 
images start coming up...my health, at that time will get much worse 
and it won’t be fine you know?...Maybe it’s body over mind, or mind 
over body, I don’t know...Because the pain is always there, I usually 
forge ahead. I won’t let it stop me’. 
 The ‘mind-body’ connection was also related to the sub-theme of hyper-
vigilance. The participants used this knowledge of themselves and of their bodies to 
monitor mood and physical symptoms. Hyper-vigilance was more noticeable in 
Samson than in Dee, although Dee reported that she was conscious about what was 
happening in her body ‘95% of the time’, compared to Samson’s ‘80% of the time’. 
  Dee: ‘When you are in pain it brings your consciousness to your own 
body, to your physical self...I never paid any attention to my body. Now, 
um, my body is pulling me back to the material me’. 
 Samson: ‘What I usually do is watch out for signs of pain and stay there 
in my room ‘til I know that the pain has almost gone...I will just try to sit 
there and the pain and the anxiety will eventually go...Where the pain 
is, that’s where my focus will be...The pain will be quite bad and 
because I’m focussing on the pain it will be worse...I usually try to 
monitor my body so that I can be very comfortable or be prepared...at 
any moment I must be aware...I have to monitor my body...I have to be 
aware of my body all of the time; when I’m working, when I’m thinking, I 
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must think at what level can I do this? At what level can my body 
tolerate this?...I’m always aware of my body – every second. I must be 
aware at every moment...My body is so sensitive. It’s sensitive to 
anything around it...I’m now watching everything around me. I will 
watch everything to see what will affect my body.’ 
Reflexivity 
 Data Collection 
 The process of interviewing the participants left a powerful impression on me. 
Both interviews induced feelings of empathy, concern and genuine compassion in 
me that did resonate for some time after the interviews. The interviews also left me 
feeling sad and angry on behalf of my participants after hearing some of the difficult 
experiences the participants shared with me. For example, both participants 
experienced suicidal ideation and also experienced feeling isolated, helpless, low 
and misunderstood. There may have been some transference and counter-
transference of emotion during these occasions and it was important for me to 
manage these feelings effectively at that time and afterwards. I used the skills I have 
learned as a practitioner to stay with the participants’ feelings as far as was relevant 
to the interview process and was safe for the participants to do so and I shared my 
difficult thoughts and feelings with both my second research supervisor and with my 
personal therapist. This helped me to explore and unpack the feelings and to think 
about how these feelings were related to my participants’ experiences and to my 
own internal schemas. 
There were occasions during the process of the interviews where I was 
conflicted about my role as a researcher and my role as a counselling psychologist in 
training. For example, prior to the interviews I had spoken to my research supervisor 
about procedures to take if the participants expressed suicidal ideation. So, when the 
participants spoke about suicidal ideation it was important to evaluate the urgency 
and context of the risk before considering acting on the risk. My assessment of both 
situations was that whilst it was difficult for me to hear such painful experiences and 
difficult thoughts, it was in my participants’ best interests for me to maintain the role 
of the researcher and to listen to my participants’ experiences. I had provided a 
space for them to express their difficult feelings, thoughts and experiences and it 
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was important for me to be reflective enough to sit with my internal conflict and 
provide the much needed opportunity for them to express themselves freely and 
without judgement. In addition, there were occasions where I felt myself wanting to 
slip into ‘CBT mode’ where I could have been more directive in my manner and 
challenged some of the thought distortions that the participants exhibited. Doing this 
would not have been helpful to the participants at that time and would have been 
counter-productive to data collection. Being reflective of this process helped me to 
maintain a researcher role, rather than a counselling role and thus maintain the 
integrity of the study and also the participants’ best interests.  
 Process of Analysis 
I was mindful of how my motivation and my critical realist perspective of the 
study could influence the decisions that I made regarding the study and also of the 
impact of these influences on my analysis of the qualitative data. Being aware of and 
considering these influences provided an awareness that helped me to ‘bracket’ 
(Finlay & Gough, 2003) these influences during data collection and analysis. I also 
considered the potential influence that the first phase of the study had on shaping 
the interviews and also on influencing the phase II participants’ responses.  
 Thematic analysis does not follow a particular theory, but using Braun & 
Clarke’s (2006) application of thematic analysis, it was important to consider whether 
I was conducting an inductive or a theoretical thematic analysis. The analysis used 
an inductive thematic analysis (Braun & Clarke, 2006), which meant that whilst I may 
have had a general idea about what themes I had been hoping to find, the themes 
had to emerge from the data and be clearly identifiable, rather than to emerge from 
pre-developed coding frames or expectations. In addition, it was also important to 
consider whether I was going to examine themes at the semantic or the 
interpretative level (Boyatzis, 1998). The analysis was carried out at the 
interpretative level, where there was an examination of the ideas, assumptions and 
ideologies that lay under the content of the data (Braun & Clarke, 2006). 
 Whilst using a thematic analysis was appropriate and invaluable, there were 
some limitations of using this analysis.  Using a thematic analysis did not allow for 
deeper interpretations of the data other than providing detailed descriptions and 
groupings of codes and sub-themes. It would have been interesting to explore the 
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meaning of pain, anxiety and low mood with the participants to unpack any 
unforeseen connections and interpretations of these words. In addition, the analysis 
did not allow for an interpretation of language used, or an exploration of the meaning 
of being able to talk to the researcher about their experiences during the interviews. 
Pain is a subjective experience and it would have been interesting and maybe 
revealing to explore these terms and their meaning to the participants in more depth 
in both the interviews and also in the analysis. 
 During the analysis it was surprising to see the emergence of personal control 
and loci of control emerge as an important theme and sub-theme in the analysis. 
Whilst this finding was unexpected, the literature review indicated that perceptions of 
personal control can emerge as a theme in qualitative interviews (Caird et al., 2011) 
and as a variable in quantitative studies (Gibson et al., 2013). The emergence of 
these themes did increase the validity of adding a qualitative phase and analysis to 
the study, as the emergence of these themes added insight and richness to the 
quantitative data. 
Summary 
In summary, six themes emerged from the interviews: pain appraisal, purpose 
and change in identity, coping strategies, anger and frustration, social construction of 
illness and, personal control. Of these themes, personal control was a common 
thread across all the themes. There were common themes with contrasting 
categories present from both the interviews, which could indicate that experiencing 
chronic pain elicits a specific cognitive and/or emotional response that assists in 
maintaining physical health and survival as this was evidenced in both participants. 
The quantitative and qualitative results will be triangulated and discussed in the next 
chapter.  
Chapter 6: Discussion 
 The aim of this sequential explanatory mixed methods study was to 
investigate how trait anxiety was related to specific health outcomes and pain 
management in SCD. The first phase of the study was quantitative and investigated 
relationships between trait anxiety and health outcomes (depression, pain intensity, 
quality of life scores) in SCD and compared these relationships to those of a 
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comparison group (BC) and a control group (Carers). The second phase of the study 
was qualitative and explored pain, anxiety and low mood in a BC and a SCD 
participant who both had clinical levels of trait anxiety. This chapter will critically 
discuss the outcome of this study and will consider the implications of the findings 
with specific relevance to counselling psychology practice. 
Findings 
 The findings from both phases have initially been discussed separately and 
have been integrated in a separate sub-section. 
 Quantitative Research Aims and Hypotheses 
 This study investigated four hypotheses.  
H1: Depression scores and pain intensity scores will be positively 
related to higher trait anxiety scores and quality of life scores will be 
negatively related to higher trait anxiety scores in the complete sample. 
Trait anxiety was significantly predicted by higher depression scores and by 
lower quality of life scores in the complete sample and in the SCD sub-sample, thus 
supporting the hypothesis. This finding supports Ristvedt & Trinkaus’ (2009) report 
that higher levels of trait anxiety were significantly related to lower levels of quality of 
life in rectal patients. High levels of trait anxiety have been found to co-exist with high 
levels of depression (Thomas et al., 1998; 2001) and whilst high trait anxiety levels 
have been associated with reduced pain tolerance, rather than with pain perception 
(James & Hardattordir, 2002; Thibodeau et al., 2013), a positive relationship was 
found between pain intensity and trait anxiety in this study. It was also interesting to 
observe that the percentage of variance attributed to depression scores was higher 
in the SCD sub-sample (67.2%) than in the complete sample (48.1%). An 
explanation for this could be that the sub-sample was a more homogenous sample 
compared to the complete sample and this increased the sensitivity of the analysis in 
observing relationships between the sets of variables (Tabachnick & Fidell, 2007). 
The relationship between trait anxiety and depression was earlier reported as 
being unclear. The current study showed a clear directional relationship between 
higher levels of trait anxiety and higher levels of depression in a combined sample of 
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SCD, BC and Carers. In this sample, it is suggested that higher levels of trait anxiety 
could be related to increased worrying and rumination behaviour leading to an 
increase in low mood due to a perception of reduced personal control in all three 
sub-groups (SCD, BC, Carers). Anie et al. (2007), Caird et al. (2011) and Thomas et 
al. (2001) all reported that the perception of reduced control over illness and 
circumstances was related to increased levels of depression in SCD. Yarkin et al. 
(2009) also found a similar relationship between trait anxiety and depression in 
carers of quadripelgics and paraplegics with pressure sores. Therefore, it is 
suggested that the perception of personal control may have a role in mediating the 
relationship between trait anxiety and depression in all of the sub-groups.   
A relationship was found between higher levels of pain intensity and higher 
levels of trait anxiety in the complete sample. Trait anxiety may have caused hyper-
vigilant behaviour in all of the sub-groups, which may have caused the participants to 
notice their pain symptoms sooner than they would have had they not been as 
vigilant. Whilst the complete sample consisted of two pain groups (SCD, BC) who 
would be expected to show this relationship between pain intensity and trait anxiety, 
such a relationship may not be as expected with the Carers sub-group. Sensory pain 
is not considered to be a main feature of being a Carer, however, the Carers in this 
sample were exposed to chronic pain and illness. This, in combination with 
comparatively high trait anxiety levels, may have pre-disposed the Carers in this 
sample to be sensitive to pain. Distraction techniques are known to be effective in 
reducing pain perception (Anie et al., 2002; Midence & Elander, 1994; O’Connell-
Edwards et al., 2009) and may be an active coping mechanism used after the 
perception of pain has been noticed, by engaging hyper-vigilant behaviour. 
Therefore, whilst higher levels of pain intensity are related to higher levels of trait 
anxiety, it cannot be concluded that the relationship is a causal one as this study was 
a cross-sectional study. It is suggested that the relationship between pain intensity 
and trait anxiety in the complete sample was the consequence of hyper-vigilance in 
the sample. 
Higher trait anxiety levels have been shown to be related to lower quality of 
life in rectal patients (Ristvedt & Trinkaus, 2009) and in this study. It is not surprising 
that this finding supported the hypothesis. Lower quality of life is a variable 
associated with heightened sensitivity to distress (Wellington et al., 2010), 
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depression (Levenson et al., 2008), and increased pain experience (Pells et al., 
2005). Therefore, as an increase in these variables is also related to higher trait 
anxiety levels, it was concluded that trait anxiety would have a negative relationship 
with quality of life. However, this relationship is not fully understood in this current 
study and could be investigated with further research. 
H2: There will be a significant multivariate main effect for illness group 
(SCD, BC and Carers) and trait anxiety and depression scores. 
 The findings only partially supported the hypothesis. The BC group had higher 
depression scores than both the SCD and the Carer groups. Also, the BC group had 
significantly higher trait anxiety scores than the Carers, but not compared to the SCD 
group. However, the SCD group did not have significantly different trait anxiety nor 
depression scores than the Carers, which had not been predicted.  
The BC group had higher depression scores than both the SCD group and the 
Carers. Whilst this was expected, the finding supports the suggestion that having 
high trait anxiety levels in SCD may be adaptive, rather than maladaptive.  This 
suggestion is supported by the fact that the SCD group were not clinically depressed 
(Beck et al., 1996) and had relatively low depression scores despite having clinical 
levels of trait anxiety. Where other studies have shown a relationship exists between 
high trait anxiety and high depression scores in pain studies (De Vries et al., 2009; 
Thomas et al., 1998), this study shows that this was not the case with SCD and 
provides more evidence for the suggestion that there are different interpretations and 
expressions of depression in SCD compared to other chronic pain illnesses.  
  It had been predicted that the BC group would have higher trait anxiety 
scores than the SCD group because the role of trait anxiety in SCD, as a method of 
monitoring symptoms and stressors, was hypothesised to be an adaptive coping 
strategy in SCD, but not in BC. Consequently, since SCD is a disease that is 
symptomatic from the first year of life (Anie, 2005; Rees, 2003), it was rationalised 
that clinical levels of trait anxiety would have developed in childhood and 
adolescence due to the difficulties experienced with the disease (Burlew et al., 2000) 
and would have been maintained at relatively constant levels through adulthood as a 
personality trait. Since clinical levels of trait anxiety are related to poorer health 
outcomes, it was suggested that having excessively high trait anxiety levels would 
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have been detrimental to both mental and physical health and would not have been 
sustainable over the lifetime. Consequently, it was predicted that the BC group would 
have higher scores of trait anxiety because of the comparatively shorter length of 
time that these participants may have had their disease and because of the change 
in life circumstances since being diagnosed i.e. from previously not having a life-
threatening disease to learning to adapt to having one, therefore experiencing 
increased distress. Although the BC group did have higher trait anxiety scores (M = 
56.63; SD = 11.58) than the SCD group (M = 49.75; SD = 5.15), this difference was 
not statistically significant. In addition, whilst the SCD trait anxiety scores were not 
significantly different from those of the Carers, the SCD group did have higher trait 
anxiety scores than the Carers (M = 43.13; SD = 11.25). The lack of difference in 
trait anxiety score could be explained by the lack of power in the study caused by the 
low sample size.  
 It was expected that the BC group would have higher trait anxiety scores than 
the Carers and this hypothesis was supported by the study. High trait anxiety levels 
have been found in breast cancer (Van Esch et al., 2011) and in rectal cancer 
(Ristvedt & Trinkaus, 2009), so it was rationalised that high trait anxiety levels would 
also be experienced in the BC group. High levels of trait anxiety have been found in 
Carers (Kuscu et al., 2009; Pagnini et al., 2012; Sansoni, Vellone & Piras, 2004; 
Vignola et al., 2008; Yarkin et al., 2009) and have been associated with high 
depression scores and low quality of life. The trait anxiety scores in Carers in these 
studies were relatively lower than the clinical group that they were compared to e.g. 
in amyotrophic lateral sclerosis (Pagnini et al., 2012; Vignola et al., 2008), 
paraplegics and quadriplegics (Yarkin et al., 2009) and in Alzheimer’s Disease 
(Sansoni et al., 2004). Therefore, it was expected that both the clinical groups would 
both have higher trait anxiety scores than the Carers, but there was no significant 
difference between the Carers and the SCD group. The lack of difference in trait 
anxiety score could be explained by the lack of power in the study caused by the low 
sample size. This will be discussed in the limitations section. 
H3: There will be a significant multivariate main effect for illness group 
(SCD, BC and Carers) and sensory and affective pain scores (pain 
intensity).  
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 The SCD group had significantly higher sensory pain scores than the Carers, 
but not the BC group. This finding shows that the SCD participants did experience 
more pain than the Carers, but not significantly more pain than the BC group. Whilst 
it was expected that the SCD group would have significantly higher sensory pain 
scores than the BC group, a possible explanation for the two groups having similar 
sensory pain scores is that people with SCD have experienced their disease since 
birth and so may have developed a greater tolerance for pain than the BC group. 
Therefore, the sensory pain scores may reflect this increased pain tolerance. 
There was no significant difference in affective pain across the groups. This 
was an interesting finding since the Carer group was a control group, whilst both the 
SCD group and the BC group were diseases with acknowledged high levels of pain. 
The implications of this finding are that both the SCD group and the BC group were 
managing their affective pain effectively and this was reflected in their scores. 
Differences in affective and sensory pain scores have been found within 
different cohorts of SCD participants i.e. in a Jamaican and a UK cohort (Thomas et 
al., 2001). The Jamaican cohort experienced less affective and sensory pain than 
the UK cohort. Thomas et al. (2001) attributed this difference to differences in 
perceived control, socioeconomic status and social support in the samples. This 
current study did not investigate or control for these variables, so whilst no 
comparisons can be made regarding these variables, it is possible that the 
differences in perceived control, socioeconomic status and social support may have 
biased the affective pain scores in this study.   
Thomas et al. (1999) demonstrated that sensory pain may not be affected by 
emotional factors in  SCD by finding that there was no significant difference in 
sensory pain across three treatment conditions (CBT intervention, attention placebo, 
waiting list control group). This finding implies that perceived pain is independent of 
psychosocial stressors. The current study supports this finding, by not finding any 
significant difference in sensory pain across the illness groups. Further to this, 
Thomas et al. (1999) also showed that there was a difference in affective pain across 
treatment conditions, with the participants in the two intervention groups having 
significantly higher affective pain compared to the control group. Thomas et al.’s 
(1999) finding implies that there is a social and emotional aspect of pain that exists 
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within SCD and contributes to the overall sense of pain. Although the current study 
did not examine affective pain within groups, it showed that there was no difference 
in affective pain across groups, which could indicate that somatisation was not 
present within this study. Somatisation is associated with affective pain (Sogultu et 
al., 2011) and where no difference in affective pain was observed across groups, it 
has been tentatively concluded that somatisation was not a factor in this study. 
Wellington et al. (2010) found that pain intensity was predicted by somatisation in 
SCD. However, their study did not evaluate affective and sensory pain separately, 
which may have shown that only affective pain was predicted by somatisation in their 
study.  
It is important to differentiate between somatisation and hyper-vigilance in this 
study, because somatisation has been defined as a pathological attention to health-
related factors such as pain, which was not found to be the case in this study. This 
study suggests that hyper-vigilance to pain in SCD may be beneficial because it can 
help SCD sufferers to monitor their symptoms and either prevent or prepare for a 
vaso-occlusive crisis in SCD. 
 The current study employed the SF- MPQ (Melzack, 1987); a well known pain 
intensity scale that has been utilised with SCD in previous studies (Edwards et al. 
2006; Thomas et al., 1999; 2001; Wellington et al., 2010). The benefits of the scale 
are that it measures both affective and sensory pain, which is important in studies 
where somatisation may be a confounding issue; an association to affective pain can 
be evaluated separately from perceived pain. As such, its use in this study helped to 
improve the reliability, validity and comparability of the pain ratings in this current 
study. 
H4: There will be a significant multivariate main effect for illness group 
(SCD, BC and Carers) and quality of life subscale scores. 
 The hypothesis for this research question was partially supported by the 
findings. The SCD group only had significantly lower general health than the Carers 
and not the BC group as predicted. This finding, whilst unexpected, means that the 
SCD group did not have lower general health than the comparison group (BC). 
Reflecting on the other quantitative findings in this study, it is not surprising that the 
SCD group had similar levels of quality of life to the BC group because the two 
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groups had similar levels of trait anxiety, sensory and affective pain. However, the 
two groups had significantly different depression scores, with the BC group being 
more depressed than the SCD group. Higher depression scores have been related 
to lower quality of life scores in previous SCD studies (Anie, 2005; Gibson et al., 
2013; Levenson et al., 2008; Taylor et al., 2010). This study, however, showed that 
the SCD participants had relatively lower depression scores (compared to the 
comparison group), despite also having lower quality of life scores (compared to the 
control group). Whilst McClish et al. (2005) did not find that quality of life scores 
related to anxiety and depression were not significantly lower in SCD compared to 
haemodialysis and cystic fibrosis participants, the findings of this current study 
indicated that SCD quality of life scores were lower than those of the control group, 
but better than those of the clinical comparison group.  
 This study employed the SF- 36 (Ware & Sherbourne, 1992), which has been 
used in previous SCD studies (Anie et al., 2002; Asnani et al., 2009; Cummins & 
Anie, 2003; Edwards et al., 2006; Jenerette et al., 2012; McClish et al., 2005, 2006; 
Sogutlu et al., 2011) and its subscales are often separated and analysed individually, 
as this current study has also done. The SF-36 (Ware & Sherbourne, 1992) has 
been validated for use in Jamaicans with SCD (Asnani et al., 2009), which indicates 
the relevance of this quality of life measure for SCD. The SCD mean subscale 
scores from this study indicated better quality of life compared to the SCD mean sub-
scale scores from Anie et al.’s (2002) study, except for physical functioning which 
was the same mean score in both samples.  
Eliminated Variables 
As mentioned earlier, five variables were eliminated from the analyses, even 
as covariates, due to the lack of relationship with trait anxiety in the preliminary 
correlations. It was surprising that gender did not correlate significantly with trait 
anxiety because previous research has indicated that anxiety influences men and 
women differently (Egloff & Schmunkle, 2004; Leavell & Ford, 1983; Thibodeau et 
al., 2013) with women supposedly more prone to anxiety than men. However, in 
studies that investigate pain, it appears that men may experience greater emotional 
difficulties than women (Leavell & Ford, 1983) and anxiety may influence pain 
perception in men more than in women (Thibodeau et al., 2013) and that this may 
Trait Anxiety in SCD       
 
81 
 
have balanced out any gender differences in the relationship between trait anxiety  in 
this study. In addition, neither Citero et al. (2007) nor McClish et al. (2006) found that 
gender differences existed in pain experiences in SCD. 
It was not surprising that age did not correlate with trait anxiety, because the 
literature posits that trait anxiety is a construct that is stable over time and can be 
identified as a personality disposition towards anxiety (Eysenck & Derakshan, 1998; 
Spielberger & Smith, 1966). This would indicate that trait anxiety levels would remain 
stable after the emotional and cognitive development phases in childhood and 
adolescence and, therefore, a significant relationship between trait anxiety and age 
in this study was not expected, since only adults over the age of 18 participated in 
the study. 
There was no relationship between hospital admission frequency over the 
previous 12 months and trait anxiety. This was an interesting finding because 
according to the premise of this thesis, higher levels of trait anxiety were expected to 
be related to an increasing number of hospital admissions over 12 months. An 
explanation for this could be that there is stigma concerning hospital attendance 
which may have been a deterrent to attending hospitals for treatment despite 
observing or experiencing negative body changes or an impending vaso-occlusive 
crisis. Jenerette et al. (2014) reported that hospitals were avoided because of 
negative past treatment, which left sufferers feeling vulnerable and ashamed due to 
being perceived as drug addicts (Elander et al., 2006; Shapiro et al., 1997; Thomas 
& Taylor, 2002), or because sufferers did not want to miss life events or every day 
activities (Jenerette et al., 2014; Thomas & Taylor, 2002). 
No relationships were found between trait anxiety and physical functioning 
(from SF – 36) or trait anxiety and bodily pain (from the SF – 36). Since physical 
functioning is more dependent on pain intensity, physical disability and fatigue 
(Ameringer & Smith, 2011; Caird et al., 2011; Swanson et al., 2011) than on 
cognitive functioning, it is not surprising that no direct relationship was found 
between physical functioning and trait anxiety. It was surprising that no relationship 
was found between bodily pain and trait anxiety, because it was thought that higher 
levels of trait anxiety would be related to pain perception due to the symptom 
perception hypothesis (Watson & Pennebaker, 1989). However, the bodily pain sub-
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scale of the SF – 36 only had two items which investigated pain magnitude and pain 
interference. These items may not have been sufficient to measure or detect a 
relationship with trait anxiety considering the limited sample size of this study.  
Limitations of the Quantitative Phase 
An obvious shortcoming of the quantitative phase was the limited sample size 
that was used for the across illness group comparisons. The sample size was 
reduced from 51 to 24 to equalise the three illness groups because there were only 
eight participants in the BC group and the other groups were matched to the size of 
this group. The reduced sample size did affect the power of the study, thus the 
probability that the MANOVAs correctly rejected the null hypotheses when the null 
hypotheses were false was weakened (Field, 2013; Tabachnick & Fidell, 2013) and 
has affected the generalisability of the study. All of the quantitative findings may 
have been more robust with a larger sample size and with less variability between 
the groups. Mertens (1998) recommended that there should be at least 15 
participants per variable in correlational designs. This study examined 51 responses 
per variable to answer the first research question and only eight participants per 
variable to answer the remaining three quantitative research questions. The study 
accommodated for this by ensuring the groups used for the MANOVAs were equal in 
size to help to ensure that the assumptions of homogeneity of variance had not been 
violated (Field, 2013; Tabachnick & Fidell, 2013). There is heterogeneity within the 
overall sample and within the groups and future studies could keep this in mind 
regarding sample size; the more heterogeneity there is within a sample, the larger 
the sample size needs to be. Effect sizes were included in the quantitative results 
report to emphasise the size of the comparative differences between the groups 
(Field, 2013) and also for use as reference for comparisons with other studies. 
In addition, the sample used for the study was recruited through the 
community rather than through the NHS and medical sites. This recruitment strategy 
was chosen because of the study’s perspective; one of the aims of the study was to 
investigate if trait anxiety was adaptive in SCD. From this perspective and the critical 
realist perspective, it would not have been prudent to recruit directly from hospital 
sites because of the implication that patients who are hospitalised are more likely to 
be emotionally and physically distressed (Anie et al., 2012; Elander et al., 2006; 
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Harris, Parker & Barker, 1998; Jenerette et al., 2014; Thomas & Taylor, 2002) and 
are therefore, more likely to report negative health outcomes. This would have been 
counter-productive to this study and would have biased the study results by the 
participants being less able to objectively and accurately report how they experience 
their health outcomes generally. Not recruiting through the NHS did increase the 
difficulty in obtaining sufficient participant numbers for statistical analysis, but did 
maintain the integrity of the study.  
Another shortcoming of the quantitative aspect of the study is that the survey 
did not ask the BC participants how long they had cancer. If this variable had been 
reported, then the age of the SCD participants (length of time having a disease) 
could have been compared to the length of time since BC diagnosis to remission to 
examine if there was a relationship between trait anxiety and length of time of illness.  
It would have been interesting to investigate the relationship between coping 
and the health outcomes used in this study. Several SCD studies report assessing 
coping (Anie et al., 2002; 2007; Cummins & Anie, 2003; Thomas et al., 1999; 2001). 
These studies used the Coping Strategies Questionnaire for Sickle Cell disease, 
which is a disease-specific measure for use in adults (CSQ; Gil, Abrams, Phillips & 
Keefe, 1989), with an adapted version available for use in children and adolescents 
(Gil, Williams, Thompson & Kinney, 1991). This measure assesses coping attempts, 
negative thinking and passive adherence – factors which are all relevant to the 
disease. It would have been interesting to examine the relationship between trait 
anxiety and coping in relation to the experience of pain to examine if there was a 
relationship between coping and hyper-vigilance. 
Several questions were left unanswered by the quantitative results. Pain 
intensity, quality of life and trait anxiety levels were relatively similar between the 
SCD and the comparison group, despite a significant difference in depression scores 
between the illness groups and contrary to the hypotheses. There was no clear 
reason for the difference in these depression scores and how these differences may 
have affected pain management in SCD. The following sub-section discusses the 
results of the qualitative analysis.  
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 Qualitative Research Aim 
To explore how a BC participant and an SCD participant with clinical 
trait anxiety experience pain, anxiety and low mood in order to expand 
on the findings from the first two research aims by adding to the 
understanding of the suggested role of trait anxiety in SCD. 
 The qualitative phase of the study was secondary to the quantitative phase. 
The third research aim explored the pain, anxiety and low mood experiences in two 
comparison cases. Only two participants self-selected for phase II, but both 
participants met the requirements of having elevated trait anxiety levels above the 
clinical cut-off score of 44 (Spielberger et al., 1983). Six themes emerged from the 
data: pain appraisal, purpose and change in identity, coping strategies, anger and 
frustration, social construction of illness and, personal control. 
 Both participants reported that they experienced pain all of the time and 
expressed that stress exacerbated their pain. Findings by Anie et al. (2012) support 
this finding. Anie et al. (2012) showed that mood levels improved when pain levels 
decreased in SCD, but that a residual more manageable pain remained regardless 
of this. In addition, one of the themes that emerged from Thomas & Taylor’s (2002) 
study was that SCD was an unremitting disease. There were also differences in the 
issues that emerged from pain appraisal between the two participants. Sam (SCD) 
expressed that his pain was more within his locus of control, compared to Dee (BC) 
who exhibited an external locus of control. Locus of control refers to an individual’s 
perception about the underlying causes for events in a person’s life. Rotter (1966) 
identified the internal locus of control (where there is a belief that outcomes of our 
actions are self-dependent) and the external locus of control (the belief that events 
are outside our personal control). Rotter (1966) suggested that whilst having an 
internal locus of control was more advantageous because it was healthy for a person 
to believe that they had the ability to control things which they are capable of 
influencing, an external locus of control was more beneficial in chronic or terminal 
illness. An external locus of control was thought to remove some of the responsibility 
that a person would have regarding a chronic or terminal illness, where having 
personal control could not influence the progression of such an illness (Rotter, 1966). 
Regarding this study, Sam (SCD) exhibited internal locus of control, which according 
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to Rotter (1966) would not be as beneficial to him as having external locus of control, 
considering that he had a chronic and potentially terminal illness. The other 
difference in pain appraisal between the two participants was that they reported 
different types of pain: Sam (SCD) reported more specific areas of pain, which have 
been found to be common pain sites in SCD (McClish et al., 2009), whereas Dee 
(BC) experienced neuropathy (peripheral nerve damage). 
 Finding meaning and purpose and experiencing a change in identity were 
issues that arose for both the participants. Finding a purpose other than experiencing 
and managing pain was important to both Sam (SCD) and Dee (BC). This finding 
supports qualitative research by Caird et al. (2011) who found that creating more 
purposeful meaning independent of SCD appeared to reduce feelings of distress and 
was related to experiencing a certain degree of external locus of control e.g. by 
being religious or spiritual. 
 Coping emerged as an important theme when experiencing anxiety, low mood 
and pain. Both participants used distraction techniques, social interactions and the 
internet to manage their pain and distress. Social support has been found to be 
helpful in managing distress and the emotions related to poor pain control (Caird et 
al., 2011; Jenerette et al., 2014; Thomas & Taylor, 2002). Distraction techniques are 
well known in pain management literature (Adam et al., 1996; Eccleston et al., 2001, 
Linton & Shaw, 2011). Using the internet to connect to social networks and maintain 
social support and purpose appears to be a more recent and helpful communication 
tool for people suffering from chronic pain. It may help to prevent chronic pain 
sufferers from feeling isolated when they are physically restricted by their pain or 
disease-specific symptoms and can improve access to friends and family.  
Anger and frustration were emotions that appeared frequently in the 
interviews. For Dee (BC) the anger was mostly about her conflict about her changing 
identity and the sense of powerlessness she experienced because of this internal 
conflict. For Sam (SCD), his anger was linked to other people’s negative perceptions 
of him, because of his disease, and fuelled his sense of purpose. Personal control 
and finding a balance between external and internal loci of control were associated 
to anger in both participants. Levels of anger and frustration increased in both 
participants when they felt increasingly powerless. This association demonstrates 
Trait Anxiety in SCD       
 
86 
 
the value in examining and trying to improve pain control and the sense of purpose 
in chronic pain conditions; negative emotion levels and distress appear to increase 
when a reduced sense of self-efficacy and/or powerlessness is felt. Research by 
Anie et al. (2010) and Taylor & Thomas (2002) support this finding.  
 A lack of understanding from medical professionals was more of an issue for 
Dee (BC) than for Sam (SCD) as it seemed, from her perspective, that her local 
doctors were not cognisant of her symptoms and presentation and therefore could 
not help her appropriately. In SCD, a lack of understanding from medical 
professionals is more linked to misunderstanding the need for medication and 
analgesics (Edwards et al., 2006; Elander et al., 2003; 2004; 2006; Howard et al., 
2005; Maxwell et al., 1999; Solomon, 2010; Thomas & Cohn, 2006) and to being 
passively adherent (Anie et al., 2007; 2012; Thomas & Taylor, 2002).  
 Personal control was an important theme that emerged from the interviews. 
With both participants, feelings of powerlessness and reduced self-efficacy were 
related to anger and frustration and to low mood. These findings are supported by 
previous studies (Caird et al., 2011; Thomas & Taylor, 2002). The participants 
attempted to regain their sense of control through suicidal ideation or through hyper-
vigilance behaviours. Hyper-vigilant behaviour was expressed more by Sam (SCD) 
than by Dee (BC). Sam (SCD) used his hyper-vigilant behaviour to monitor signs of 
pain to prepare himself for or, to try to prevent a vaso-occlusive crisis from occurring. 
Doing this appeared to help his sense of personal control over his pain management 
as he was able to either prepare for, or prevent a crisis. Hyper-vigilance may have 
been adaptive in this circumstance compared to other studies of hyper-vigilance 
where health outcomes were reduced because of increased hyper-vigilance 
behaviours (Crombez et al., 2004; McDermid, et al., 1996). 
 Advantages and Disadvantages of Using Qualitative Methodology 
 There were several advantages and disadvantages of using qualitative 
methodology. Both participants were interviewed over the telephone due to 
geographical distances. Whilst both participants had been recruited in the UK, both 
had travelled abroad since they had participated in Phase I and were thus 
interviewed whilst they were abroad. Although it can be difficult to monitor emotional 
distress over the telephone, counselling psychology practice requires a high level of 
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skill in attending to voice nuances (Egan, 2010) and the researcher was able to use 
this skill to attend to emotional distress in the participants. The fact that the 
participants’ primary residence was abroad may have added uncontrollable variance 
to the study. For example, the participants may have had different experiences in 
healthcare and stigmatization in these other countries compared to predominantly 
UK participants. However, this current study’s findings have not been generalised to 
the UK population and the study has been positioned as a ‘pilot’ or introductory study 
whose findings require future research with a larger, more controlled sample size.  
 Semi-structured interviewing was used to interview the participants (see 
Appendix D). This followed the critical realist position that specific research 
questions needed to be answered, but that an informal approach allowed the 
participants to ‘feel’ their way through their thinking with the guidance of the 
researcher. This process enabled the conversation to flow more naturally, in a way 
similar to a real world conversation (Robson, 2011). Other advantages of using this 
method of interviewing were that there was freedom for the participant to explore 
unpredicted avenues of thought and provide data-rich responses and there was also 
interviewer flexibility in selecting aspects of the discourse to follow up (Coolican, 
2001). The disadvantages of using this method were that there was weak reliability 
between the participants, according to the post-positivist view (Creswell, 2009; 
Creswell & Plano Clark, 2006) but this was to be expected considering this was a 
socially constructed method of data collection and participants experiencing two 
different diseases were interviewed. This form of data collection was time consuming 
because of the flexibility of the structure of the questioning and the time taken to 
transcribe the interviews.  
 This study used a thematic analysis guided by Braun & Clarke (2006). This 
method of analysis was advantageous to the study as it summarised key features of 
the data and was not tied to a particular level of interpretation (Robson, 2011). This 
method also fit the critical realist paradigm (Bhaskar, 1988). However, this form of 
analysis limited the study to describing themes. Further exploration in the interviews 
and an in-depth data analysis would be required for more in-depth subjective 
experiences to be explored. Another disadvantage of using thematic analysis to 
analyse the data was that researcher reliability was reduced as the interpretation of 
themes was subjective to the researcher with supervisory support. It was also 
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important to be aware of internal consistency in the researcher and of researcher 
reflexivity. This was achieved by receiving supervisor feedback, keeping a record of 
analysis and analytical process and by examining researcher process throughout the 
analysis.  
Integration of Quantitative and Qualitative Findings 
Depending on the perspective of the reader, the first advantage/limitation of 
the study was that it was a mixed method study. Despite its difficulties, the 
integration of quantitative and qualitative elements was beneficial to the study and 
provided a holistic view of trait anxiety in SCD and how it may be related to pain 
management. From a critical realist perspective, it was an advantage and a privilege 
to be able to investigate and explore the personal experiences regarding pain. 
Reality was tested in the quantitative phase and was subjectively explored when it 
was observed that testing reality failed to provide a whole truth. Trait anxiety is a 
quantitative construct which needed to be quantified in the participants first; 
subsequently, potential relationships to pain management needed to be investigated 
and established. Once this was completed, it was apparent that further explorations 
were needed to source alternative issues or constructs that would enhance the 
understanding of the concept of trait anxiety in SCD and its relationship to pain 
management. 
There were two occasions where there was mixing of the quantitative and 
qualitative data. The first point was at the intermediate stage when participants for 
the second phase were selected based on the responses given in the first phase. 
Both participants were selected to be interviewed for the qualitative phase because 
they had clinical trait anxiety; trait anxiety scores greater than 44 (Spielberger et al., 
1983). The second point of integration was in this section where there is both 
complementary and convergent triangulation (Ivankova, Creswell & Stick, 2006; 
Ostlund et al., 2011).   
In the first phase of the study, it was shown that both the SCD and BC 
participants had higher levels of trait anxiety than the controls. Although the SCD 
group’s mean trait anxiety score was not significantly different to the BC group’s 
mean score, the results from phase II show that the SCD participant reported more 
hyper-vigilant behaviours than the BC participant did . This supports the argument 
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that the role of trait anxiety in SCD may be different to the role of trait anxiety in BC. 
Past research has argued that hyper-vigilance in fibromyalgia was related to 
increased pain intensity and lower pain thresholds (McDermid et al., 1996) and to 
increased pain intensity, higher levels of distress and higher levels of catastrophic 
thinking about pain (Crombez et al., 2004). In this current study there was no 
significant difference in sensory or affective pain between the SCD and the BC 
group, which indicated that increased hyper-vigilance did not always lead to 
increased pain intensity across groups and the relationship with and purpose of 
hyper-vigilance and pain may be different across pain groups. For example, hyper-
vigilance was associated with lower health outcomes in fibromyalgia compared to 
chronic low back pain (Crombez et al., 2004) and between fibromyalgia and 
rheumatoid arthritis (McDermid et al., 1996). 
Hyper-vigilance was not measured directly in this study. However, a 
relationship between high levels of trait anxiety and hyper-vigilance has been 
established in the literature (Cisler, Bacon & Williams, 2009; Crombez et al., 2004; 
Eysenck, 1992; Ouimet, Gawronski & Dozois, 2009; Yiend, 2010). In addition, 
experimental studies have evidenced a relationship between high levels of trait 
anxiety and vigilance for threat (Broadbent & Broadbent, 1988; Mogg, Bradley & 
Hallowell, 1994), thus showing a link between the concept of hyper-vigilance and 
trait anxiety. The Pennebaker Inventory for Limbic Languidness (Pennebaker, 1982) 
has been used to measure hyper-vigilance (McDermid et al., 1996), but does not 
specifically measure hyper-vigilance. This inventory was inappropriate for use in this 
study because participants would have to rate common symptoms and bodily 
sensations on a 5-item rating scale that has items that are genuine symptoms for 
both SCD and BC in differing degrees, for example, swollen joints are persistent 
symptoms in SCD. Therefore, using this measure may have biased the results. In 
addition, the Pain Vigilance and Awareness Questionnaire (McCracken, 1997) is a 
broad measure of attention to pain which can be applied to various pain populations. 
This measure was not used in this study because of its focus on attention to pain, 
whereas the objective of this study was to measure how hyper-vigilance could be an 
adaptive construct. It was decided to use a more generic hyper-vigilance measure 
i.e. STAI-T, that did not focus specifically on pain. 
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Another interesting finding was that the BC group had higher depression 
scores than the SCD group. The BC participant in phase II was shown to have a 
higher depression score and a more external locus of control compared to the SCD 
participant. Benassi, Sweeney & Dufour (1988) conducted a meta-analysis that 
effectively showed that external locus of control was related to depression scores; 
greater externality was significantly associated with higher depression scores and 
this relationship was consistent across the studies they investigated. The findings 
from this current study do appear to support this relationship. Thus, it could be 
suggested that exhibiting an internal locus of control could be related to lower 
depression scores. Applying this hypothesis to this study, it is suggested that the 
SCD participant simultaneously had clinical levels of trait anxiety and a non-clinical 
depression score because he exhibited an internal locus of control. This is an 
interesting finding because past studies have indicated that high trait anxiety is 
reported with high levels of depression as reported in literature review, but this was 
not the case with the SCD participant in phase II. This finding is supported by 
Thomas et al. (1999) who found that reducing anxiety and depression in SCD did 
reduce external locus of control perceptions, and by Gibson et al. (2013) who found 
that internal locus of control was associated with higher quality of life scores and 
lower depression scores.  
Phase II also showed that feeling powerless was linked to distress and was 
linked to locus of control. A shortcoming of the current study is that locus of control 
was not quantitatively examined. Locus of control has been examined in SCD (Anie 
et al., 2007; Gibson et al., 2013; Thomas et al., 1999) and has demonstrated the 
importance of considering the relationship between locus of control and depression 
in SCD. Future studies could examine the relationship between locus of control and 
hyper-vigilance to examine if being hyper-vigilant in SCD is related to a greater 
sense of pain control, thus improving their pain management.  
An unexpected finding was that both participants, despite having elevated 
levels of clinical anxiety, both identified experiencing anger and frustration rather 
than anxiety. This is an interesting finding because it directly links the emotions of 
anxiety and anger. One interpretation is that expressions of anger and frustration in 
chronic illness could be an indication of underlying high levels of anxiety and that the 
higher the levels of anxiety, the more likely feelings of anger and frustration will be 
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expressed and projected. Future research could investigate the relationships 
between trait anxiety, depression and loci of control to determine if relationships exist 
between the three variables and what direction, or influence these variables have on 
each other in chronic pain illnesses. 
This study did show that having a life purpose that was separate to managing 
pain may protect against depression and distress. The internet was shown to be a 
useful medium and coping strategy to communicate with ‘the outside’ world when 
isolated due to physical disability and or prevention of pain. 
Coping was not quantitatively assessed in this study. Coping has been 
extensively researched in SCD (Anie et al., 2002; 2007; Cummins & Anie, 2003; 
Simon et al., 2009; Thomas et al., 1999; 2001); passive adherence coping is 
associated with higher levels of depression and anxiety and active coping is 
associated with an internal locus of control. Investigating coping in this study may 
have provided some insight into how coping may have mediated the potential 
relationships between loci of control, trait anxiety and how pain is managed in SCD. 
There are a number of advantages of using the mixed method approach for 
this study. Using both quantitative and qualitative approaches produced a more 
complete understanding of how trait anxiety affected health outcomes in SCD. In 
addition, there were two different types of research questions being asked: one type 
required nomothetic responses, the other required idiographic responses; hence the 
necessity for this mixed approach. The combination of research approaches is 
transferable to real world settings because of the complexity of the phenomena 
concerning the approach that mimics real world situations (Robson, 2011) and 
consequently increases the generalizability of the study’s results (Creswell, 2009; 
Pluye et al., 2009). However, the findings from this study cannot be generalised due 
to the relatively small sample size.  
Using this type of design was time consuming (Burke & Onwuegbuzie, 2004) 
and progress to phase II was hampered by the low sample size and recruitment 
difficulties experienced in phase I. It was also possible that the research outcomes 
were the result of heterogeneity which the study was unable to control for. The 
qualitative part of the study depended on interviewing an SCD and a BC participant, 
but was dependent on participants in phase I being willing to participate in phase II 
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and meeting the criteria of having clinical levels of trait anxiety. Another difficulty of 
using mixed method designs in this study was that it was difficult to judge what had 
been gained by utilising both approaches in the study. It was especially important 
during this study to constantly reflect and examine what the intention of the individual 
phases of the study were and what was being gained from integrating them. This 
process helped to maintain the integrity of both approaches in the study and 
maintain an integrated study. This was done by maintaining research supervision, by 
reviewing research process and by analysing data as it was received. 
In general, it appears that integrating quantitative and qualitative data and 
methods was beneficial to the study and helped to answer the research questions 
holistically.  
Implications, Relevance and Recommendations of the Study 
 Implications for Practice and Relevance to Counselling Psychology 
This study highlights that psychological variables do affect pain management 
in SCD. Thomas et al. (1998; 1999) showed that a CBT intervention to improve pain 
management was only effective for 6 months. After 6 months, levels of anxiety and 
depression went back to pre-intervention levels. Thomas et al. (1999) suggested that 
this return to pre-intervention levels of distress, anxiety and depression was related 
to a gradual increase in ‘less adaptive’ coping strategies over the six month period 
after the CBT intervention had been completed, for example, noticing and acting on 
pain sensations and focussing attention onto the body. It may be worth considering if 
this occurred because elevated trait anxiety levels in SCD may have facilitated 
hyper-vigilant behaviour that monitored bodily symptoms to prevent or prepare for 
vaso-occlusive crises. According to this theory, engaging strategies to actively 
reduce anxiety levels could lead to more vaso-occlusive crises being experienced, 
which would increase levels of powerlessness and distress in SCD and thus may not 
be beneficial to pain management. Health professionals developing psychological 
interventions for pain management in SCD may need to consider supporting hyper-
vigilant behaviour to a degree where it is not counter-productive and could lead to 
increased pain intensity as reported in previous studies (Crombez et al., 2004; 
McDermid et al., 1996).  
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 It is important for psychological practitioners to be mindful that anxiety and 
depression can interact in different ways in different pain conditions. This study 
demonstrates this and supports the argument that pre-intervention anxiety can 
predict patterns of change in treatments for depression and that practitioners need to 
be mindful of the lack of ability to generalise regarding all pain conditions, but SCD in 
particular. Forand & De Rubeis (2013) support this argument. In addition, 
practitioners may need to be mindful that expressions of anger and frustration may 
indicate underlying and unrecognised anxiety that may need to be addressed as a 
primary concern before addressing emotions of anger and frustration. 
 The qualitative results indicated that psychological practitioners should 
consider developing interventions that focus on exploring anger and frustration, 
rather than depression. Whilst these emotions are related, it may be that the 
approach taken may focus on reducing depression by managing anger and 
increasing the perception of personal control, rather than focussing generally on 
reducing anxiety and depression. It was also shown that how health professionals 
view SCD participants can affect healthcare utilisation and passive adherence 
coping. Consequently, it is important that healthcare practitioners are more informed 
in their decision-making regarding patient care in SCD and are more sensitive to 
cultural beliefs about pain management. 
 Counselling Psychologists work within general medicine settings where SCD 
clients present with acute and chronic pain and distress. This study demonstrates 
the importance of considering the role that psychological variables play in pain 
management; however, it is also important to consider that SCD clients may not 
believe that psychology plays a role in pain management. It may be difficult to 
access SCD clients because of this belief and increasing awareness of the 
counselling psychology role in pain management may be an essential part of the role 
of a counselling psychologist. 
 Implications for Research 
 As mentioned earlier, future research could investigate the effectiveness of 
personal control/anger management interventions for pain management. A 
longitudinal study examining trait anxiety from childhood through to adolescence 
could identify if trait anxiety is a trait that develops in the early years of the disease to 
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manage pain in the illness, or if it is a situational trait regarding the disease. A 
shortcoming of the survey used in this study is that it did not measure the time 
between diagnoses to recruitment of the BC participants. Thus, a comparison 
between SCD and BC examining the effects of the longevity of the diseases was not 
possible in the study. A comparison can be made by examining the relationship 
between the ages of SCD participants and the BC participants’ time from diagnosis. 
It would also be interesting to compare the relationship between trait anxiety and 
pain in SCD compared to fibromyalgia to examine the effect of hyper-vigilance on the 
experience of pain. An in-depth phenomenological approach to exploring the 
experience of SCD may give a more thorough understanding of the experience of 
the disease and of how locus of control and/or hyper-vigilance may affect pain 
management. 
 Reviewing Smith et al.’s (2005) draft conceptual model, it was observed that 
the model emphasised healthcare utilisation rather than pain experience. The current 
study placed emphasis on pain management, with pain experience being the most 
prominent and persistent feature of the disease. Considering this and integrating the 
current study’s findings into the model (see Figure 3), it has been suggested that 
there is a directional link between disease – related variables and psychosocial 
variables that was not in the original model. This study demonstrated that treatment 
and pain location can affect quality of life, coping behaviours (hyper-vigilance) and 
social support and that these variables can also affect treatment efficacy and pain 
location. It is suggested that the relationship between distress disability and 
psychosocial behaviours is a two-way relationship because distress disability was 
found to be related to hyper-vigilance (coping behaviours). Finally, the findings from 
this study suggest that there is a two-way relationship between readiness variables 
and pain. It is hypothesised that a relationship exists between hyper-vigilance of the 
perceived threat of pain and pain experience/management and also that pain 
intensity and experience can affect the perceived threat. Future studies can focus on 
improving and refining the model and evaluating the relevance of the suggestions 
that this study has made. 
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Conclusion 
In conclusion, the findings from this study suggest that trait anxiety plays a 
role in SCD; hyper-vigilant behaviour (as represented by elevated levels of trait 
anxiety in SCD) may help sufferers to monitor their physical symptoms and alert 
them to negative changes in order to prevent or prepare for vaso-occlusive crises. 
By investigating the relationship between trait anxiety and several health outcomes it 
was possible to refine the specific variables that needed to be explored further 
through subjective experience. It is hoped that this thesis has added to the 
psychological knowledge about SCD and has highlighted the impact of psychological 
processes on pain management in SCD in adults. This study could have focussed on 
either the quantitative or the qualitative phase, but it was only by mixing 
methodologies that a better understanding of the research problem was achieved. 
Several avenues for future research have been highlighted throughout the 
discussion and it is hoped that the results of this study will be productive and 
beneficial for the people who suffer from Sickle Cell Disease.
Trait Anxiety in SCD       
 
96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Disease-related variables 
- Genotype 
- Haematologic measures 
- Medical complications 
- Co-morbidity 
- Treatment 
- Pain location 
Psychosocial variables 
- Stress 
- Mental health status 
- Coping behaviours 
- Social Support 
Demographics 
- Age 
- Gender 
- Education 
Readiness variables 
- Access 
- Perceived threat 
- Perceived 
benefits/barriers 
 
 
Distress Disability 
 
 
Healthcare Utilisation 
 
 
Pain 
Figure 3: Suggested additions to the conceptual explanatory model of pain in SCD 
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ETHICAL PRACTICE CHECKLIST (Professional Doctorates) 
 
SUPERVISOR:  Meredith Terlecki  ASSESSOR: Virginia Lam 
 
STUDENT: Dede-Kossi Osakonor  DATE (sent to assessor): 26/06/2012 
 
Proposed research topic: Trait anxiety in Sickle Cell Disease: investigating and exploring links to the 
management of pain in Sickle Cell Disease.  
Course: Prof. Doc Counselling Psychology 
1.   Will free and informed consent of participants be obtained?  YES  
2.   If there is any deception is it justified?     N/A   
   
3.   Will information obtained remain confidential?     YES  
     
4.   Will participants be made aware of their right to withdraw at any time? YES 
5.   Will participants be adequately debriefed?    YES—see below 
       
6.   If this study involves observation does it respect participants’ privacy? NA 
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2. Physical   NO 
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REQUEST FOR AMENDMENT TO AN ETHICS APPLICATION 
 
 
 FOR BSc, MSc/MA & TAUGHT PROFESSIONAL DOCTORATE STUDENTS  
Please complete this form if you are requesting approval for proposed amendment(s) to 
an ethics application that has been approved by the School of Psychology. 
Name of applicant:  Dede-Kossi Osakonor    
Programme of study: Professional Doctorate in Counselling Psychology   
Title of research: Trait anxiety in Sickle Cell Disease: investigating and exploring links to the 
management of pain 
Name of supervisor: Dr Meredith Terlecki   
Briefly outline the nature of your proposed amendment(s) and associated rationale(s) in the 
boxes below 
Proposed amendment Rationale 
I would like to change the comparison group 
from Bowel cancer to Blood Cancer as I have 
found it difficult to recruit Bowel Cancer 
participants. 
My study is a mixed-method study which 
includes three participant groups: Sickle Cell 
Disease, Bowel Cancer and Carers. This 
change does not affect any aspect of the 
study, other than that the comparison group 
will be Blood cancer, rather than Bowel 
cancer. 
 
To be able to interview participants over the 
telephone, in addition to the previously 
The ethical approval I received includes me 
collecting qualitative data through face-to-
face semi-structured interviews. I am asking 
to conduct recorded interviews through the 
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approved method of interviewing in person. 
 
telephone for the convenience of the 
participants who may find it difficult to 
physically attend meetings. 
 
Please tick YES NO 
Is your supervisor aware of your proposed amendment(s) and 
agree to them? 
X  
 
Student’s signature (please type your name): Dede-Kossi Osakonor  
Date: 13.04.2014    
 
TO BE COMPLETED BY REVIEWER 
 
 
Amendment(s) approved 
 
YES 
 
 
 
Comments 
 
Reviewer: M. Finn 
Date:  21/04/14 
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UNIVERSITY OF EAST LONDON 
School of Psychology 
Stratford Campus 
Water Lane 
London E15 4LZ 
 
The Principal Investigator(s) 
Dede-Kossi Osakonor 
U1019289@uel.ac.uk 
I would like to invite you to participate in a research study that is being 
conducted as part of my Professional Doctorate in Counselling Psychology 
degree at the University of East London. 
Project Description 
The study is exploring how mood affects pain management and quality of 
life in Sickle Cell Disease, Blood Cancer and in Carers. Participants will 
be asked to go to this website 
http://www.surveymonkey.com/s/UELpainmood2013 and complete as 
much of it as possible. The questions should not take more than 15 minutes 
to answer and you can save your answers and return to complete the 
questionnaire when you have time.  
It is possible that participants may feel distressed during or after 
completing the questionnaire – counselling agencies and help lines have 
been provided at the end of the questionnaire to help with the distress. 
 
Confidentiality of the Data and safety 
Your data will be anonymous unless you wish to participate in the 2
nd
 
phase of the study as you will have to provide your contact details to be 
contacted to participate in the 2
nd
 phase of the study. However the data 
provided in the 2
nd
 phase of the study will be anonymised and will not be 
linked to any contact details or personal information. The primary 
researcher will be the only person who has access to the data.  
All the data will be kept electronically for 3 years after the conclusion of 
the study on a password protected external hard-drive. After 3 years the 
electronic data file will be deleted and only reports and articles 
summarising the data will continue to exist.  
You are not obliged to take part in this study. You are free to withdraw at 
any time. Should you choose to withdraw from the study you may do so 
without any consequences.  
Please feel free to email me any questions that you may have at 
u1019289@uel.ac.uk  
If you have any questions or concerns about how the study has been 
conducted, please contact the study’s supervisor: Dr Meredith Terlecki, 
School of Psychology, University of East London, Water Lane, London 
E15 4LZ, +44 (0)20 8223 4463,  m.terlecki@uel.ac.uk  
Or 
Chair of the School of Psychology Research Ethics Sub-committee: Dr. 
Mark Finn, School of Psychology, University of East London, Water Lane, 
London E15 4LZ, 020 8223 4493,  m.finn@uel.ac.uk  
Thank you. 
 
Dede-Kossi Osakonor 
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UNIVERSITY OF EAST LONDON 
School of Psychology 
Stratford Campus 
Water Lane 
London E15 4LZ 
 
The Principal Investigator 
Dede-Kossi Osakonor 
U1019289@uel.ac.uk 
 
The purpose of this letter is to provide you with the information that you need to consider in deciding whether to 
participate a research study. The study is being conducted as part of my Professional Doctorate in Counselling 
Psychology degree at the University of East London. 
Project Title 
Trait anxiety in Sickle Cell Disease: investigating and exploring links to the management of pain in Sickle Cell 
Disease. 
Project Description 
The study is exploring how mood affects pain management and quality of life in Sickle Cell Disease and in 
Blood Cancer. Participants will be asked questions over a 50 minute period in a one-to-one interview about how 
they describe their moods, their hospital admissions, their pain and their quality of life. The interviews will be 
audio recorded and participants will be able to ask questions about the research and about the questions that will 
be asked. The interviews may also be conducted over the telephone if participants have mobility difficulties and 
may find it difficult to physically attend a meeting. The researcher’s phone will not be on speakerphone during 
this interview and the researcher will be alone in a private and secure room to ensure participant confidentiality 
and privacy. The telephone interviews will also be recorded through a recording device application on the 
researcher’s phone. 
It is possible that participants may feel distressed during or after the interview and counselling agencies and help 
lines will be provided to help with the distress. 
Confidentiality of the Data and safety 
The interviews will be coded by providing a serial number on the interview that will be stored separately from 
contact information. The primary researcher will be the only person who has access to either form of data which 
will not be shared with anyone else. In the transcriptions all identifiable names will be changed. The audio data 
will be stored digitally on a password locked external hard-drive.  
All the data will be kept electronically for 3 years after the conclusion of the study on a password protected 
external hard-drive. All paper records will be destroyed at the end of the study. 
The interviews will take place at a room in your local support group in London, or over the telephone. 
You are not obliged to take part in this study and should not feel coerced. You are free to withdraw at any time. 
Should you choose to withdraw from the study you may do so without disadvantage to yourself and without any 
obligation to give a reason.  
Please feel free to ask me any questions. If you are happy to continue you will be asked to sign a consent form 
prior to your participation. Please retain this invitation letter for reference.  
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If you have any questions or concerns about how the study has been conducted, please contact the study’s 
supervisor: Dr Meredith Terlecki, School of Psychology, University of East London, Water Lane, London E15 
4LZ, +44 (0)20 8223 4463,  m.terlecki@uel.ac.uk 
or  
Chair of the School of Psychology Research Ethics Sub-committee: Dr. Mark Finn, School of Psychology, 
University of East London, Water Lane, London E15 4LZ. 
(Tel: 020 8223 4493. Email: m.finn@uel.ac.uk) 
Thank you in anticipation. 
Yours sincerely, 
Dede-Kossi Osakonor 
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UNIVERSITY OF EAST LONDON 
 
Consent to participate in a research study  
Trait anxiety in Sickle Cell Disease: investigating and exploring links to the management of pain in 
Sickle Cell Disease. 
I have read the information sheet relating to the above research study and have been given a copy 
to keep. The nature and purposes of the research have been explained to me, and I have had the 
opportunity to discuss the details and ask questions about this information. I understand what is 
being proposed and the procedures in which I will be involved have been explained to me. 
I understand that my involvement in this study, and particular data from this research, will remain 
strictly confidential. Only the researcher involved in the study will have access to identifying data. It 
has been explained to me what will happen once the research study has been completed. 
I hereby freely and fully consent to participate in the study which has been fully explained to me. 
Having given this consent I understand that I have the right to withdraw from the study at any time 
without disadvantage to myself and without being obliged to give any reason.  
 
Participant’s Name (BLOCK CAPITALS)  
 
……………………………………………………………………………………. 
Participant’s Signature  
 
……………………………………………………………………………………….. 
Researcher’s Name (BLOCK CAPITALS)  
 
……………………………………………………………………………………….. 
Researcher’s Signature  
 
………………………………………………………………………………………… 
 
Date: ……………………..……. 
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Participant Information 
  
I would like to invite you to participate in a research study that is being conducted as part of my Professional Doctorate in Counselling  
Psychology degree at the University of East London. Before you decide whether or not to take part, it is important for you to understand why  
the research is being done and what it will involve. Please take time to read the following information carefully.  
  
Project Description  
The study is exploring how mood affects pain management and quality of life in Sickle Cell Disease, Blood Cancer and in Carers. Participants  
will be asked to go to this website https://www.surveymonkey.com/s/UELpainmood2013 and complete as much of it as possible. The questions  
should not take more than 15 minutes to answer and you can return to complete the questionnaire when you have time.  
  
It is possible that participants may feel distressed during or after completing the questionnaire – counselling agencies and help lines have  
been provided at the end of the questionnaire to help with the distress.  
  
Confidentiality of the Data and safety  
Your data will be anonymous unless you wish to participate in the 2nd phase of the study. The primary researcher will be the only person who  
has access to the data.  
All the data will be kept electronically for 3 years after the conclusion of the study on a password protected external hard-drive. After 3 years  
the electronic data file will be deleted and only reports and articles summarising the data will continue to exist.  
You are not obliged to take part in this study. You are free to withdraw at any time. Should you choose to withdraw from the study you may do  
so without any consequences.  
  
Please feel free to email me any questions that you may have at u1019289@uel.ac.uk  
If you have any questions or concerns about how the study has been conducted, please contact the study’s supervisor: Dr Meredith Terlecki,  
School of Psychology, University of East London, Water Lane, London E15 4LZ, +44 (0)20 8223 4463, m.terlecki@uel.ac.uk  
Or  
Chair of the School of Psychology Research Ethics Sub-committee: Dr. Mark Finn, School of Psychology, University of East London, Water  
Lane, London E15 4LZ, 020 8223 4493, m.finn@uel.ac.uk  
  
Thank you.  
  
Dede-Kossi Osakonor  
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Participant Consent Form 
  
as part of my Professional Doctorate in Counselling Psychology degree at the 
*1. I would like to invite you to participate in a research study that is being conducted 
University of East London. Before you decide whether or not to take part, it is important 
for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully. 
Project Description 
The study is exploring how mood affects pain management and quality of life in Sickle 
Cell Disease, Blood Cancer and in Carers. Participants will be asked to go to this 
website 
https://www.surveymonkey.com/s/UELpainmood2013 and complete as much of it as 
possible. The questions should not take more than 15 minutes to answer and you can 
save your answers and return to complete the questionnaire when you have time. 
It is possible that participants may feel distressed during or after completing the 
questionnaire – counselling agencies and help lines have been provided at the end of 
the questionnaire to help with the distress. 
Confidentiality of the Data and safety 
Your data will be anonymous unless you wish to participate in the 2nd phase of the 
study. The primary researcher will be the only person who has access to the data. 
All the data will be kept electronically for 3 years after the conclusion of the study on a 
password protected external hard-drive. After 3 years the electronic data file will be 
deleted and only reports and articles summarising the data will continue to exist. 
You are not obliged to take part in this study. You are free to withdraw at any time. 
Should you choose to withdraw from the study you may do so without any 
consequences. 
Please feel free to email me any questions that you may have at u1019289@uel.ac.uk 
If you have any questions or concerns about how the study has been conducted, 
please contact the study’s supervisor: Dr Meredith Terlecki, School of Psychology, 
University of East London, Water Lane, London E15 4LZ, +44 (0)20 8223 4463, 
m.terlecki@uel.ac.uk 
Or 
Chair of the School of Psychology Research Ethics Sub-committee: Dr. Mark Finn, 
School of Psychology, University of East London, Water Lane, London E15 4LZ, 020 
8223 4493, m.finn@uel.ac.uk 
Thank you. 
 
Dede-Kossi 
Osakonor 
 
Trait Anxiety in SCD       
 
126 
 
I agree to participate 
  
  
I do not wish to participate 
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Participant Group 
  
*2. Which of these applies to you? 
I have sickle cell disease 
  
I have thalassaemia 
  
I have a blood cancer  
(please write what type in the  
'other' box)  
I am a carer 
  
Other (please specify)  
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3. What is your gender? 
Male 
  
  
Female 
*4. Do you consider yourself to have a disability? 
No 
  
  
Physical impairment 
Sensory impairment 
  
  
  
Mental health condition 
Learning disability/difficulty 
Long-standing illness 
  
  
I do not wish to disclose 
Other 
  
Other (please specify)  
5. How old are you? 
Years 
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*6. What is your ethnic origin? 
Black or Black British African 
  
  
Black or Black British Caribbean 
Any other Black background 
White and Black African 
  
  
  
White and Black Caribbean 
White and Asian 
  
Any other mixed race background 
White British 
White Irish 
  
  
  
  
  
  
White European 
Other white background 
Asian or Asian British Indian 
Asian or Asian British Bangladeshi 
Asian or Asian British Pakistani 
Other asian background 
Chinese 
  
  
  
  
  
Other chinese background 
Other (please specify)  
the last 12 months? 
*7. How many times have you been admitted to hospital because of your illness within 
  
*8. How many unbearably painful episodes did you experience within the last month? 
  
9. Have you had any psychological therapy to help you manage your illness? 
YES, please specify: 
NO 
10. What is your marital status? 
Single 
  
  
  
Married 
Civil partnership 
Divorced 
  
  
  
Widowed 
Separated 
A member of an unmarried couple 
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11. Do you currently have a carer? 
Yes, full time 
  
  
Yes, part time 
No 
  
12. Are you employed? 
Yes, full time 
  
  
  
  
Yes, part time 
I am self-employed 
No, I am unable to work 
No, I am retired 
  
No, I am a homemaker/housewife/househusband 
No, I am a student 
  
  
  
No, I am unable to find work 
Other (please specify)  
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A number of statements which people have used to describe themselves are given below. Read each statement and then choose the  
statement that applies to you and that indicates how you generally feel. There are no right or wrong answers. Do not spend too much time on  
any one statement and click the answer which seems to describe how you generally feel. PLEASE RESPOND TO ALL ITEMS.  
*13. I feel pleasant 
Almost Never Sometimes Often Almost Always 
    
*14. I feel nervous and restless 
Almost Never Sometimes Often Almost Always 
    
*15. I feel satisfied with myself 
Almost Never Sometimes Often Almost Always 
    
*16. I wish I could be as happy as others seem to be 
Almost Never Sometimes Often Almost Always 
    
*17. I feel like a failure 
Almost Never Sometimes Often Almost Always 
    
*18. I feel rested 
Almost Never Sometimes Often Almost Always 
    
*19. I am 'cool, calm and collected' 
Almost Never Sometimes Often Almost Always 
    
*20. I feel that difficulties are piling up so that I cannot overcome them 
Almost Never Sometimes Often Almost Always 
    
*21. I worry too much about something that really does not matter 
Almost Never Sometimes Often Almost Always 
    
*22. I am happy 
Almost Never Sometimes Often Almost Always 
    
*23. I have disturbing thoughts 
Almost Never Sometimes Often Almost Always 
    
*24. I lack self-confidence 
Almost Never Sometimes Often Almost Always 
    
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*25. I feel secure 
Almost Never Sometimes Often Almost Always 
    
*26. I make decisions easily 
Almost Never Sometimes Often Almost Always 
    
*27. I feel inadequate 
Almost Never Sometimes Often Almost Always 
    
*28. I am content 
Almost Never Sometimes Often Almost Always 
    
*29. Some unimportant thought runs through my mind and bothers me 
Almost Never Sometimes Often Almost Always 
    
*30. I take disappointments so keenly that I cannot put them out of my mind 
Almost Never Sometimes Often Almost Always 
    
*31. I am a steady person 
Almost Never Sometimes Often Almost Always 
    
*32. I get in a state of tension or turmoil as I think over my recent concerns or interests 
Almost Never Sometimes Often Almost Always 
    
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For this part of the questionnaire there are groups of statements. Please read each group of statements carefully, then pick out the one  
statement in each group which best describes the way you have been feeling in the PAST MONTH. Tick the box beside the statement you  
picked. If several responses seem to apply to you, choose the one that applies to you TODAY.   
  
There are no right or wrong answers. Do not spend too much time thinking about each item.   
PLEASE RESPOND TO ALL ITEMS.  
*33. BDI1 
I do not feel sad 
I feel sad 
  
  
  
I am sad all the time and cannot snap out of it 
I am so sad or unhappy that I cannot stand it 
  
*34. BDI2 
I am not particularly discouraged about the future 
I feel discouraged about the future 
  
  
  
  
I feel I have nothing to look forward to 
I feel that the future is hopeless and that things cannot improve 
*35. BDI3 
I do not feel like a failure 
  
  
  
I feel I have failed more than the average person 
As I look back on my life I can see a lot of failures 
I feel I am a complete failure as a person 
  
*36. BDI4 
I get as much satisfaction out of things as I used to 
I do not enjoy things the way I used to 
  
  
  
I do not get real satisfaction out of anything anymore 
I am dissatisfied or bored with everything 
  
*37. BDI5 
I do not feel particularly guilty 
  
  
I feel guilty a good part of the time 
I feel quite guilty most of the time 
I feel guilty all of the time 
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*38. BDI6 
I do not feel I am being punished 
I feel I may be punished 
I expect to be punished 
  
  
  
  
I feel I am being punished 
*39. BDI7 
I do not feel disappointed in myself 
I am disappointed in myself 
I am disgusted with myself 
I hate myself 
  
  
  
  
*40. BDI8 
I do not feel I am any worse than anybody else 
  
  
I am critical of myself for my weaknesses and mistakes 
I blame myself all the time for my faults 
  
  
I blame myself for everything bad that happens 
*41. BDI9 
I do not have any thoughts of killing myself 
  
  
I have thoughts of killing myself but I would not carry them out 
I would like to kill myself 
  
  
I would like to kill myself if I had a chance 
*42. BDI10 
I do not cry more than usual 
I cry more than I used to 
I cry all the time now 
  
  
  
  
I used to be able to cry, but now I cannot cry even if I want to 
*43. BDI11 
I am no more irritated now than I ever am 
  
  
I get annoyed or irritated more easily than I used to 
I feel irritated all the time now 
  
I do not get irritated at all by the things that used to irritate me 
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*44. BDI12 
I have not lost interest in other people 
  
  
I am less interested in other people than I used to be 
I have lost most of my interest in other people 
I have lost all of my interest in other people 
  
  
*45. BDI13 
I make decisions about as well as I ever could 
I put off making decisions more than I used to 
  
  
  
I have greater difficulties in making decisions than before 
I cannot make decisions at all anymore 
  
*46. BDI14 
I do not feel I look any worse than I used to 
  
  
  
I am worried that I am looking old and unattractive 
I feel that there are permanent changes in my appearance that make me look unattractive 
I believe that I look ugly 
  
*47. BDI15 
I can work about as well as before 
  
  
It takes an extra effort to get started at doing something 
I have to push myself very hard to do anything 
I cannot do any work at all 
  
  
*48. BDI16 
I can sleep as well as usual 
  
  
  
  
I do not sleep as well as I used to 
I wake up 1-2 hours earlier than usual and find it hard to get back to sleep 
I wake up several hours earlier than I used to and cannot get back to sleep 
*49. BDI17 
I do not get more tired than usual 
  
  
  
I get tired more easily than I used to 
I get tired from doing almost anything 
I am too tired to do anything 
  
Trait Anxiety in SCD       
 
136 
 
*50. BDI18 
My appetite is no worse than usual 
  
  
My appetite is not as good as it used to be 
My appetite is much worse now 
I have no appetite anymore 
  
  
*51. BDI19 
I have not lost much weight, if any, lately 
I have lost more than 5 pounds 
  
  
  
  
I have lost more than 10 pounds 
I have lost more than 15 pounds 
I am purposely trying to lose weight by eating less, yes or no?  
*52. BDI20 
I am no more worried about my health than usual 
  
  
I am worried about physical problems such as aches and pains; or upset stomach; or constipation 
I am very worried about physical problems and it is hard to think of much else 
  
  
I am so worried about my physical problems that I cannot think about anything else 
*53. BDI21 
I have not noticed any recent change in my interest in sex 
I am less interested in sex than I used to be 
I am much less interested in sex now 
I have lost interest in sex completely 
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physical pain feels like. Each of the words in the left column describes a quality or 
characteristic that pain can have. So, for each pain quality in the left column, CHOOSE 
the response that tells how much of that specific quality your pain has. Rate every pain 
quality. 
None 
Throbbing 
Shooting 
Stabbing 
Sharp 
Cramping 
Gnawing 
Hot-burning 
Aching 
Heavy 
Tender 
Splitting 
Tiring-exhausting 
Sickening 
Fearful 
Punishing-cruel 
Mild Moderate Severe 
*54. The purpose of this checklist is for you to give us an idea about what your 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(no pain) to 10 (the worst possible pain). 
  
*55. Please choose the number that represents how bad your pain is right now from 0 
*56. Please choose the statement that best describes your present pain. 
0 no pain 
1 mild 
  
  
  
2 discomforting 
3 distressing 
4 horrible 
  
  
  
5 excruciating 
*57. Is your pain... 
Brief 
  
  
Intermittent 
Continuous 
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For each question, tick the answer that best applies to you.  
*58. In general, would you say your health is: 
Excellent 
  
  
Very Good 
Good 
Fair 
  
  
  
Poor 
*59. Compared to one year ago, how would you rate your health in general now? 
Much better now than one year ago 
  
  
Somewhat better now than one year ago 
About the same 
  
Somewhat worse now than one year ago 
Much worse now than one year ago 
  
  
your health now limit you in these activities? If so, how much? 
Yes, limited a lot 
Vigorous activities, such  
as running, lifting heavy  
objects, participating in  
strenuous sports 
Moderate activities, such  
as moving a table,  
pushing a vacuum  
cleaner, bowling, or  
playing golf 
Lifting or carrying  
groceries 
Climbing several flights of  
stairs 
Climbing one flight of  
stairs 
Bending, kneeling, or  
stooping 
Walking more than a mile 
Walking several blocks 
Walking one block 
Bathing or dressing  
yourself 
Yes, limited a little 
*60. The following items are about activities you might do during a typical day. Does 
No, not limited at all 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
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work or other regular daily activities as a result of your physical health? 
Yes 
Cut down the amount of  
time you spent on work or  
other activities 
Accomplished less than  
you would like 
Were limited in the kind of  
work or other activities 
Had difficulty performing  
the work or other activities  
(for example, it took extra  
effort) 
No 
*61. During the past 4 weeks, have you had any of the following problems with your 
  
 
 
 
 
 
 
work or other regular daily activities as a result of any emotional problems (such as 
feeling depressed or anxious)? 
Yes 
Cut down the amount of  
time you spent on work or  
other activities 
Accomplished less than  
you would like 
Didn't do work or other  
activities as carefully as  
usual 
No 
*62. During the past 4 weeks, have you had any of the following problems with your 
  
 
 
 
 
problems interfered with your normal social activities with family, friends, neighbors, or 
groups? 
Not at all 
Slightly 
  
  
  
*63. During the past 4 weeks, to what extent has your physical health or emotional 
Moderately 
Quite a bit 
Extremely 
  
  
*64. How much bodily pain have you had during the past 4 weeks? 
None 
  
  
Very mild 
Mild 
  
Moderate 
Severe 
  
  
Very severe 
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(including both work outside the home and housework)? 
Not at all 
  
  
  
*65. During the past 4 weeks, how much did pain interfere with your normal work 
A little bit 
Moderately 
Quite a bit 
Extremely 
  
  
during the past 4 weeks. For each question, please give the one answer that comes 
closest to the way you have been feeling. 
How much of the time during the past 4 weeks . . . 
All of the time 
Did you feel lively? 
Have you been a very  
nervous person? 
Have you felt so down in  
the dumps that nothing  
could cheer you up? 
Have you felt calm and  
peaceful? 
Did you have a lot of  
energy? 
Have you felt downhearted  
and blue? 
Did you feel worn out? 
Have you been a happy  
person? 
Did you feel tired? 
Most of the time 
A good bit of the  
time 
Some of the time A little of the time None of the time 
*66. These questions are about how you feel and how things have been with you 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
emotional problems interfered with your social activities (like visiting with friends, 
relatives, etc.)? 
All of the time 
  
  
  
  
*67. During the past 4 weeks, how much of the time has your physical health or 
Most of the time 
Some of the time 
A little of the time 
None of the time 
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*68. How TRUE or FALSE is each of the following statements for you. 
Definitely 
I seem to get sick a little  
easier than other people 
I am as healthy as  
anybody I know 
I expect my health to get  
worse 
My health is excellent 
Mostly true Don't know Mostly false Definitely false 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
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Opt-in for second part of the research 
OPT-INTO PHASE II of the study  
  
  
The first part of the study looked at how your mood affected your hospital admissions, pain and quality of life over the last year.   
  
The second part of the study aims to explore how your experiences of your disease/illness have affected your mood over the last year by asking  
you questions that the first part of the study did not ask or allow you to answer.   
  
If you feel that you have more to say about how your illness affects you and would be prepared to meet with the researcher for 50 minutes of  
your time for a confidential and anonymous interview in a safe and secure place, then please leave your email address and/or your contact  
phone number and I will get back to you when the first phase of the study is completed within the next 3-4 months.  
  
If you are not interested in taking part in the personal interviews then please move on to the next page.  
  
*Please note that you may withdraw from participating in phase II at any time without having to give any reasons.  
69. If you would like to participate in phase II of the study then please complete the 
boxes below. 
*you do not have to leave your contact phone number 
Forename 
Email address 
Contact phone number 
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*70. Where did you find out about this study? 
A support group 
A charity 
  
  
  
GP or other health professional 
Psychologist 
  
  
An NHS service 
Health forum 
  
  
  
Social media 
Word of mouth 
Through the researcher 
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Debriefing Page 
 
 
 
 
  
Debrief Page 
  
Thank you for participating in this research.  
This study is exploring how mood affects pain management and quality of life in chronic disease e.g. Sickle Cell Disease, thalassaemia, blood  
cancers and also in Carers.   
  
If you feel distressed after completing the questionnaire then there are some contact numbers and help lines that you can contact if you would  
like help with the distress.  
  
Pain helpline: Pain concern: 03001230789, www.painconcern.org.uk  
  
Sickle Cell Disease helpline: Sickle Cell society: 020 8961 7795, www.sicklecellsociety.org  
  
Cancer Help UK helpline: 0808 800 4040, www.cancerhelp.org.uk  
  
Carers helpline: Carers UK: 0808 808 7777, www.carersuk.org  
  
List of psychologists in your area: http://www.bps.org.uk/psychology-public/find-psychologist/find-psychologist  
  
  
Your data will be anonymous unless you wish to participate in the second phase of the study. The primary researcher will be the only person  
who has access to the data.   
All the data will be kept electronically for 3 years after the conclusion of the study on a password protected external hard-drive.   
You are not obliged to take part in this study. You are free to withdraw at any time. Should you choose to withdraw from the study you may do  
so without any consequences.   
  
If you have any queries about the study, then please contact me, Dede-Kossi Osakonor at u1019289@uel.ac.uk.  
  
If you have any questions or concerns about how the study has been conducted, please contact the study’s supervisor: Dr Meredith Terlecki,  
School of Psychology, University of East London, Water Lane, London E15 4LZ, +44 (0)20 8223 4463, m.terlecki@uel.ac.uk   
Or  
Chair of the School of Psychology Research Ethics Sub-committee: Dr. Mark Finn, School of Psychology, University of East London, Water  
Lane, London E15 4LZ, 020 8223 4493, m.finn@uel.ac.uk   
  
Thank you for your time and for participating in this study.  
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Appendix D 
Interview Outline 
 
Interview Outline 
1. 
 
 
 
 
 
2. 
 
 
 
 
 
3. 
 
 
 
 
 
4. 
General experience of pain 
How would you describe your pain? 
What makes your pain worse? 
What helps to alleviate your pain? 
How does it affect your day to day life? 
What do you think it means when you experience general pain? 
General anxiety 
How would you describe your anxiety? 
What causes you to feel more anxious? 
Is there anything that reduces your anxiety? 
How do you think your anxiety affects your pain? 
How do you think your anxiety affects your general health? 
General low mood 
How would you describe your low mood? 
What causes you to feel low? 
What helps your mood to improve? 
How does your low mood affect your pain? 
How does your low mood affect your general health? 
General questions 
When you have experienced general pain, have you become more conscious 
of what is happening in your body? If so, what percentage of time would you 
say you are pre-occupied by the pain? 
How has your experience of pain, anxiety or low mood changed over time? 
What does having this illness mean to you about your identity? 
Is there anything else you would like to tell me about your illness? 
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Appendix E 
MANOVA analyses with unequal group sizes 
(SCD = 28; BC = 8; Carers = 15) 
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The MANOVA conducted to evaluate between-group differences in trait 
anxiety and depression scores across the unequal groups showed that Box’s test of 
equality covariance matrices was significant at p = .020, indicating the covariance 
matrices were unequal, thus violating the conditions of the MANOVA. The result of 
the overall MANOVA was significant and has been included in Table 7. Bonferroni 
post hoc pairwise comparisons showed that the BC group reported significantly 
higher trait anxiety scores (M = 56.63, SD = 11.58) relative to the Carers (M = 44.60, 
SD = 12.75; p = .077). There was no significant difference in the trait anxiety scores 
between the SCD group (M = 50.07, SD = 11.58) and the BC group (M = 56.63, SD 
= 11.58; p = .531), or between the SCD group (M = 50.07, SD = 11.58) and the 
Carers (M = 44.60, SD = 12.75; p = .475). With regard to depression scores, the BC 
group also reported higher depression scores (M = 33.63, SD = 17.44) than both the 
SCD group (M = 18.54; SD = 11.63; p = .011) and the Carers group (M = 11.80, SD 
= 10.21; p = .001). There was no significant difference in depression scores between 
the SCD group (M = 18.54; SD = 11.63) and the Carers group (M = 11.80, SD = 
10.21; p = .279). In summary these results from the unequal MANOVA, whilst 
violating the conditions of the MANOVA, were still consistent with MANOVA 1 
reported in the quantitative results section. 
The MANOVA conducted to evaluate between-group differences in sensory 
and affective pain scores across the unequal groups showed that Box’s test of 
equality of covariance matrices was not significant at p = .714, indicating the 
covariance matrices were not unequal. The result of the overall MANOVA was 
significant and has been included in Table 7. Bonferroni post hoc pairwise 
comparisons showed that the SCD group reported significantly higher sensory pain 
scores (M = 16.29, SD = 6.98) relative to the Carers (M = 5.27, SD = 7.81; p = .001). 
There were no significant differences in sensory pain between the SCD group (M = 
16.29, SD = 6.98) and the BC group (M = 11.63, SD = 11.07; p = .449), or between 
the BC group (M = 11.63, SD = 11.07) and the Carers (M = 5.27, SD = 7.81; p = 
.221). These findings were consistent with the findings from MANOVA 2. The 
difference between MANOVA 2 and this current MANOVA was that there was a 
significant difference reported in the affective pain scores. The Bonferroni post hoc 
pairwise comparisons showed that the SCD group reported significantly higher 
affective pain scores (M = 5.18, SD = 3.27) than the Carers (M = 2.07, SD = 3.35; p 
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= .028), but not significantly different from the BC group (M = 3.75, SD = 4.98; p = 
.978). In summary, the sensory pain results from this MANOVA were consistent with 
the results from MANOVA 2; however the affective pain results which were 
insignificant in MANOVA 2 were significant for the unequal groups MANOVA. 
The MANOVA conducted to evaluate between-group differences in quality of 
life subscale scores (physical health limitations, emotional health limitations, fatigue, 
emotional wellbeing, social functioning and general health) across the unequal 
groups showed that Box’s test of equality covariance matrices was significant at p = 
.012, indicating the covariance matrices were unequal, thus violating the conditions 
of the MANOVA. The result of the overall MANOVA was significant and has been 
included in Table 7. Bonferroni post hoc pairwise comparisons showed that there 
was no significant difference in fatigue between the SCD group (M = 124.29, SD = 
93.07) and the BC group (M = 65.00, SD = 70.71; p = .347). The SCD group had 
more physical health limitations (M = 103.57, SD = 147.78) than the Carers (M = 
273.33, SD = 186.96; p = .007). Both the SCD group (M = 80.36, SD = 55.43; p = 
.005) and the BC group (M = 62.50, SD = 42.56; p = .008) had lower social 
functioning scores than the Carers (M = 138.33, SD = 58.18). Both the SCD group 
(M = 131.25, SD = 106.85; p = .001) and the BC group (M = 103.13, SD = 86.02; p = 
.001) had lower general health scores than the Carers (M = 305.00, SD = 132.02). In 
summary, there were no group differences between the SCD group and the BC 
group, but there were group differences between both these groups and the Carers 
in physical health limitations, social functioning and general health scores in this 
MANOVA that were slightly different to the findings from MANOVA 3. In addition, 
there were no group differences in fatigue scores in this MANOVA compared to 
MANOVA 3.  
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Table 7 
Multivariate Analysis of Variance results for unequal Illness Groups and DVs 
(mood, pain intensity, quality of life) (SCD, n = 28; BC, n = 8; Carers, n = 15) 
 Pillai’s 
Trace 
df1 df2 
Multivariate 
F 
d p 
Mood 
(STAI-
T) & 
(BDI-II) 
.270 4 96 3.75 .156 .007** 
 Wilks’ 
Lambda 
     
Pain 
Intensity 
(SF-
MPQ) 
.698 4 96 4.64 .178 .002** 
 Pillai’s 
Trace 
     
Quality 
of Life 
(SF-36) 
.500 12 88 2.45 .333 .009** 
Note. * p < .05, ** p < .01; STAI = State-Trait Anxiety Inventory (Spielberger et al., 
1983); BDI-II = Beck Depression Inventory II (Beck et al., 1996); SF- MPQ = Short 
Form McGill Pain Questionnaire (Melzack, 1987); SF – 36 = Short Form Health 
Survey 36 (Ware & Sherbourne, 1992).  
 
 
 
